activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	161209	CHEMBL767400	Inhibition of Protein kinase C eta	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)Cc3ccc(CNC(CO)CO)cc3)s2)o1		CHEMBL300936	=	IC50	nM	35000.0	CHEMBL3616	Homo sapiens	IC50	nM	35000.0
	161209	CHEMBL767400	Inhibition of Protein kinase C eta	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)Cc3ccc(CNC(CO)CO)cc3)s2)o1		CHEMBL300936	=	IC50	nM	35000.0	CHEMBL3616	Homo sapiens	IC50	nM	35000.0
	182060	CHEMBL767400	Inhibition of Protein kinase C eta	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	IC50	nM	45000.0	CHEMBL3616	Homo sapiens	IC50	nM	45000.0
	193002	CHEMBL767397	Inhibition of human protein kinase C eta	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	22.0	CHEMBL3616	Homo sapiens	IC50	uM	0.022
	207176	CHEMBL767397	Inhibition of human protein kinase C eta	B	O=C(N[C@@H]1CNC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL59828	=	IC50	nM	4.0	CHEMBL3616	Homo sapiens	IC50	uM	0.004
	217790	CHEMBL767397	Inhibition of human protein kinase C eta	B	O=C(N[C@@H]1CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL52529	=	IC50	nM	0.6	CHEMBL3616	Homo sapiens	IC50	uM	0.0006
	218989	CHEMBL767397	Inhibition of human protein kinase C eta	B	O=C(N[C@@H]1CNCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL67442	=	IC50	nM	80.0	CHEMBL3616	Homo sapiens	IC50	uM	0.08
	221449	CHEMBL767397	Inhibition of human protein kinase C eta	B	O=C(N[C@@H]1CCCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL304549	=	IC50	nM	60.0	CHEMBL3616	Homo sapiens	IC50	uM	0.06
	226779	CHEMBL770095	Inhibition of Protein kinase C eta	B	CCN1CCC(n2cc(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc32)CC1		CHEMBL54382	=	IC50	nM	40.0	CHEMBL3616	Homo sapiens	IC50	uM	0.04
	233208	CHEMBL770095	Inhibition of Protein kinase C eta	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1.CS(=O)(=O)O		CHEMBL432130	=	IC50	nM	52.0	CHEMBL3616	Homo sapiens	IC50	uM	0.052
	247740	CHEMBL770095	Inhibition of Protein kinase C eta	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccc5)C4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL291975	=	IC50	nM	42.0	CHEMBL3616	Homo sapiens	IC50	uM	0.042
	249197	CHEMBL770095	Inhibition of Protein kinase C eta	B	Cn1cc(C2=C(c3cn(C4CCNCC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL55788	=	IC50	nM	200.0	CHEMBL3616	Homo sapiens	IC50	uM	0.2
	250570	CHEMBL770095	Inhibition of Protein kinase C eta	B	CC(C)N1CCC(n2cc(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc32)CC1		CHEMBL301860	=	IC50	nM	130.0	CHEMBL3616	Homo sapiens	IC50	uM	0.13
	251945	CHEMBL770095	Inhibition of Protein kinase C eta	B	CN1CCC(n2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)CC1		CHEMBL52654	=	IC50	nM	40.0	CHEMBL3616	Homo sapiens	IC50	uM	0.04
	254636	CHEMBL770095	Inhibition of Protein kinase C eta	B	Cn1cc(C2=C(c3cn(C4CCN(CC5CC5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL55394	=	IC50	nM	50.0	CHEMBL3616	Homo sapiens	IC50	uM	0.05
	256029	CHEMBL770095	Inhibition of Protein kinase C eta	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	IC50	nM	400.0	CHEMBL3616	Homo sapiens	IC50	uM	0.4
	257378	CHEMBL770095	Inhibition of Protein kinase C eta	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccc5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300549	=	IC50	nM	500.0	CHEMBL3616	Homo sapiens	IC50	uM	0.5
	257391	CHEMBL770095	Inhibition of Protein kinase C eta	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.0	CHEMBL3616	Homo sapiens	IC50	uM	0.005
	258775	CHEMBL770095	Inhibition of Protein kinase C eta	B	CN1CCC(n2cc(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc32)CC1		CHEMBL53596	=	IC50	nM	50.0	CHEMBL3616	Homo sapiens	IC50	uM	0.05
	262667	CHEMBL770095	Inhibition of Protein kinase C eta	B	Cn1cc(C2=C(c3cn(C4CCN(C(=O)OC(C)(C)C)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL293805	=	IC50	nM	8000.0	CHEMBL3616	Homo sapiens	IC50	uM	8.0
	265159	CHEMBL767401	Inhibition of Protein kinase C eta	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	273997	CHEMBL767401	Inhibition of Protein kinase C eta	B	CN(C(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)[C@H]1CCCNC[C@H]1NC(=O)c1ccc(O)cc1		CHEMBL2310935	=	IC50	nM	31000.0	CHEMBL3616	Homo sapiens	IC50	uM	31.0
	276559	CHEMBL767401	Inhibition of Protein kinase C eta	B	O=C(N[C@@H]1CNC[C@H]1NC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL59677	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	278922	CHEMBL767401	Inhibition of Protein kinase C eta	B	O=C(N[C@@H]1CNC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL59828	=	IC50	nM	4.0	CHEMBL3616	Homo sapiens	IC50	uM	0.004
	284843	CHEMBL767401	Inhibition of Protein kinase C eta	B	C[C@@]1(OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)CCCNC[C@H]1NC(=O)c1ccc(O)cc1		CHEMBL433101	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	289626	CHEMBL767401	Inhibition of Protein kinase C eta	B	O=C(NC[C@@H]1CCC[C@H]1NC(=O)c1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL293500	=	IC50	nM	2300.0	CHEMBL3616	Homo sapiens	IC50	uM	2.3
	294631	CHEMBL767401	Inhibition of Protein kinase C eta	B	O=C(N[C@@H]1CCCNC[C@H]1NC(=O)c1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL59687	=	IC50	nM	50.0	CHEMBL3616	Homo sapiens	IC50	uM	0.05
	294639	CHEMBL767401	Inhibition of Protein kinase C eta	B	O=C(N[C@@H]1CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL52529	=	IC50	nM	1.0	CHEMBL3616	Homo sapiens	IC50	uM	0.001
	297269	CHEMBL767401	Inhibition of Protein kinase C eta	B	O=C(N[C@@H]1CCC[C@H]1OCc1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL294303	=	IC50	nM	30.0	CHEMBL3616	Homo sapiens	IC50	uM	0.03
	299841	CHEMBL767401	Inhibition of Protein kinase C eta	B	O=C(N[C@@H]1CCC[C@H]1COC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60455	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	303409	CHEMBL767401	Inhibition of Protein kinase C eta	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	308756	CHEMBL772568	Displacement of [3H]PDBu from protein kinase C eta-C1A domain	B	CCCCCCCCCCCN1c2ccccc2C[C@@H](CO)OC(=O)[C@@H]1C(C)C		CHEMBL102991	=	Ki	nM	6330.0	CHEMBL3616	Homo sapiens	Ki	nM	6330.0
	308757	CHEMBL772570	Displacement of [3H]PDBu from protein kinase C eta-C1B domain	B	CCCCCCCCCCCN1c2ccccc2C[C@@H](CO)OC(=O)[C@@H]1C(C)C		CHEMBL102991	=	Ki	nM	189.0	CHEMBL3616	Homo sapiens	Ki	nM	189.0
	308770	CHEMBL857602	Binding affinity for protein kinase C eta-C1A domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	4.3	CHEMBL3616	Homo sapiens	Kd	nM	4.3
	308771	CHEMBL772569	Binding affinity for protein kinase C eta-C1B domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	0.45	CHEMBL3616	Homo sapiens	Kd	nM	0.45
	312755	CHEMBL772568	Displacement of [3H]PDBu from protein kinase C eta-C1A domain	B	CCCCCCCCCCc1ccc2c(c1)N(C)[C@@H](C(C)C)C(=O)O[C@H](CO)C2		CHEMBL102858	=	Ki	nM	1590.0	CHEMBL3616	Homo sapiens	Ki	nM	1590.0
	312756	CHEMBL772570	Displacement of [3H]PDBu from protein kinase C eta-C1B domain	B	CCCCCCCCCCc1ccc2c(c1)N(C)[C@@H](C(C)C)C(=O)O[C@H](CO)C2		CHEMBL102858	=	Ki	nM	37.0	CHEMBL3616	Homo sapiens	Ki	nM	37.0
	330329	CHEMBL772568	Displacement of [3H]PDBu from protein kinase C eta-C1A domain	B	CCCCCCCCCCc1cccc2c1C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL103091	=	Ki	nM	4250.0	CHEMBL3616	Homo sapiens	Ki	nM	4250.0
	330330	CHEMBL772570	Displacement of [3H]PDBu from protein kinase C eta-C1B domain	B	CCCCCCCCCCc1cccc2c1C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL103091	=	Ki	nM	111.0	CHEMBL3616	Homo sapiens	Ki	nM	111.0
	330343	CHEMBL772568	Displacement of [3H]PDBu from protein kinase C eta-C1A domain	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL318971	>	Ki	nM	10000.0	CHEMBL3616	Homo sapiens	Ki	nM	10000.0
	330344	CHEMBL772570	Displacement of [3H]PDBu from protein kinase C eta-C1B domain	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL318971	=	Ki	nM	120.0	CHEMBL3616	Homo sapiens	Ki	nM	120.0
	396158	CHEMBL767402	Inhibition of Protein kinase C eta	B	O=C(NC1CN2CCC(CC2)C1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL306884	=	IC50	nM	26.0	CHEMBL3616	Homo sapiens	IC50	uM	0.026
	397397	CHEMBL767402	Inhibition of Protein kinase C eta	B	O=C(NC1CCC[C@@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL71331	=	IC50	nM	1.0	CHEMBL3616	Homo sapiens	IC50	uM	0.001
	402633	CHEMBL767402	Inhibition of Protein kinase C eta	B	O=C(N[C@@H]1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL311399	=	IC50	nM	22.0	CHEMBL3616	Homo sapiens	IC50	uM	0.022
	403973	CHEMBL767402	Inhibition of Protein kinase C eta	B	O=C(NC1C2CCC(C2)C1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL305667	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	413932	CHEMBL767402	Inhibition of Protein kinase C eta	B	CN1C2CCC1C(NC(=O)c1ccc(O)cc1)C(OC(=O)c1cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c1)C2		CHEMBL306883	=	IC50	nM	2500.0	CHEMBL3616	Homo sapiens	IC50	uM	2.5
	418755	CHEMBL767402	Inhibition of Protein kinase C eta	B	O=C(NC1C2CCC(C2)C1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL305667	=	IC50	nM	4500.0	CHEMBL3616	Homo sapiens	IC50	uM	4.5
	418764	CHEMBL767402	Inhibition of Protein kinase C eta	B	O=C(NC1C2CC(C3CCCC32)C1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL72480	=	IC50	nM	50.0	CHEMBL3616	Homo sapiens	IC50	uM	0.05
	419951	CHEMBL767402	Inhibition of Protein kinase C eta	B	O=C(NC1CN2CCC(CC2)C1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL306884	=	IC50	nM	490.0	CHEMBL3616	Homo sapiens	IC50	uM	0.49
	419960	CHEMBL767402	Inhibition of Protein kinase C eta	B	O=C(NC1C2CC(C3CCCC32)C1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL72480	=	IC50	nM	1900.0	CHEMBL3616	Homo sapiens	IC50	uM	1.9
	422834	CHEMBL767402	Inhibition of Protein kinase C eta	B	CN1C2CCC1C(NC(=O)c1ccc(O)cc1)C(OC(=O)c1cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c1)C2		CHEMBL306883	=	IC50	nM	2800.0	CHEMBL3616	Homo sapiens	IC50	uM	2.8
	426593	CHEMBL767402	Inhibition of Protein kinase C eta	B	O=C(NC1CNC[C@@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL422056	=	IC50	nM	4.0	CHEMBL3616	Homo sapiens	IC50	uM	0.004
	429124	CHEMBL767402	Inhibition of Protein kinase C eta	B	CC1(C)C2CCC1(C)C(OC(=O)c1cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c1)C2NC(=O)c1ccc(O)cc1		CHEMBL306170	=	IC50	nM	310.0	CHEMBL3616	Homo sapiens	IC50	uM	0.31
	489540	CHEMBL772754	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C eta C1a domain	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL318971	>	Ki	nM	10000.0	CHEMBL3616	Homo sapiens	Ki	nM	10000.0
	489541	CHEMBL772567	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C eta C1b domain	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL318971	=	Ki	nM	119.9	CHEMBL3616	Homo sapiens	Ki	nM	119.9
	506214	CHEMBL772754	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C eta C1a domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	3770.0	CHEMBL3616	Homo sapiens	Ki	nM	3770.0
	506215	CHEMBL772567	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C eta C1b domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	5.5	CHEMBL3616	Homo sapiens	Ki	nM	5.5
	507443	CHEMBL772754	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C eta C1a domain	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL28205	=	Ki	nM	2489.0	CHEMBL3616	Homo sapiens	Ki	nM	2489.0
	507444	CHEMBL772567	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C eta C1b domain	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL28205	=	Ki	nM	6.4	CHEMBL3616	Homo sapiens	Ki	nM	6.4
	611255	CHEMBL770099	Inhibition of human protein kinase C eta	B	O=C(N[C@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL307747	=	IC50	nM	22.0	CHEMBL3616	Homo sapiens	IC50	uM	0.022
	615197	CHEMBL770099	Inhibition of human protein kinase C eta	B	O=C(N[C@H]1CSCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL67788	=	IC50	nM	100.0	CHEMBL3616	Homo sapiens	IC50	uM	0.1
	615205	CHEMBL770099	Inhibition of human protein kinase C eta	B	O=C(N[C@H]1CS(=O)(=O)CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL303205	=	IC50	nM	830.0	CHEMBL3616	Homo sapiens	IC50	uM	0.83
	616490	CHEMBL770099	Inhibition of human protein kinase C eta	B	O=C(N[C@H]1CCCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL302998	=	IC50	nM	60.0	CHEMBL3616	Homo sapiens	IC50	uM	0.06
	625264	CHEMBL770099	Inhibition of human protein kinase C eta	B	O=C(N[C@H]1COCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL70078	=	IC50	nM	10.0	CHEMBL3616	Homo sapiens	IC50	uM	0.01
	754645	CHEMBL770092	Inhibition of Protein kinase C eta expressed in Sf-9 cells	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	22.0	CHEMBL3616	Homo sapiens	IC50	uM	0.022
	755783	CHEMBL770092	Inhibition of Protein kinase C eta expressed in Sf-9 cells	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL66923	=	IC50	nM	4.0	CHEMBL3616	Homo sapiens	IC50	uM	0.004
	756889	CHEMBL770092	Inhibition of Protein kinase C eta expressed in Sf-9 cells	B	CC(C)(C)C(=O)OCOC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CNC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL304175	=	IC50	nM	4.0	CHEMBL3616	Homo sapiens	IC50	uM	0.004
	758130	CHEMBL770092	Inhibition of Protein kinase C eta expressed in Sf-9 cells	B	CCOC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL66452	=	IC50	nM	52.0	CHEMBL3616	Homo sapiens	IC50	uM	0.052
	760153	CHEMBL770092	Inhibition of Protein kinase C eta expressed in Sf-9 cells	B	O=C(N[C@@H]1CNC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)OCC2CCCCC2)c(O)c1)c1ccc(O)cc1		CHEMBL302304	=	IC50	nM	50.0	CHEMBL3616	Homo sapiens	IC50	uM	0.05
	762307	CHEMBL770092	Inhibition of Protein kinase C eta expressed in Sf-9 cells	B	O=C(N[C@@H]1CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL52529	=	IC50	nM	0.6	CHEMBL3616	Homo sapiens	IC50	uM	0.0006
Not Active	763423	CHEMBL770093	Inhibition of Protein kinase C eta expressed in Sf-9 cells (inactive)	B	CC(C)(C)C(=O)OCOC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL67980		IC50	nM		CHEMBL3616	Homo sapiens	IC50	uM	
	764592	CHEMBL767403	Binding affinity for Protein kinase C eta C1a domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	4.3	CHEMBL3616	Homo sapiens	Kd	nM	4.3
	764593	CHEMBL767406	Binding affinity for Protein kinase C eta C1b domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	0.45	CHEMBL3616	Homo sapiens	Kd	nM	0.45
	768949	CHEMBL770092	Inhibition of Protein kinase C eta expressed in Sf-9 cells	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CNC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL304626	=	IC50	nM	16.0	CHEMBL3616	Homo sapiens	IC50	uM	0.016
	768955	CHEMBL770092	Inhibition of Protein kinase C eta expressed in Sf-9 cells	B	CC(C)COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CNC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL68418	=	IC50	nM	50.0	CHEMBL3616	Homo sapiens	IC50	uM	0.05
	769090	CHEMBL767405	Displacement of [3H]- PDBu from Protein kinase C eta C1a domain	B	CC(C)[C@H]1/C(S)=N/[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL63262	=	Ki	nM	2160.0	CHEMBL3616	Homo sapiens	Ki	nM	2160.0
	769091	CHEMBL767407	Displacement of [3H]- PDBu from Protein kinase C eta C1b domain	B	CC(C)[C@H]1/C(S)=N/[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL63262	=	Ki	nM	20.6	CHEMBL3616	Homo sapiens	Ki	nM	20.6
	770048	CHEMBL767405	Displacement of [3H]- PDBu from Protein kinase C eta C1a domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	3770.0	CHEMBL3616	Homo sapiens	Ki	nM	3770.0
	770049	CHEMBL767407	Displacement of [3H]- PDBu from Protein kinase C eta C1b domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	5.5	CHEMBL3616	Homo sapiens	Ki	nM	5.5
	776747	CHEMBL770092	Inhibition of Protein kinase C eta expressed in Sf-9 cells	B	CCOC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CNC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL307543	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	780232	CHEMBL770092	Inhibition of Protein kinase C eta expressed in Sf-9 cells	B	CCCCOC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CNC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL66750	=	IC50	nM	40.0	CHEMBL3616	Homo sapiens	IC50	uM	0.04
	785845	CHEMBL770092	Inhibition of Protein kinase C eta expressed in Sf-9 cells	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL66923	=	IC50	nM	30.0	CHEMBL3616	Homo sapiens	IC50	uM	0.03
	785852	CHEMBL770092	Inhibition of Protein kinase C eta expressed in Sf-9 cells	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL66923	=	IC50	nM	400.0	CHEMBL3616	Homo sapiens	IC50	uM	0.4
	785858	CHEMBL770092	Inhibition of Protein kinase C eta expressed in Sf-9 cells	B	CC(C)OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL431568	=	IC50	nM	260.0	CHEMBL3616	Homo sapiens	IC50	uM	0.26
	786999	CHEMBL770092	Inhibition of Protein kinase C eta expressed in Sf-9 cells	B	O=C(N[C@@H]1CNC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL59828	=	IC50	nM	4.0	CHEMBL3616	Homo sapiens	IC50	uM	0.004
	788138	CHEMBL770092	Inhibition of Protein kinase C eta expressed in Sf-9 cells	B	CC(=O)OCOC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CNC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL67528	=	IC50	nM	14.0	CHEMBL3616	Homo sapiens	IC50	uM	0.014
	789705	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	N[C@@H]1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL432168	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	793582	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	NC[C@H]1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL307708	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	794652	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1CN2CCC(CC2)[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL78129	=	IC50	nM	26.0	CHEMBL3616	Homo sapiens	IC50	uM	0.026
	794661	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1CC(C(=O)C(F)(F)F)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL262980	<	IC50	nM	10.0	CHEMBL3616	Homo sapiens	IC50	uM	0.01
	795787	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	CC(=O)C1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL441802	=	IC50	nM	30.0	CHEMBL3616	Homo sapiens	IC50	uM	0.03
	798001	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1COCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL306373	=	IC50	nM	10.0	CHEMBL3616	Homo sapiens	IC50	uM	0.01
	798010	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1CNCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL67442	=	IC50	nM	90.0	CHEMBL3616	Homo sapiens	IC50	uM	0.09
	798019	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1C[C@H](CO)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL75661	=	IC50	nM	2.0	CHEMBL3616	Homo sapiens	IC50	uM	0.002
	800441	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1C[C@@H](CO)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL75004	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	804154	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1CC(O)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL306580	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	809510	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1CNC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL59828	=	IC50	nM	4.0	CHEMBL3616	Homo sapiens	IC50	uM	0.004
	809519	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	CC1(C)C2CCC1(C)[C@@H](OC(=O)c1cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c1)[C@@H]2NC(=O)c1ccc(O)cc1		CHEMBL309078	=	IC50	nM	310.0	CHEMBL3616	Homo sapiens	IC50	uM	0.31
	810671	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	CN1C2CCC1C(NC(=O)c1ccc(O)cc1)C(OC(=O)c1cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c1)C2		CHEMBL306883	=	IC50	nM	2800.0	CHEMBL3616	Homo sapiens	IC50	uM	2.8
	811840	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1CSCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL76537	=	IC50	nM	100.0	CHEMBL3616	Homo sapiens	IC50	uM	0.1
	811849	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1CS(=O)(=O)CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL305718	=	IC50	nM	800.0	CHEMBL3616	Homo sapiens	IC50	uM	0.8
	813177	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@H]1CNCCC[C@@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL77970	=	IC50	nM	260.0	CHEMBL3616	Homo sapiens	IC50	uM	0.26
	813186	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1CCCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL304549	=	IC50	nM	60.0	CHEMBL3616	Homo sapiens	IC50	uM	0.06
	813195	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	COC(=O)C1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL77399	=	IC50	nM	90.0	CHEMBL3616	Homo sapiens	IC50	uM	0.09
	818009	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	CC(C)C1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL76920	=	IC50	nM	4.0	CHEMBL3616	Homo sapiens	IC50	uM	0.004
	818018	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	CNC(=O)C1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL312067	=	IC50	nM	130.0	CHEMBL3616	Homo sapiens	IC50	uM	0.13
	820330	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL52529	=	IC50	nM	1.0	CHEMBL3616	Homo sapiens	IC50	uM	0.001
	820339	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	CS(=O)(=O)C1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL306623	=	IC50	nM	62.0	CHEMBL3616	Homo sapiens	IC50	uM	0.062
	821383	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1C2CCC(C2)[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL80525	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	821392	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1C2CC(C3CCCC32)[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL263910	=	IC50	nM	50.0	CHEMBL3616	Homo sapiens	IC50	uM	0.05
	822483	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	823723	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(N[C@@H]1C[C@@H](O)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL309034	=	IC50	nM	4.0	CHEMBL3616	Homo sapiens	IC50	uM	0.004
	826272	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	O=C(NC1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL49354	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	826280	CHEMBL770096	Inhibitory concentration against recombinant human Protein kinase C eta isozyme	B	NC[C@@H]1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL308263	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	866924	CHEMBL767404	Displacement of 3[H]PDBu from Protein kinase C eta C1a domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@@H]3C(=O)C(C)=C[C@H]32)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL265998	=	Ki	nM	14.9	CHEMBL3616	Homo sapiens	Ki	nM	14.9
	866925	CHEMBL767408	Displacement of 3[H]PDBu from Protein kinase C eta C1b domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@@H]3C(=O)C(C)=C[C@H]32)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL265998	=	Ki	nM	0.35	CHEMBL3616	Homo sapiens	Ki	nM	0.35
	902317	CHEMBL767404	Displacement of 3[H]PDBu from Protein kinase C eta C1a domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Ki	nM	10.2	CHEMBL3616	Homo sapiens	Ki	nM	10.2
	902318	CHEMBL767408	Displacement of 3[H]PDBu from Protein kinase C eta C1b domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Ki	nM	0.95	CHEMBL3616	Homo sapiens	Ki	nM	0.95
	907699	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(OC1CCCC1Oc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL48988	=	IC50	nM	10.0	CHEMBL3616	Homo sapiens	IC50	uM	0.01
	908800	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(OC[C@@H](Cc1ccc(O)cc1)NS(=O)(=O)c1ccccc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL345767	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	908808	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(OCCCc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL151800	<	IC50	nM	50.0	CHEMBL3616	Homo sapiens	IC50	uM	0.05
	910233	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	CC(CCc1ccc(O)cc1)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL148745	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	912845	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(OCC(Cc1ccc(O)cc1)NS(=O)(=O)c1ccc2ccccc2c1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL151823	=	IC50	nM	35000.0	CHEMBL3616	Homo sapiens	IC50	uM	35.0
	920400	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC2CNCC2Cc2ccc(O)cc2)cc1O		CHEMBL48546	=	IC50	nM	500.0	CHEMBL3616	Homo sapiens	IC50	uM	0.5
	921560	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)OCCCc2ccc(O)cc2)cc1O		CHEMBL149313	=	IC50	nM	170.0	CHEMBL3616	Homo sapiens	IC50	uM	0.17
	924031	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(OC1CNCC1Cc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL300422	=	IC50	nM	4300.0	CHEMBL3616	Homo sapiens	IC50	uM	4.3
	925525	CHEMBL772752	Inhibition of recombinant human Protein kinase C eta	B	O=C(OCC(NS(=O)(=O)c1ccccc1)c1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL150422	=	3.3	uM	3.3	CHEMBL3616	Homo sapiens	3.3	uM	3.3
	928343	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(NC1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL49354	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	928351	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	Cc1ccc(S(=O)(=O)N2CCC[C@@H](OC(=O)c3cc(O)c(C(=O)c4c(O)cccc4C(=O)O)c(O)c3)[C@H](NC(=O)c3ccc(O)cc3)C2)cc1		CHEMBL146846	=	IC50	nM	100.0	CHEMBL3616	Homo sapiens	IC50	uM	0.1
	928359	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(OCC(Cc1ccc(O)cc1)NS(=O)(=O)c1ccccc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL358264	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	930974	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(NC1CCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL48636	=	IC50	nM	0.6	CHEMBL3616	Homo sapiens	IC50	uM	0.0006
	930982	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(NC(COC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)Cc1ccc(O)cc1)c1ccc(O)cc1		CHEMBL151731	=	IC50	nM	2300.0	CHEMBL3616	Homo sapiens	IC50	uM	2.3
	932337	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(NC(COC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)Cc1ccc(O)cc1)c1ccccc1		CHEMBL343362	=	IC50	nM	18000.0	CHEMBL3616	Homo sapiens	IC50	uM	18.0
	933782	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(OCCCCc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL439996	=	IC50	nM	250.0	CHEMBL3616	Homo sapiens	IC50	uM	0.25
	935235	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(NCCOC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL149873	=	IC50	nM	230.0	CHEMBL3616	Homo sapiens	IC50	uM	0.23
	936660	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(OC1CCCC1Cc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL295806	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	938253	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	CN(C)C(COC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)Cc1ccc(O)cc1		CHEMBL421790	=	IC50	nM	1400.0	CHEMBL3616	Homo sapiens	IC50	uM	1.4
	938261	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(OCC(COc1ccc(O)cc1)NS(=O)(=O)c1ccccc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL150264	=	IC50	nM	500.0	CHEMBL3616	Homo sapiens	IC50	uM	0.5
	939399	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	CS(=O)(=O)NC(COC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)Cc1ccc(O)cc1		CHEMBL149604	=	IC50	nM	390.0	CHEMBL3616	Homo sapiens	IC50	uM	0.39
	939407	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(OC1CCCC1Cc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL295806	=	IC50	nM	10.0	CHEMBL3616	Homo sapiens	IC50	uM	0.01
	939415	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC2CCCC2Cc2ccc(O)cc2)cc1O		CHEMBL48665	=	IC50	nM	40.0	CHEMBL3616	Homo sapiens	IC50	uM	0.04
	939425	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	942033	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC[C@@H](Cc2ccc(O)cc2)NS(=O)(=O)c2ccccc2)cc1O		CHEMBL146847	<	IC50	nM	50.0	CHEMBL3616	Homo sapiens	IC50	uM	0.05
	945938	CHEMBL772753	Evaluated against recombinant human Protein kinase C eta	B	O=C(OC[C@H](Cc1ccc(O)cc1)NS(=O)(=O)c1ccccc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL151822	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	953102	CHEMBL772751	Inhibition of Protein kinase C eta	B	Nc1nccc(-c2c[nH]c3c(Br)ccc(O)c23)n1		CHEMBL296682	=	IC50	nM	1300.0	CHEMBL3616	Homo sapiens	IC50	uM	1.3
	990895	CHEMBL758469	Inhibition of protein kinase C eta	B	O=C(N[C@@H]1c2ccccc2CC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL177308	<	IC50	nM	10.0	CHEMBL3616	Homo sapiens	IC50	uM	0.01
	993188	CHEMBL758469	Inhibition of protein kinase C eta	B	O=C(N[C@@H]1CNCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL177635	=	IC50	nM	4.0	CHEMBL3616	Homo sapiens	IC50	uM	0.004
	995780	CHEMBL758469	Inhibition of protein kinase C eta	B	O=C(N[C@@H]1Cc2ccccc2C1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL367162	<	IC50	nM	25.0	CHEMBL3616	Homo sapiens	IC50	uM	0.025
	1001897	CHEMBL770094	Inhibition of Protein kinase C eta	B	O=C(NC1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL49354	<	IC50	nM	100.0	CHEMBL3616	Homo sapiens	IC50	uM	0.1
	1004354	CHEMBL758469	Inhibition of protein kinase C eta	B	O=C(N[C@@H]1CCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL427118	=	IC50	nM	0.6	CHEMBL3616	Homo sapiens	IC50	uM	0.0006
	1004492	CHEMBL770094	Inhibition of Protein kinase C eta	B	O=C(N[C@H]1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL367488	=	IC50	nM	260.0	CHEMBL3616	Homo sapiens	IC50	uM	0.26
	1005826	CHEMBL758469	Inhibition of protein kinase C eta	B	O=C(N[C@@H]1c2ccccc2C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL444877	=	IC50	nM	35000.0	CHEMBL3616	Homo sapiens	IC50	uM	35.0
	1014355	CHEMBL758469	Inhibition of protein kinase C eta	B	O=C(N[C@@H]1c2ccccc2C[C@@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL367127	<	IC50	nM	50.0	CHEMBL3616	Homo sapiens	IC50	uM	0.05
	1017314	CHEMBL770094	Inhibition of Protein kinase C eta	B	O=C(N[C@@H]1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL311399	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	1146415	CHEMBL770091	Inhibition of Protein kinase C eta	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCO[C@H](CN1CCCC1)CCn1cc2c2ccccc21		CHEMBL419866	=	IC50	nM	350.0	CHEMBL3616	Homo sapiens	IC50	uM	0.35
	1148924	CHEMBL770091	Inhibition of Protein kinase C eta	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.0	CHEMBL3616	Homo sapiens	IC50	uM	0.005
	1151429	CHEMBL770091	Inhibition of Protein kinase C eta	B	CNC[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL311543	=	IC50	nM	31.0	CHEMBL3616	Homo sapiens	IC50	uM	0.031
	1153811	CHEMBL770091	Inhibition of Protein kinase C eta	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	IC50	nM	52.0	CHEMBL3616	Homo sapiens	IC50	uM	0.052
	1161785	CHEMBL770091	Inhibition of Protein kinase C eta	B	CN1CCN(C[C@@H]2CCn3cc(c4ccccc43)C3=C(C(=O)NC3=O)c3cn(c4ccccc34)CCO2)CC1		CHEMBL91959	=	IC50	nM	2000.0	CHEMBL3616	Homo sapiens	IC50	uM	2.0
	1161796	CHEMBL770091	Inhibition of Protein kinase C eta	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCO[C@H](CN1CCOCC1)CCn1cc2c2ccccc21		CHEMBL315357	=	IC50	nM	1700.0	CHEMBL3616	Homo sapiens	IC50	uM	1.7
	1163298	CHEMBL770091	Inhibition of Protein kinase C eta	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCO[C@H](CNCc1ccccc1)CCn1cc2c2ccccc21		CHEMBL328229	=	IC50	nM	2500.0	CHEMBL3616	Homo sapiens	IC50	uM	2.5
	1168638	CHEMBL770091	Inhibition of Protein kinase C eta	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCO[C@H](CNS(=O)(=O)c1ccccc1)CCn1cc2c2ccccc21		CHEMBL315389	=	IC50	nM	1900.0	CHEMBL3616	Homo sapiens	IC50	uM	1.9
	1169950	CHEMBL770091	Inhibition of Protein kinase C eta	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCO[C@H](CO)CCn1cc2c2ccccc21		CHEMBL292495	=	IC50	nM	300.0	CHEMBL3616	Homo sapiens	IC50	uM	0.3
	1180287	CHEMBL770091	Inhibition of Protein kinase C eta	B	NC[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL316239	=	IC50	nM	240.0	CHEMBL3616	Homo sapiens	IC50	uM	0.24
	1189633	CHEMBL772756	Displacement of [3H]PDBu from protein kinase C eta C1b domain	B	CCCCCCCC(=O)O[C@H]1/C(=C/C(=O)OC)CC2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3CCC[C@H](C[C@@H]4CCO[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3		CHEMBL46252	=	Ki	nM	23.5	CHEMBL3616	Homo sapiens	Ki	nM	23.5
	1192009	CHEMBL772756	Displacement of [3H]PDBu from protein kinase C eta C1b domain	B	CCCCCCCC(=O)O[C@H]1/C(=C/C(=O)OC)CC2C[C@H]([C@@H](C)O)OC(=O)C[C@@H](O)C[C@@H]3CCC[C@H](C[C@@H]4CCO[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3		CHEMBL46053	>	Ki	nM	500.0	CHEMBL3616	Homo sapiens	Ki	nM	500.0
	1197031	CHEMBL772756	Displacement of [3H]PDBu from protein kinase C eta C1b domain	B	CCCCCCCC(=O)O[C@H]1/C(=C/C(=O)OC)CC2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)CCO[C@H](C(C)(C)C)C[C@@H]3CCO[C@H](/C=C/C(C)(C)[C@]1(O)O2)O3		CHEMBL45053	=	Ki	nM	70.2	CHEMBL3616	Homo sapiens	Ki	nM	70.2
	1214212	CHEMBL772755	Displacement of [3H]PDBu from protein kinase C eta C1b domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	0.9	CHEMBL3616	Homo sapiens	Kd	nM	0.9
	1228429	CHEMBL761875	Inhibition of protein kinase C eta	B	O=C(NC1CCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL48636	=	IC50	nM	1.0	CHEMBL3616	Homo sapiens	IC50	uM	0.001
	1233145	CHEMBL761875	Inhibition of protein kinase C eta	B	O=C(NC1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL49354	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	1245256	CHEMBL761875	Inhibition of protein kinase C eta	B	O=C(OC1CNCC1Cc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL300422	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	1245265	CHEMBL761875	Inhibition of protein kinase C eta	B	O=C(OC1CCCC1Cc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL295806	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	1250297	CHEMBL761875	Inhibition of protein kinase C eta	B	O=C(NC1CNCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL265559	=	IC50	nM	4.0	CHEMBL3616	Homo sapiens	IC50	uM	0.004
	1255034	CHEMBL761875	Inhibition of protein kinase C eta	B	O=C(NC1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL49354	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	1256475	CHEMBL761875	Inhibition of protein kinase C eta	B	O=C(OC1CCCC1Oc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL48988	=	IC50	nM	10.0	CHEMBL3616	Homo sapiens	IC50	uM	0.01
	1259050	CHEMBL761875	Inhibition of protein kinase C eta	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC2CNCC2Cc2ccc(O)cc2)cc1O		CHEMBL48546	=	IC50	nM	50.0	CHEMBL3616	Homo sapiens	IC50	uM	0.05
	1259059	CHEMBL761875	Inhibition of protein kinase C eta	B	O=C(OC1CCCC1Cc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL295806	=	IC50	nM	10.0	CHEMBL3616	Homo sapiens	IC50	uM	0.01
	1265105	CHEMBL761875	Inhibition of protein kinase C eta	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC2CCCC2Cc2ccc(O)cc2)cc1O		CHEMBL48665	=	IC50	nM	40.0	CHEMBL3616	Homo sapiens	IC50	uM	0.04
	1269312	CHEMBL770097	Inhibition of Protein Kinase C eta	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	1269320	CHEMBL770097	Inhibition of Protein Kinase C eta	B	O=C(N[C@@H]1CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL52529	=	IC50	nM	0.6	CHEMBL3616	Homo sapiens	IC50	uM	0.0006
	1269328	CHEMBL770098	Inhibition of human Protein Kinase C eta	B	NC[C@@H]1C[C@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL67290	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	1275871	CHEMBL770098	Inhibition of human Protein Kinase C eta	B	O=C(N[C@H]1C[C@@H](CO)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL431955	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	uM	0.02
	1278523	CHEMBL770097	Inhibition of Protein Kinase C eta	B	O=C(N[C@@H]1CNC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL59828	=	IC50	nM	4.0	CHEMBL3616	Homo sapiens	IC50	uM	0.004
	1279716	CHEMBL770098	Inhibition of human Protein Kinase C eta	B	O=C(N[C@H]1C[C@H](CO)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL306427	=	IC50	nM	2.0	CHEMBL3616	Homo sapiens	IC50	uM	0.002
	1285816	CHEMBL770098	Inhibition of human Protein Kinase C eta	B	N[C@@H]1C[C@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL417051	=	IC50	nM	2.0	CHEMBL3616	Homo sapiens	IC50	uM	0.002
	1300782	CHEMBL770098	Inhibition of human Protein Kinase C eta	B	O=C(N[C@H]1C[C@H](O)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL67716	=	IC50	nM	4.0	CHEMBL3616	Homo sapiens	IC50	uM	0.004
	1300790	CHEMBL770098	Inhibition of human Protein Kinase C eta	B	O=C(N[C@H]1C[C@@H](O)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1.O=C(N[C@H]1C[C@H](O)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL1794808	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	1305097	CHEMBL770098	Inhibition of human Protein Kinase C eta	B	NC[C@H]1C[C@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL421866	=	IC50	nM	3.0	CHEMBL3616	Homo sapiens	IC50	uM	0.003
	1483096	CHEMBL835534	Percentage inhibition of Protein kinase C eta at 50 uM	B	CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2cn(CCCN)c3ccccc23)C1=O		CHEMBL188282	=	Activity	%	55.0	CHEMBL3616	Homo sapiens	Activity	%	55.0
	1483108	CHEMBL835534	Percentage inhibition of Protein kinase C eta at 50 uM	B	CCCCCNC1=C(c2cn(C)c3ccccc23)C(=O)N(C)C1=O		CHEMBL365337	=	Activity	%	98.0	CHEMBL3616	Homo sapiens	Activity	%	98.0
	1711422	CHEMBL869663	Displacement of [3H]phorbol 12,13-dibutyrate from PKC eta-C1A	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	>	Ki	nM	10000.0	CHEMBL3616	Homo sapiens	Ki	nM	10000.0
	1711423	CHEMBL869664	Displacement of [3H]phorbol 12,13-dibutyrate from PKC eta-C1B	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	=	Ki	nM	144.0	CHEMBL3616	Homo sapiens	Ki	nM	144.0
	1711431	CHEMBL861073	Induction of GFP-tagged PKC eta translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 10 uM	B	CCCCCCN1C[C@H]2C[C@@H](CO)NC(=O)[C@H](C(C)C)N(C)c3cccc1c32		CHEMBL207363	=	Ratio		1.92	CHEMBL3616	Homo sapiens	Ratio		1.92
	1711437	CHEMBL861075	Induction of GFP-tagged PKC eta translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 1 uM	B	CCCCCCN1C[C@H]2C[C@@H](CO)NC(=O)[C@H](C(C)C)N(C)c3cccc1c32		CHEMBL207363	=	Ratio		1.84	CHEMBL3616	Homo sapiens	Ratio		1.84
	1711443	CHEMBL861076	Induction of GFP-tagged PKC eta translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 0.5 uM	B	CCCCCCN1C[C@H]2C[C@@H](CO)NC(=O)[C@H](C(C)C)N(C)c3cccc1c32		CHEMBL207363	=	Ratio		1.01	CHEMBL3616	Homo sapiens	Ratio		1.01
Not Determined	1711449	CHEMBL861071	Induction of GFP-tagged PKC eta translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 30 uM	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866		Ratio			CHEMBL3616	Homo sapiens	Ratio		
Not Determined	1711455	CHEMBL861072	Induction of GFP-tagged PKC eta translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 20 uM	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866		Ratio			CHEMBL3616	Homo sapiens	Ratio		
	1711461	CHEMBL861073	Induction of GFP-tagged PKC eta translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 10 uM	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	=	Ratio		1.72	CHEMBL3616	Homo sapiens	Ratio		1.72
	1711467	CHEMBL861074	Induction of GFP-tagged PKC eta translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 5 uM	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	=	Ratio		1.78	CHEMBL3616	Homo sapiens	Ratio		1.78
	1711477	CHEMBL861076	Induction of GFP-tagged PKC eta translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 0.5 uM	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	=	Ratio		0.97	CHEMBL3616	Homo sapiens	Ratio		0.97
	1711479	CHEMBL861075	Induction of GFP-tagged PKC eta translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 1 uM	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	=	Ratio		1.46	CHEMBL3616	Homo sapiens	Ratio		1.46
	1723375	CHEMBL863186	Inhibition of PKCeta	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	8300.0	CHEMBL3616	Homo sapiens	Ki	nM	8300.0
	1723450	CHEMBL863186	Inhibition of PKCeta	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	8300.0	CHEMBL3616	Homo sapiens	Ki	nM	8300.0
	1723451	CHEMBL863186	Inhibition of PKCeta	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	8300.0	CHEMBL3616	Homo sapiens	Ki	nM	8300.0
	1723452	CHEMBL863186	Inhibition of PKCeta	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	8300.0	CHEMBL3616	Homo sapiens	Ki	nM	8300.0
	1723453	CHEMBL863186	Inhibition of PKCeta	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	8300.0	CHEMBL3616	Homo sapiens	Ki	nM	8300.0
	1723454	CHEMBL863186	Inhibition of PKCeta	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	8300.0	CHEMBL3616	Homo sapiens	Ki	nM	8300.0
	1734114	CHEMBL854415	Residual activity at human PKCeta at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	91.0	CHEMBL3616	Homo sapiens	Activity	%	91.0
	1744601	CHEMBL866840	Inhibition of PKCeta	B	O=C(NC1CC1)c1cc(NCc2cnc(Nc3ccccn3)s2)c(F)cc1F		CHEMBL377734	>	IC50	nM	40000.0	CHEMBL3616	Homo sapiens	IC50	nM	40000.0
	1769432	CHEMBL910943	Inhibition of PKCeta	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL3616	Homo sapiens	IC50	uM	1.0
	1790034	CHEMBL854702	Percentage activity of human PKC eta in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	100.0	CHEMBL3616	Homo sapiens	Activity	%	100.0
	2025184	CHEMBL887011	Inhibition of human PKCeta at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	117.0	CHEMBL3616	Homo sapiens	Inhibition	%	117.0
	2025444	CHEMBL887011	Inhibition of human PKCeta at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	104.0	CHEMBL3616	Homo sapiens	Inhibition	%	104.0
	2025445	CHEMBL887011	Inhibition of human PKCeta at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	90.0	CHEMBL3616	Homo sapiens	Inhibition	%	90.0
	2025446	CHEMBL887011	Inhibition of human PKCeta at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	121.0	CHEMBL3616	Homo sapiens	Inhibition	%	121.0
	2064413	CHEMBL927265	Displacement of [3H]PDBu from PKCeta C1B domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	5.5	CHEMBL3616	Homo sapiens	Ki	nM	5.5
	2064423	CHEMBL927265	Displacement of [3H]PDBu from PKCeta C1B domain	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	=	Ki	nM	140.0	CHEMBL3616	Homo sapiens	Ki	nM	140.0
	2064433	CHEMBL927265	Displacement of [3H]PDBu from PKCeta C1B domain	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)C2		CHEMBL399981	=	Ki	nM	0.34	CHEMBL3616	Homo sapiens	Ki	nM	0.34
	2064443	CHEMBL927265	Displacement of [3H]PDBu from PKCeta C1B domain	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)CC2		CHEMBL401369	=	Ki	nM	25.0	CHEMBL3616	Homo sapiens	Ki	nM	25.0
Not Determined	2064481	CHEMBL926298	Induction of GFP-tagged PKCeta translocation in HeLa cells assessed as ratio of protein level in plasma membrane to cytosol at 10 uM	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)CC2		CHEMBL401369		Ratio			CHEMBL3616	Homo sapiens	Ratio		
	2064482	CHEMBL926299	Induction of GFP-tagged PKCeta translocation in HeLa cells assessed as ratio of protein level in plasma membrane to cytosol at 1 uM	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)CC2		CHEMBL401369	=	Ratio		2.15	CHEMBL3616	Homo sapiens	Ratio		2.15
	2064483	CHEMBL926300	Induction of GFP-tagged PKCeta translocation in HeLa cells assessed as ratio of protein level in plasma membrane to cytosol at 500 nM	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)CC2		CHEMBL401369	=	Ratio		1.84	CHEMBL3616	Homo sapiens	Ratio		1.84
	2064484	CHEMBL926301	Induction of GFP-tagged PKCeta translocation in HeLa cells assessed as ratio of protein level in plasma membrane to cytosol at 100 nM	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)CC2		CHEMBL401369	=	Ratio		1.75	CHEMBL3616	Homo sapiens	Ratio		1.75
	2064490	CHEMBL926299	Induction of GFP-tagged PKCeta translocation in HeLa cells assessed as ratio of protein level in plasma membrane to cytosol at 1 uM	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ratio		2.64	CHEMBL3616	Homo sapiens	Ratio		2.64
	2085342	CHEMBL929993	Displacement of [3H]PDBu from PKCeta C1B domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cn3nc(C(F)(F)F)c4ccc(c2c43)N1C		CHEMBL261387	=	Ki	nM	29.7	CHEMBL3616	Homo sapiens	Ki	nM	29.7
	2085352	CHEMBL929993	Displacement of [3H]PDBu from PKCeta C1B domain	B	Cc1nn2cc3c4c(ccc1c42)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)C3		CHEMBL441897	=	Ki	nM	223.0	CHEMBL3616	Homo sapiens	Ki	nM	223.0
	2085353	CHEMBL929993	Displacement of [3H]PDBu from PKCeta C1B domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cn3ncc4ccc(c2c43)N1C		CHEMBL271403	=	Ki	nM	9.9	CHEMBL3616	Homo sapiens	Ki	nM	9.9
	2085366	CHEMBL929993	Displacement of [3H]PDBu from PKCeta C1B domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	5.5	CHEMBL3616	Homo sapiens	Ki	nM	5.5
	2147358	CHEMBL922143	Activity of human PKCeta kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	120.0	CHEMBL3616	Homo sapiens	Activity	%	120.0
	2158780	CHEMBL922543	Inhibition of PKCeta	B	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	>	IC50	nM	40000.0	CHEMBL3616	Homo sapiens	IC50	uM	40.0
	2168113	CHEMBL927983	Inhibition of PKCeta	B	Cc1c(Nc2c(C#N)cnc3sc(-c4cccc(CN(C)C)c4)cc23)ccc2[nH]ccc12		CHEMBL402818	=	IC50	nM	62.0	CHEMBL3616	Homo sapiens	IC50	nM	62.0
	2251063	CHEMBL1011938	Inhibition of PKCeta at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	106.0	CHEMBL3616	Homo sapiens	INH	%	106.0
	2362672	CHEMBL1034877	Inhibition of PKCeta by fluorescence polarization assay	B	COc1ccc(-c2cncc(C#N)c2Nc2ccc3[nH]ccc3c2)cc1OC		CHEMBL492251	=	IC50	nM	16350.0	CHEMBL3616	Homo sapiens	IC50	uM	16.35
	2367319	CHEMBL1028105	Inhibition of human PKCeta	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	IC50	nM	2.0	CHEMBL3616	Homo sapiens	IC50	uM	0.002
	2420227	CHEMBL962522	Inhibition of human PKCeta	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	>	IC50	nM	100000.0	CHEMBL3616	Homo sapiens	IC50	nM	100000.0
	2420244	CHEMBL962522	Inhibition of human PKCeta	B	CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(=O)O)c(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23254	>	IC50	nM	100000.0	CHEMBL3616	Homo sapiens	IC50	nM	100000.0
	2470320	CHEMBL992497	Inhibition of PRKCH at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3616	Homo sapiens	INH	%	10.0
Not Active	2488631	CHEMBL1024661	Inhibition of PKCeta at 1 uM	B	CC(=O)C1=C(O)C=C2Oc3c4c(cc(O)c3[C@]2(C)C1=O)OC(C)(C)NC4=O		CHEMBL474846		Activity			CHEMBL3616	Homo sapiens	Activity		
	2489319	CHEMBL991252	Inhibition of human full length PKCeta	B	COc1ccc(CN(C)C)c(-c2cc3c(Nc4ccc5[nH]ccc5c4C)c(C#N)cnc3s2)c1	Outside typical range	CHEMBL479835	=	IC50	nM	360000.0	CHEMBL3616	Homo sapiens	IC50	uM	360.0
	2559672	CHEMBL982973	Inhibition of PKCeta	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCCC4)cc23)ccc2[nH]ccc12		CHEMBL477817	=	IC50	nM	51000.0	CHEMBL3616	Homo sapiens	IC50	nM	51000.0
	2596892	CHEMBL1017912	Inhibition of PRKCH assessed as enzyme activity relative to control	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Activity	%	32.0	CHEMBL3616	Homo sapiens	Activity	%	32.0
	2596899	CHEMBL1017912	Inhibition of PRKCH assessed as enzyme activity relative to control	B	C[C@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL457871	=	Activity	%	15.0	CHEMBL3616	Homo sapiens	Activity	%	15.0
	2624353	CHEMBL1007480	Inhibition of human PKCeta by IMAP assay	B	Cc1c(Nc2c(C#N)cncc2-c2ccc(OCCN3CCN(C)CC3)cc2)ccc2[nH]ccc12		CHEMBL467069	=	IC50	nM	450.0	CHEMBL3616	Homo sapiens	IC50	nM	450.0
	2636761	CHEMBL1021134	Inhibition of PKCeta	B	CN1CCN(CCOc2cccc(-c3cncc(C#N)c3Nc3cccc4[nH]ccc34)c2)CC1		CHEMBL467321	=	IC50	nM	940.0	CHEMBL3616	Homo sapiens	IC50	nM	940.0
	2721746	CHEMBL1053590	Inhibition of PKCeta at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	2892474	CHEMBL1050833	Selectivity for PRKCH as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Selectivity		0.5017	CHEMBL3616	Homo sapiens	Selectivity		0.5017
	2905416	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905417	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905418	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905419	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905420	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905421	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905422	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905423	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905424	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905425	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905426	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905427	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905428	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905429	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905430	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	350.0	CHEMBL3616	Homo sapiens	Kd	nM	350.0
	2905431	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905432	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905433	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905434	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905435	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905436	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905437	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	1800.0	CHEMBL3616	Homo sapiens	Kd	nM	1800.0
	2905438	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905439	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905440	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905441	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	290.0	CHEMBL3616	Homo sapiens	Kd	nM	290.0
	2905442	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905443	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905444	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905445	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905446	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905447	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905448	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	4.8	CHEMBL3616	Homo sapiens	Kd	nM	4.8
	2905449	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905450	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905451	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905452	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2905453	CHEMBL1060261	Binding constant for PRKCH kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	2921197	CHEMBL1057606	Inhibition of PRKCH assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL3616	Homo sapiens	Activity	%	100.0
	2924749	CHEMBL1056860	Inhibition of PKCeta assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	87.0	CHEMBL3616	Homo sapiens	Activity	%	87.0
	2924750	CHEMBL1056860	Inhibition of PKCeta assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	91.0	CHEMBL3616	Homo sapiens	Activity	%	91.0
	2924751	CHEMBL1056860	Inhibition of PKCeta assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	91.0	CHEMBL3616	Homo sapiens	Activity	%	91.0
	2924752	CHEMBL1056860	Inhibition of PKCeta assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	83.0	CHEMBL3616	Homo sapiens	Activity	%	83.0
	2938459	CHEMBL1041406	Inhibition of PKCeta at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	2.0	CHEMBL3616	Homo sapiens	INH	%	2.0
	2944860	CHEMBL1049983	Inhibition of PRKCN at 2 uM	B	c1cncc(CN2CCC(n3ncc4c(N5CCOCC5)nc(-c5ccc6[nH]ccc6c5)nc43)CC2)c1		CHEMBL583194	=	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	2992431	CHEMBL1040090	Inhibition of PKCeta by SPA	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	IC50	nM	6.1	CHEMBL3616	Homo sapiens	IC50	nM	6.1
	2992441	CHEMBL1040090	Inhibition of PKCeta by SPA	B	CN(C)CCOc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc2c1		CHEMBL565632	=	IC50	nM	11.0	CHEMBL3616	Homo sapiens	IC50	nM	11.0
	2992444	CHEMBL1040090	Inhibition of PKCeta by SPA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	IC50	nM	10.0	CHEMBL3616	Homo sapiens	IC50	nM	10.0
	2992448	CHEMBL1040090	Inhibition of PKCeta by SPA	B	CN1CCN(c2cccc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL585500	=	IC50	nM	36.0	CHEMBL3616	Homo sapiens	IC50	nM	36.0
	2992454	CHEMBL1040090	Inhibition of PKCeta by SPA	B	CN1CCN(c2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3c2)CC1		CHEMBL568580	=	IC50	nM	25.0	CHEMBL3616	Homo sapiens	IC50	nM	25.0
	2992459	CHEMBL1040090	Inhibition of PKCeta by SPA	B	CN(C)CCOc1cccc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1		CHEMBL566853	=	IC50	nM	47.0	CHEMBL3616	Homo sapiens	IC50	nM	47.0
	2992465	CHEMBL1040090	Inhibition of PKCeta by SPA	B	CN(C)CCCn1cc(C2=C(c3csc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL566424	=	IC50	nM	293.0	CHEMBL3616	Homo sapiens	IC50	nM	293.0
	2992467	CHEMBL1040090	Inhibition of PKCeta by SPA	B	CN(C)CCCn1cc(C2=C(c3cccc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL584483	=	IC50	nM	349.0	CHEMBL3616	Homo sapiens	IC50	nM	349.0
	2992477	CHEMBL1040090	Inhibition of PKCeta by SPA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCOCC2)nc2ccccc12		CHEMBL584817	=	IC50	nM	2545.0	CHEMBL3616	Homo sapiens	IC50	nM	2545.0
	2992483	CHEMBL1040090	Inhibition of PKCeta by SPA	B	CN(C)CCCn1cc(C2=C(c3n[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL585281	>	IC50	nM	315.0	CHEMBL3616	Homo sapiens	IC50	nM	315.0
	3001931	CHEMBL1047195	Inhibition of PKCeta by IMAP fluorescence polarization technology	B	Cc1c(Nc2c(C#N)cncc2-c2cc3cc(CN4CCN(C)CC4)ccc3o2)ccc2[nH]ccc12		CHEMBL571581	=	IC50	nM	33.0	CHEMBL3616	Homo sapiens	IC50	nM	33.0
	3011614	CHEMBL1037488	Inhibition of PKCeta by IMAP kinase assay	B	C#Cc1cccc(-c2ccc(CN3CCN(C)CC3)o2)c1Cc1ccc2c(c1C)C=CC2		CHEMBL570865	=	IC50	nM	140.0	CHEMBL3616	Homo sapiens	IC50	nM	140.0
	3017856	CHEMBL1039090	Inhibition of PKCeta by IMAP kinase assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(OCCN3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL567124	=	IC50	nM	330.0	CHEMBL3616	Homo sapiens	IC50	nM	330.0
	3052448	CHEMBL1070483	Residual activity of PKCeta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	104.0	CHEMBL3616	Homo sapiens	Residual activity	%	104.0
	3052700	CHEMBL1040277	Residual activity of PKCeta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	97.0	CHEMBL3616	Homo sapiens	Residual activity	%	97.0
	3054009	CHEMBL1050340	Residual activity of PKCeta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	55.0	CHEMBL3616	Homo sapiens	Residual activity	%	55.0
	3054261	CHEMBL1070483	Residual activity of PKCeta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	97.0	CHEMBL3616	Homo sapiens	Residual activity	%	97.0
	3055548	CHEMBL1040277	Residual activity of PKCeta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	92.0	CHEMBL3616	Homo sapiens	Residual activity	%	92.0
	3056853	CHEMBL1050340	Residual activity of PKCeta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	71.0	CHEMBL3616	Homo sapiens	Residual activity	%	71.0
	3057105	CHEMBL1070483	Residual activity of PKCeta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	117.0	CHEMBL3616	Homo sapiens	Residual activity	%	117.0
	3058425	CHEMBL1040277	Residual activity of PKCeta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	122.0	CHEMBL3616	Homo sapiens	Residual activity	%	122.0
	3059709	CHEMBL1050340	Residual activity of PKCeta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	81.0	CHEMBL3616	Homo sapiens	Residual activity	%	81.0
	3084379	CHEMBL1072658	Inhibition of PKCeta	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	98.0	CHEMBL3616	Homo sapiens	IC50	uM	0.098
	3089535	CHEMBL1070549	Inhibition of PKCeta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CN2CCNCC2)ccc2[nH]ccc12		CHEMBL593619	=	IC50	nM	550.0	CHEMBL3616	Homo sapiens	IC50	nM	550.0
	3089559	CHEMBL1070549	Inhibition of PKCeta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@@H](N)C2)ccc2[nH]ccc12		CHEMBL606245	=	IC50	nM	350.0	CHEMBL3616	Homo sapiens	IC50	nM	350.0
	3089565	CHEMBL1070549	Inhibition of PKCeta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCNCC2)ccc2[nH]ccc12		CHEMBL603418	=	IC50	nM	190.0	CHEMBL3616	Homo sapiens	IC50	nM	190.0
	3089589	CHEMBL1070549	Inhibition of PKCeta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC(N)CC2)ccc2[nH]ccc12		CHEMBL593883	=	IC50	nM	100.0	CHEMBL3616	Homo sapiens	IC50	nM	100.0
	3089591	CHEMBL1070549	Inhibition of PKCeta by fluorescence polarization assay	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC(NS(C)(=O)=O)CC2)ccc2[nH]ccc12		CHEMBL595048	=	IC50	nM	88.0	CHEMBL3616	Homo sapiens	IC50	nM	88.0
	3185706	CHEMBL1105156	Inhibition of PKCeta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(CN3CCN(C)CC3)n2)ccc2[nH]ccc12		CHEMBL1084411	=	IC50	nM	120.0	CHEMBL3616	Homo sapiens	IC50	nM	120.0
	3214019	CHEMBL1103214	Inhibition of PKCeta at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	-8.0	CHEMBL3616	Homo sapiens	INH	%	-8.0
	3219695	CHEMBL1110446	Inhibition of PKCeta at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Inhibition	%	106.0	CHEMBL3616	Homo sapiens	INH	%	106.0
	3219840	CHEMBL1114003	Inhibition of PKCeta	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(S(=O)(=O)N3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL1080994	=	IC50	nM	100.0	CHEMBL3616	Homo sapiens	IC50	nM	100.0
	3219841	CHEMBL1114003	Inhibition of PKCeta	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1cccc(S(=O)(=O)N2CCN(C)CC2)c1		CHEMBL1080995	=	IC50	nM	490.0	CHEMBL3616	Homo sapiens	IC50	nM	490.0
	3224932	CHEMBL1101010	Inhibition of PKCeta at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	3226311	CHEMBL1101010	Inhibition of PKCeta at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	3240831	CHEMBL1109676	Inhibition of PKCeta	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	>	IC50	nM	1000.0	CHEMBL3616	Homo sapiens	IC50	uM	1.0
	3332112	CHEMBL1166823	Inhibition of PRKCH at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	3333527	CHEMBL1166823	Inhibition of PRKCH at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	3334932	CHEMBL1166823	Inhibition of PRKCH at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	3336352	CHEMBL1166823	Inhibition of PRKCH at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	3337628	CHEMBL1166823	Inhibition of PRKCH at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	3338959	CHEMBL1166823	Inhibition of PRKCH at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	3339213	CHEMBL1166823	Inhibition of PRKCH at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	3340516	CHEMBL1166823	Inhibition of PRKCH at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	3341894	CHEMBL1166823	Inhibition of PRKCH at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	3343341	CHEMBL1166823	Inhibition of PRKCH at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	3358766	CHEMBL1175232	Inhibition of PRKCH at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	67.0	CHEMBL3616	Homo sapiens	INH	%	67.0
	3359208	CHEMBL1175232	Inhibition of PRKCH at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	79.0	CHEMBL3616	Homo sapiens	INH	%	79.0
	3443496	CHEMBL1244262	Inhibition of PKCeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	11.0	CHEMBL3616	Homo sapiens	INH	%	11.0
	3443713	CHEMBL1244262	Inhibition of PKCeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	3444868	CHEMBL1244262	Inhibition of PKCeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	2.0	CHEMBL3616	Homo sapiens	INH	%	2.0
	3445266	CHEMBL1244938	Binding affinity to PRKCH	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	140.0	CHEMBL3616	Homo sapiens	Kd	nM	140.0
	3445492	CHEMBL1244262	Inhibition of PKCeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	-6.0	CHEMBL3616	Homo sapiens	INH	%	-6.0
	3445709	CHEMBL1244262	Inhibition of PKCeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	22.0	CHEMBL3616	Homo sapiens	INH	%	22.0
	3445904	CHEMBL1244262	Inhibition of PKCeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	78.0	CHEMBL3616	Homo sapiens	INH	%	78.0
	3446094	CHEMBL1244262	Inhibition of PKCeta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	5.0	CHEMBL3616	Homo sapiens	INH	%	5.0
	3448585	CHEMBL1244938	Binding affinity to PRKCH	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	3449020	CHEMBL1244938	Binding affinity to PRKCH	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	290.0	CHEMBL3616	Homo sapiens	Kd	nM	290.0
	3449816	CHEMBL1244938	Binding affinity to PRKCH	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	3450210	CHEMBL1244938	Binding affinity to PRKCH	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	3450405	CHEMBL1244938	Binding affinity to PRKCH	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	3451122	CHEMBL1244938	Binding affinity to PRKCH	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	uM	10.0
	3463329	CHEMBL1251589	Inhibition of PRKCH at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	99.0	CHEMBL3616	Homo sapiens	INH	%	99.0
	3463873	CHEMBL1251589	Inhibition of PRKCH at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	8.0	CHEMBL3616	Homo sapiens	INH	%	8.0
	3464092	CHEMBL1251589	Inhibition of PRKCH at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	7.0	CHEMBL3616	Homo sapiens	INH	%	7.0
	3502332	CHEMBL1259594	Inhibition of PKCeta at 1 uM	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)[C@H](N)Cc4ccc(F)cc4)CC3)c12		CHEMBL1257282	>	Inhibition	%	90.0	CHEMBL3616	Homo sapiens	INH	%	90.0
	3504861	CHEMBL1260399	Inhibition of [3H]PDBu binding to PKCeta C1B peptide	B	CO[C@@H](CC[C@H](C)[C@H]1O[C@@]23C[C@H](OC(=O)C[C@H]([C@@H](C)O)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)[C@@H]1C)c1cc(O)ccc1Br		CHEMBL1256416	=	Ki	nM	0.36	CHEMBL3616	Homo sapiens	Ki	nM	0.36
	3504869	CHEMBL1260399	Inhibition of [3H]PDBu binding to PKCeta C1B peptide	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	0.45	CHEMBL3616	Homo sapiens	Kd	nM	0.45
	3504877	CHEMBL1260399	Inhibition of [3H]PDBu binding to PKCeta C1B peptide	B	CC1(C)CC[C@@H]2CC(=O)O[C@@H](CO)CC(=O)O[C@@H]3C[C@@H](CCCCc4ccccc4)O[C@@]1(C3)O2		CHEMBL1258117	=	Ki	nM	12.0	CHEMBL3616	Homo sapiens	Ki	nM	12.0
	3504885	CHEMBL1260399	Inhibition of [3H]PDBu binding to PKCeta C1B peptide	B	O=C1C[C@H]2CCC[C@]3(C[C@@H](C[C@@H](CCCCc4ccccc4)O3)OC(=O)C[C@H](CO)O1)O2		CHEMBL1258349	=	Ki	nM	180.0	CHEMBL3616	Homo sapiens	Ki	nM	180.0
	3504894	CHEMBL1260399	Inhibition of [3H]PDBu binding to PKCeta C1B peptide	B	CC1(C)CC[C@@H]2CC(=O)O[C@@H](CO)CC(=O)O[C@@H]3C[C@@H](CCCCc4cccc(O)c4)O[C@@]1(C3)O2		CHEMBL1258348	=	Ki	nM	4.4	CHEMBL3616	Homo sapiens	Ki	nM	4.4
	5116130	CHEMBL1632823	Inhibition of PKCeta at 1 uM	B	CC(C)NCC(Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3c2[C@H](C)SC3)CC1		CHEMBL1632380	>	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	5116131	CHEMBL1632823	Inhibition of PKCeta at 1 uM	B	CC(C)NC[C@H](Cc1ccc(Cl)cc1)C(=O)N1CCN(c2ncnc3c2[C@H](C)OC3)CC1		CHEMBL1632391	>	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	5120389	CHEMBL1648683	Inhibition of human PKCeta at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	107.0	CHEMBL3616	Homo sapiens	INH	%	107.0
	6265574	CHEMBL1798283	Inhibition of PRKCH at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL3616	Homo sapiens	INH	%	65.0
	6265678	CHEMBL1798283	Inhibition of PRKCH at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	=	Inhibition	%	79.0	CHEMBL3616	Homo sapiens	INH	%	79.0
	6277527	CHEMBL1804506	Binding affinity to recombinant human PKCeta in after 2 hrs by microequilibrium dialysis assay	B	CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C		CHEMBL230006	=	Kd	nM	250.0	CHEMBL3616	Homo sapiens	Kd	uM	0.25
	6277528	CHEMBL1804506	Binding affinity to recombinant human PKCeta in after 2 hrs by microequilibrium dialysis assay	B	CN(C)c1ccc2c(CC(=O)NCCNC(=O)[C@@]3(C)CC[C@]4(C)CC[C@]5(C)C(=CC(=O)[C@@H]6[C@@]7(C)CC[C@H](O)C(C)(C)[C@@H]7CC[C@]65C)[C@@H]4C3)cc(=O)oc2c1		CHEMBL1800956	=	Kd	nM	640.0	CHEMBL3616	Homo sapiens	Kd	uM	0.64
Not Active	6277530	CHEMBL1804507	Binding affinity to PKCeta in human HeLa cell lysates at 10 nM to 100 uM after 2 hrs by immunoprecipitation analysis	B	CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)NCCN=[N+]=[N-])CC[C@]3(C)CC[C@]21C		CHEMBL1800958		Activity			CHEMBL3616	Homo sapiens	Activity		
Not Active	6277531	CHEMBL1804507	Binding affinity to PKCeta in human HeLa cell lysates at 10 nM to 100 uM after 2 hrs by immunoprecipitation analysis	B	C#CCNC(=O)Cc1cc(=O)oc2cc(N(C)C)ccc12		CHEMBL1800959		Activity			CHEMBL3616	Homo sapiens	Activity		
	6297267	CHEMBL1809449	Inhibition of [3H]PDBu binding to PKCeta-C1B domain peptide	B	C=C[C@@]1(C)CC[C@](C)(C(C)C)c2cc3c4c(c[nH]c4c21)CC(=O)NC(=O)[C@H](C(C)C)N3C		CHEMBL1807163	=	Ki	nM	360.0	CHEMBL3616	Homo sapiens	Ki	nM	360.0
	6297273	CHEMBL1809455	Binding affinity to PKCeta-C1B domain peptide using [3H]-labeled compound	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	0.45	CHEMBL3616	Homo sapiens	Kd	nM	0.45
	6335501	CHEMBL1821101	Inhibition of N-terminal GST-fused PKClota (1-587) expressed in baculovirus expression system at 3 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCCC[C@@H]1OC[C@H](N)[C@@H]1O		CHEMBL447577	=	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	6335505	CHEMBL1821097	Inhibition of N-terminal GST-fused PKCeta (1-683) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCCC[C@@H]1OC[C@H](N)[C@@H]1O		CHEMBL447577	=	Inhibition	%	56.6	CHEMBL3616	Homo sapiens	INH	%	56.6
	6335506	CHEMBL1821096	Inhibition of N-terminal GST-fused PKClota (1-587) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCCC[C@@H]1OC[C@H](N)[C@@H]1O		CHEMBL447577	=	Inhibition	%	98.5	CHEMBL3616	Homo sapiens	INH	%	98.5
	6335517	CHEMBL1821097	Inhibition of N-terminal GST-fused PKCeta (1-683) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333	=	Inhibition	%	43.8	CHEMBL3616	Homo sapiens	INH	%	43.8
	6335518	CHEMBL1821096	Inhibition of N-terminal GST-fused PKClota (1-587) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333	=	Inhibition	%	100.4	CHEMBL3616	Homo sapiens	INH	%	100.4
	6335527	CHEMBL1821101	Inhibition of N-terminal GST-fused PKClota (1-587) expressed in baculovirus expression system at 3 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCCC[C@@H]1OC[C@@H](N)[C@@H]1O		CHEMBL1819205	=	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	6335531	CHEMBL1821097	Inhibition of N-terminal GST-fused PKCeta (1-683) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCCC[C@@H]1OC[C@@H](N)[C@@H]1O		CHEMBL1819205	=	Inhibition	%	47.0	CHEMBL3616	Homo sapiens	INH	%	47.0
	6335532	CHEMBL1821096	Inhibition of N-terminal GST-fused PKClota (1-587) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCCC[C@@H]1OC[C@@H](N)[C@@H]1O		CHEMBL1819205	=	Inhibition	%	94.8	CHEMBL3616	Homo sapiens	INH	%	94.8
	6335541	CHEMBL1821101	Inhibition of N-terminal GST-fused PKClota (1-587) expressed in baculovirus expression system at 3 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCCC[C@H]1OC[C@@H](N)[C@@H]1O		CHEMBL1819204	=	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	6335545	CHEMBL1821097	Inhibition of N-terminal GST-fused PKCeta (1-683) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCCC[C@H]1OC[C@@H](N)[C@@H]1O		CHEMBL1819204	=	Inhibition	%	55.4	CHEMBL3616	Homo sapiens	INH	%	55.4
	6335546	CHEMBL1821096	Inhibition of N-terminal GST-fused PKClota (1-587) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCCC[C@H]1OC[C@@H](N)[C@@H]1O		CHEMBL1819204	=	Inhibition	%	99.9	CHEMBL3616	Homo sapiens	INH	%	99.9
	6340993	CHEMBL1827579	Activity of PRKCH kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	98.0	CHEMBL3616	Homo sapiens	Activity	%	98.0
	7567447	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7567935	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7568403	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7568835	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7569438	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7569910	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7570373	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7570800	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7570954	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7571411	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7571887	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7572350	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7572766	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7572935	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7573392	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7573868	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7574337	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	290.0	CHEMBL3616	Homo sapiens	Kd	nM	290.0
	7574745	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7574913	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7575374	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7575845	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7576887	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7577346	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7577824	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7577852	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7578257	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7578895	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	9.5	CHEMBL3616	Homo sapiens	Kd	nM	9.5
	7579269	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7579719	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	350.0	CHEMBL3616	Homo sapiens	Kd	nM	350.0
	7580220	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	810.0	CHEMBL3616	Homo sapiens	Kd	nM	810.0
	7580623	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7581253	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7581638	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7582112	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7582576	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7582976	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7583599	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7583999	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7584470	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	46.0	CHEMBL3616	Homo sapiens	Kd	nM	46.0
	7584932	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7585336	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7585895	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7586341	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7586812	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	1800.0	CHEMBL3616	Homo sapiens	Kd	nM	1800.0
	7587266	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7587448	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7587867	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7588320	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7588791	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7589242	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7589413	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7589837	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	140.0	CHEMBL3616	Homo sapiens	Kd	nM	140.0
	7590304	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7590778	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7591229	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7591386	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7591808	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7592280	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7592753	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7593353	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7593788	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7594260	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	2.4	CHEMBL3616	Homo sapiens	Kd	nM	2.4
	7594743	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7595321	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7595765	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7596268	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7596715	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7597293	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7597746	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7597777	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7598247	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3616	Homo sapiens	Kd	nM	10000.0
	7598689	CHEMBL1908746	Binding constant for PRKCH kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	4.8	CHEMBL3616	Homo sapiens	Kd	nM	4.8
	7961121	CHEMBL1931542	Inhibition of PKCeta	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL3616	Homo sapiens	IC50	uM	30.0
	7961122	CHEMBL1931542	Inhibition of PKCeta	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL3616	Homo sapiens	IC50	uM	30.0
	8061232	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.93	CHEMBL3616	Homo sapiens	Inhibition	%	1.93
	8061409	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.89	CHEMBL3616	Homo sapiens	Inhibition	%	-0.89
	8061633	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.79	CHEMBL3616	Homo sapiens	Inhibition	%	2.79
	8061740	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.72	CHEMBL3616	Homo sapiens	Inhibition	%	2.72
	8061931	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.86	CHEMBL3616	Homo sapiens	Inhibition	%	2.86
	8062155	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	-0.57	CHEMBL3616	Homo sapiens	Inhibition	%	-0.57
	8062271	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	6.3	CHEMBL3616	Homo sapiens	Inhibition	%	6.3
	8062657	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	8.55	CHEMBL3616	Homo sapiens	Inhibition	%	8.55
	8062755	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	5.32	CHEMBL3616	Homo sapiens	Inhibition	%	5.32
	8062979	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	4.86	CHEMBL3616	Homo sapiens	Inhibition	%	4.86
	8063111	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	3.81	CHEMBL3616	Homo sapiens	Inhibition	%	3.81
	8063502	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.3	CHEMBL3616	Homo sapiens	Inhibition	%	2.3
	8063610	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-0.32	CHEMBL3616	Homo sapiens	Inhibition	%	-0.32
	8063834	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-0.29	CHEMBL3616	Homo sapiens	Inhibition	%	-0.29
	8064016	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.1	CHEMBL3616	Homo sapiens	Inhibition	%	2.1
	8064131	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	29.41	CHEMBL3616	Homo sapiens	Inhibition	%	29.41
	8064355	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	43.64	CHEMBL3616	Homo sapiens	Inhibition	%	43.64
	8064565	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.38	CHEMBL3616	Homo sapiens	Inhibition	%	1.38
	8064703	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.42	CHEMBL3616	Homo sapiens	Inhibition	%	0.42
	8064927	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-1.25	CHEMBL3616	Homo sapiens	Inhibition	%	-1.25
	8065093	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.15	CHEMBL3616	Homo sapiens	Inhibition	%	1.15
	8065433	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	-0.37	CHEMBL3616	Homo sapiens	Inhibition	%	-0.37
	8065608	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.3	CHEMBL3616	Homo sapiens	Inhibition	%	1.3
	8065947	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	87.96	CHEMBL3616	Homo sapiens	Inhibition	%	87.96
	8066157	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	4.76	CHEMBL3616	Homo sapiens	Inhibition	%	4.76
	8066517	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.16	CHEMBL3616	Homo sapiens	Inhibition	%	3.16
	8066683	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.68	CHEMBL3616	Homo sapiens	Inhibition	%	1.68
	8067031	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	4.28	CHEMBL3616	Homo sapiens	Inhibition	%	4.28
	8067206	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.95	CHEMBL3616	Homo sapiens	Inhibition	%	0.95
	8067551	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.31	CHEMBL3616	Homo sapiens	Inhibition	%	1.31
	8067761	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	21.13	CHEMBL3616	Homo sapiens	Inhibition	%	21.13
	8068120	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.86	CHEMBL3616	Homo sapiens	Inhibition	%	3.86
	8068284	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.23	CHEMBL3616	Homo sapiens	Inhibition	%	0.23
	8068508	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.0	CHEMBL3616	Homo sapiens	Inhibition	%	2.0
	8068633	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	3.5	CHEMBL3616	Homo sapiens	Inhibition	%	3.5
	8068807	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.18	CHEMBL3616	Homo sapiens	Inhibition	%	2.18
	8069031	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.61	CHEMBL3616	Homo sapiens	Inhibition	%	2.61
	8069156	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	3.71	CHEMBL3616	Homo sapiens	Inhibition	%	3.71
	8069451	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	17.29	CHEMBL3616	Homo sapiens	Inhibition	%	17.29
	8069836	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-0.95	CHEMBL3616	Homo sapiens	Inhibition	%	-0.95
	8069962	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.09	CHEMBL3616	Homo sapiens	Inhibition	%	2.09
	8070358	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-1.46	CHEMBL3616	Homo sapiens	Inhibition	%	-1.46
	8070483	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.36	CHEMBL3616	Homo sapiens	Inhibition	%	1.36
	8070707	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.07	CHEMBL3616	Homo sapiens	Inhibition	%	0.07
	8070781	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	61.51	CHEMBL3616	Homo sapiens	Inhibition	%	61.51
	8071162	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.95	CHEMBL3616	Homo sapiens	Inhibition	%	2.95
	8071288	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.08	CHEMBL3616	Homo sapiens	Inhibition	%	-0.08
	8071512	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.61	CHEMBL3616	Homo sapiens	Inhibition	%	2.61
	8071685	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.62	CHEMBL3616	Homo sapiens	Inhibition	%	3.62
	8072034	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	2.29	CHEMBL3616	Homo sapiens	Inhibition	%	2.29
	8072124	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.61	CHEMBL3616	Homo sapiens	Inhibition	%	0.61
	8072348	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-1.2	CHEMBL3616	Homo sapiens	Inhibition	%	-1.2
	8072505	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.8	CHEMBL3616	Homo sapiens	Inhibition	%	2.8
	8072854	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.66	CHEMBL3616	Homo sapiens	Inhibition	%	1.66
	8073021	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.72	CHEMBL3616	Homo sapiens	Inhibition	%	2.72
	8073370	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.44	CHEMBL3616	Homo sapiens	Inhibition	%	1.44
	8073489	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.77	CHEMBL3616	Homo sapiens	Inhibition	%	-0.77
	8073713	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-1.47	CHEMBL3616	Homo sapiens	Inhibition	%	-1.47
	8073946	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	19.54	CHEMBL3616	Homo sapiens	Inhibition	%	19.54
	8074098	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	6.1	CHEMBL3616	Homo sapiens	Inhibition	%	6.1
	8074452	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.73	CHEMBL3616	Homo sapiens	Inhibition	%	0.73
	8074609	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.28	CHEMBL3616	Homo sapiens	Inhibition	%	3.28
	8074833	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.22	CHEMBL3616	Homo sapiens	Inhibition	%	0.22
	8074960	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-2.11	CHEMBL3616	Homo sapiens	Inhibition	%	-2.11
	8075295	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-2.71	CHEMBL3616	Homo sapiens	Inhibition	%	-2.71
	8075532	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	67.34	CHEMBL3616	Homo sapiens	Inhibition	%	67.34
	8075673	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.84	CHEMBL3616	Homo sapiens	Inhibition	%	3.84
	8075897	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	8.96	CHEMBL3616	Homo sapiens	Inhibition	%	8.96
	8076039	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.89	CHEMBL3616	Homo sapiens	Inhibition	%	1.89
	8076411	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-1.3	CHEMBL3616	Homo sapiens	Inhibition	%	-1.3
	8076545	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-3.36	CHEMBL3616	Homo sapiens	Inhibition	%	-3.36
	8076871	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-1.13	CHEMBL3616	Homo sapiens	Inhibition	%	-1.13
	8077118	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	96.28	CHEMBL3616	Homo sapiens	Inhibition	%	96.28
	8077470	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.8	CHEMBL3616	Homo sapiens	Inhibition	%	0.8
	8077621	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.45	CHEMBL3616	Homo sapiens	Inhibition	%	1.45
	8077988	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.58	CHEMBL3616	Homo sapiens	Inhibition	%	0.58
	8078127	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-3.29	CHEMBL3616	Homo sapiens	Inhibition	%	-3.29
	8078351	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-5.2	CHEMBL3616	Homo sapiens	Inhibition	%	-5.2
	8078453	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.55	CHEMBL3616	Homo sapiens	Inhibition	%	-0.55
	8078703	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	99.03	CHEMBL3616	Homo sapiens	Inhibition	%	99.03
	8079043	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.76	CHEMBL3616	Homo sapiens	Inhibition	%	3.76
	8079201	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.53	CHEMBL3616	Homo sapiens	Inhibition	%	0.53
	8079425	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.23	CHEMBL3616	Homo sapiens	Inhibition	%	0.23
	8079567	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.68	CHEMBL3616	Homo sapiens	Inhibition	%	0.68
	8079930	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.99	CHEMBL3616	Homo sapiens	Inhibition	%	2.99
	8080035	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.63	CHEMBL3616	Homo sapiens	Inhibition	%	2.63
	8080259	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.88	CHEMBL3616	Homo sapiens	Inhibition	%	1.88
	8080287	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-1.68	CHEMBL3616	Homo sapiens	Inhibition	%	-1.68
	8080511	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	1.97	CHEMBL3616	Homo sapiens	Inhibition	%	1.97
	8080626	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	-0.44	CHEMBL3616	Homo sapiens	Inhibition	%	-0.44
	8081014	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.01	CHEMBL3616	Homo sapiens	Inhibition	%	-2.01
	8081149	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.14	CHEMBL3616	Homo sapiens	Inhibition	%	0.14
	8081517	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	9.93	CHEMBL3616	Homo sapiens	Inhibition	%	9.93
	8081844	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	2.97	CHEMBL3616	Homo sapiens	Inhibition	%	2.97
	8082096	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	42.33	CHEMBL3616	Homo sapiens	Inhibition	%	42.33
	8082209	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	-0.65	CHEMBL3616	Homo sapiens	Inhibition	%	-0.65
	8082433	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.71	CHEMBL3616	Homo sapiens	Inhibition	%	3.71
	8082606	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.29	CHEMBL3616	Homo sapiens	Inhibition	%	0.29
	8082729	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	7.1	CHEMBL3616	Homo sapiens	Inhibition	%	7.1
	8082953	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.68	CHEMBL3616	Homo sapiens	Inhibition	%	2.68
	8083109	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	3.58	CHEMBL3616	Homo sapiens	Inhibition	%	3.58
	8083432	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.82	CHEMBL3616	Homo sapiens	Inhibition	%	1.82
	8083686	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	88.46	CHEMBL3616	Homo sapiens	Inhibition	%	88.46
	8084020	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.79	CHEMBL3616	Homo sapiens	Inhibition	%	4.79
	8084205	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	2.36	CHEMBL3616	Homo sapiens	Inhibition	%	2.36
	8084547	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	-1.26	CHEMBL3616	Homo sapiens	Inhibition	%	-1.26
	8084708	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	4.66	CHEMBL3616	Homo sapiens	Inhibition	%	4.66
	8085030	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.34	CHEMBL3616	Homo sapiens	Inhibition	%	3.34
	8085286	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-5.63	CHEMBL3616	Homo sapiens	Inhibition	%	-5.63
	8085618	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.14	CHEMBL3616	Homo sapiens	Inhibition	%	2.14
	8085807	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	3.07	CHEMBL3616	Homo sapiens	Inhibition	%	3.07
	8086146	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.17	CHEMBL3616	Homo sapiens	Inhibition	%	1.17
	8086308	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	3.63	CHEMBL3616	Homo sapiens	Inhibition	%	3.63
	8086532	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	8.67	CHEMBL3616	Homo sapiens	Inhibition	%	8.67
	8086631	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.11	CHEMBL3616	Homo sapiens	Inhibition	%	1.11
	8087066	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	5.49	CHEMBL3616	Homo sapiens	Inhibition	%	5.49
	8087224	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	5.65	CHEMBL3616	Homo sapiens	Inhibition	%	5.65
	8087562	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	7.06	CHEMBL3616	Homo sapiens	Inhibition	%	7.06
	8087700	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.75	CHEMBL3616	Homo sapiens	Inhibition	%	3.75
	8087924	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	3.65	CHEMBL3616	Homo sapiens	Inhibition	%	3.65
	8088066	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.16	CHEMBL3616	Homo sapiens	Inhibition	%	4.16
	8088438	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.53	CHEMBL3616	Homo sapiens	Inhibition	%	1.53
	8088566	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	5.28	CHEMBL3616	Homo sapiens	Inhibition	%	5.28
	8088883	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	67.57	CHEMBL3616	Homo sapiens	Inhibition	%	67.57
	8089235	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.59	CHEMBL3616	Homo sapiens	Inhibition	%	1.59
	8089383	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.51	CHEMBL3616	Homo sapiens	Inhibition	%	0.51
	8089727	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.14	CHEMBL3616	Homo sapiens	Inhibition	%	0.14
	8089907	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.15	CHEMBL3616	Homo sapiens	Inhibition	%	1.15
	8090131	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.26	CHEMBL3616	Homo sapiens	Inhibition	%	1.26
	8090296	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.37	CHEMBL3616	Homo sapiens	Inhibition	%	1.37
	8090463	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.77	CHEMBL3616	Homo sapiens	Inhibition	%	0.77
	8090826	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.81	CHEMBL3616	Homo sapiens	Inhibition	%	0.81
	8091031	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.12	CHEMBL3616	Homo sapiens	Inhibition	%	3.12
	8091392	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	5.56	CHEMBL3616	Homo sapiens	Inhibition	%	5.56
	8091547	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.46	CHEMBL3616	Homo sapiens	Inhibition	%	3.46
	8091771	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	5.6	CHEMBL3616	Homo sapiens	Inhibition	%	5.6
	8091887	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	7.33	CHEMBL3616	Homo sapiens	Inhibition	%	7.33
	8092248	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.37	CHEMBL3616	Homo sapiens	Inhibition	%	1.37
	8092399	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	5.83	CHEMBL3616	Homo sapiens	Inhibition	%	5.83
	8092771	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.43	CHEMBL3616	Homo sapiens	Inhibition	%	1.43
	8092900	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.1	CHEMBL3616	Homo sapiens	Inhibition	%	3.1
	8093124	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	5.09	CHEMBL3616	Homo sapiens	Inhibition	%	5.09
	8093212	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.94	CHEMBL3616	Homo sapiens	Inhibition	%	3.94
	8093576	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	81.36	CHEMBL3616	Homo sapiens	Inhibition	%	81.36
	8093715	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.14	CHEMBL3616	Homo sapiens	Inhibition	%	2.14
	8093939	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.35	CHEMBL3616	Homo sapiens	Inhibition	%	-0.35
	8094059	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.6	CHEMBL3616	Homo sapiens	Inhibition	%	0.6
	8094463	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.42	CHEMBL3616	Homo sapiens	Inhibition	%	2.42
	8094638	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.05	CHEMBL3616	Homo sapiens	Inhibition	%	1.05
	8094794	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.23	CHEMBL3616	Homo sapiens	Inhibition	%	4.23
	8095018	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	4.58	CHEMBL3616	Homo sapiens	Inhibition	%	4.58
	8095158	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-0.51	CHEMBL3616	Homo sapiens	Inhibition	%	-0.51
	8095361	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.6	CHEMBL3616	Homo sapiens	Inhibition	%	3.6
	8095585	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	2.95	CHEMBL3616	Homo sapiens	Inhibition	%	2.95
	8095726	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	4.73	CHEMBL3616	Homo sapiens	Inhibition	%	4.73
	8096098	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.69	CHEMBL3616	Homo sapiens	Inhibition	%	3.69
	8096215	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	6.23	CHEMBL3616	Homo sapiens	Inhibition	%	6.23
	8096439	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.59	CHEMBL3616	Homo sapiens	Inhibition	%	3.59
	8096578	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.86	CHEMBL3616	Homo sapiens	Inhibition	%	1.86
	8096734	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	7.05	CHEMBL3616	Homo sapiens	Inhibition	%	7.05
	8096958	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.72	CHEMBL3616	Homo sapiens	Inhibition	%	3.72
	8097105	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.98	CHEMBL3616	Homo sapiens	Inhibition	%	1.98
	8097412	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.31	CHEMBL3616	Homo sapiens	Inhibition	%	0.31
	8097636	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	2.72	CHEMBL3616	Homo sapiens	Inhibition	%	2.72
	8097786	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	96.79	CHEMBL3616	Homo sapiens	Inhibition	%	96.79
	8098143	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	3.15	CHEMBL3616	Homo sapiens	Inhibition	%	3.15
	8098263	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.43	CHEMBL3616	Homo sapiens	Inhibition	%	0.43
	8098487	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.12	CHEMBL3616	Homo sapiens	Inhibition	%	1.12
	8098667	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.37	CHEMBL3616	Homo sapiens	Inhibition	%	0.37
	8098852	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	3.09	CHEMBL3616	Homo sapiens	Inhibition	%	3.09
	8099220	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.63	CHEMBL3616	Homo sapiens	Inhibition	%	3.63
	8099362	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.8	CHEMBL3616	Homo sapiens	Inhibition	%	3.8
	8099586	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.47	CHEMBL3616	Homo sapiens	Inhibition	%	3.47
	8099780	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.36	CHEMBL3616	Homo sapiens	Inhibition	%	0.36
	8099927	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.56	CHEMBL3616	Homo sapiens	Inhibition	%	5.56
	8100297	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	3.38	CHEMBL3616	Homo sapiens	Inhibition	%	3.38
	8100637	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	6.05	CHEMBL3616	Homo sapiens	Inhibition	%	6.05
	8100777	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.18	CHEMBL3616	Homo sapiens	Inhibition	%	2.18
	8101161	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	6.14	CHEMBL3616	Homo sapiens	Inhibition	%	6.14
	8101303	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.81	CHEMBL3616	Homo sapiens	Inhibition	%	-0.81
	8101712	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.95	CHEMBL3616	Homo sapiens	Inhibition	%	3.95
	8101965	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	1.53	CHEMBL3616	Homo sapiens	Inhibition	%	1.53
	8102120	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-3.0	CHEMBL3616	Homo sapiens	Inhibition	%	-3.0
	8102475	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	3.12	CHEMBL3616	Homo sapiens	Inhibition	%	3.12
	8102819	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-2.7	CHEMBL3616	Homo sapiens	Inhibition	%	-2.7
	8102997	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.45	CHEMBL3616	Homo sapiens	Inhibition	%	0.45
	8103193	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	97.88	CHEMBL3616	Homo sapiens	Inhibition	%	97.88
	8103417	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	97.12	CHEMBL3616	Homo sapiens	Inhibition	%	97.12
	8103555	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.84	CHEMBL3616	Homo sapiens	Inhibition	%	1.84
	8103929	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.69	CHEMBL3616	Homo sapiens	Inhibition	%	3.69
	8104114	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.84	CHEMBL3616	Homo sapiens	Inhibition	%	0.84
	8104262	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.73	CHEMBL3616	Homo sapiens	Inhibition	%	4.73
	8104486	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.52	CHEMBL3616	Homo sapiens	Inhibition	%	5.52
	8104632	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.24	CHEMBL3616	Homo sapiens	Inhibition	%	1.24
	8104970	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.43	CHEMBL3616	Homo sapiens	Inhibition	%	5.43
	8105110	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	3.99	CHEMBL3616	Homo sapiens	Inhibition	%	3.99
	8105334	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	3.69	CHEMBL3616	Homo sapiens	Inhibition	%	3.69
	8105500	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.46	CHEMBL3616	Homo sapiens	Inhibition	%	2.46
	8105638	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-4.38	CHEMBL3616	Homo sapiens	Inhibition	%	-4.38
	8105862	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	4.07	CHEMBL3616	Homo sapiens	Inhibition	%	4.07
	8105918	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.22	CHEMBL3616	Homo sapiens	Inhibition	%	0.22
	8106142	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-0.44	CHEMBL3616	Homo sapiens	Inhibition	%	-0.44
	8106307	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	6.55	CHEMBL3616	Homo sapiens	Inhibition	%	6.55
	8106463	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	5.2	CHEMBL3616	Homo sapiens	Inhibition	%	5.2
	8106687	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	19.59	CHEMBL3616	Homo sapiens	Inhibition	%	19.59
	8106816	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.58	CHEMBL3616	Homo sapiens	Inhibition	%	0.58
	8107161	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.78	CHEMBL3616	Homo sapiens	Inhibition	%	1.78
	8107333	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.02	CHEMBL3616	Homo sapiens	Inhibition	%	3.02
	8107758	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.87	CHEMBL3616	Homo sapiens	Inhibition	%	2.87
	8107893	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.62	CHEMBL3616	Homo sapiens	Inhibition	%	2.62
	8108275	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.55	CHEMBL3616	Homo sapiens	Inhibition	%	1.55
	8108450	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.24	CHEMBL3616	Homo sapiens	Inhibition	%	-0.24
	8108821	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.34	CHEMBL3616	Homo sapiens	Inhibition	%	5.34
	8108963	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.32	CHEMBL3616	Homo sapiens	Inhibition	%	1.32
	8109301	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.76	CHEMBL3616	Homo sapiens	Inhibition	%	2.76
	8109655	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.99	CHEMBL3616	Homo sapiens	Inhibition	%	-0.99
	8109826	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	4.62	CHEMBL3616	Homo sapiens	Inhibition	%	4.62
	8110182	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	6.3	CHEMBL3616	Homo sapiens	Inhibition	%	6.3
	8110461	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.2	CHEMBL3616	Homo sapiens	Inhibition	%	3.2
	8110627	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.14	CHEMBL3616	Homo sapiens	Inhibition	%	0.14
	8111009	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	73.41	CHEMBL3616	Homo sapiens	Inhibition	%	73.41
	8111132	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	2.69	CHEMBL3616	Homo sapiens	Inhibition	%	2.69
	8111356	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	2.14	CHEMBL3616	Homo sapiens	Inhibition	%	2.14
	8111483	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	87.08	CHEMBL3616	Homo sapiens	Inhibition	%	87.08
	8111649	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-0.28	CHEMBL3616	Homo sapiens	Inhibition	%	-0.28
	8111873	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	2.86	CHEMBL3616	Homo sapiens	Inhibition	%	2.86
	8112078	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.87	CHEMBL3616	Homo sapiens	Inhibition	%	0.87
	8112215	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.66	CHEMBL3616	Homo sapiens	Inhibition	%	-0.66
	8112439	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-5.32	CHEMBL3616	Homo sapiens	Inhibition	%	-5.32
	8112607	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	4.76	CHEMBL3616	Homo sapiens	Inhibition	%	4.76
	8112779	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.81	CHEMBL3616	Homo sapiens	Inhibition	%	1.81
	8113003	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.91	CHEMBL3616	Homo sapiens	Inhibition	%	-0.91
	8113155	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	78.88	CHEMBL3616	Homo sapiens	Inhibition	%	78.88
	8113291	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.22	CHEMBL3616	Homo sapiens	Inhibition	%	1.22
	8113515	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.32	CHEMBL3616	Homo sapiens	Inhibition	%	1.32
	8113639	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.94	CHEMBL3616	Homo sapiens	Inhibition	%	3.94
	8113979	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.13	CHEMBL3616	Homo sapiens	Inhibition	%	-0.13
	8114155	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	6.28	CHEMBL3616	Homo sapiens	Inhibition	%	6.28
	8114511	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	5.34	CHEMBL3616	Homo sapiens	Inhibition	%	5.34
	8114787	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	-0.62	CHEMBL3616	Homo sapiens	Inhibition	%	-0.62
	8114953	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.5	CHEMBL3616	Homo sapiens	Inhibition	%	1.5
	8115177	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	1.23	CHEMBL3616	Homo sapiens	Inhibition	%	1.23
	8115342	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.65	CHEMBL3616	Homo sapiens	Inhibition	%	0.65
	8115686	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.59	CHEMBL3616	Homo sapiens	Inhibition	%	1.59
	8115819	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	96.35	CHEMBL3616	Homo sapiens	Inhibition	%	96.35
	8116202	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.08	CHEMBL3616	Homo sapiens	Inhibition	%	-0.08
	8116405	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	89.71	CHEMBL3616	Homo sapiens	Inhibition	%	89.71
	8116763	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.07	CHEMBL3616	Homo sapiens	Inhibition	%	2.07
	8116935	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	6.59	CHEMBL3616	Homo sapiens	Inhibition	%	6.59
	8117330	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-1.41	CHEMBL3616	Homo sapiens	Inhibition	%	-1.41
	8117488	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	95.38	CHEMBL3616	Homo sapiens	Inhibition	%	95.38
	8117842	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-1.74	CHEMBL3616	Homo sapiens	Inhibition	%	-1.74
	8117980	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.45	CHEMBL3616	Homo sapiens	Inhibition	%	3.45
	8118204	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	5.62	CHEMBL3616	Homo sapiens	Inhibition	%	5.62
	8118320	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.17	CHEMBL3616	Homo sapiens	Inhibition	%	1.17
	8118492	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.9	CHEMBL3616	Homo sapiens	Inhibition	%	4.9
	8118716	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.44	CHEMBL3616	Homo sapiens	Inhibition	%	3.44
	8118852	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.83	CHEMBL3616	Homo sapiens	Inhibition	%	4.83
	8119123	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.08	CHEMBL3616	Homo sapiens	Inhibition	%	1.08
	8119506	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.68	CHEMBL3616	Homo sapiens	Inhibition	%	3.68
	8119673	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.65	CHEMBL3616	Homo sapiens	Inhibition	%	3.65
	8120016	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.26	CHEMBL3616	Homo sapiens	Inhibition	%	3.26
	8120155	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.94	CHEMBL3616	Homo sapiens	Inhibition	%	0.94
	8120379	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	3.26	CHEMBL3616	Homo sapiens	Inhibition	%	3.26
	8120539	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.67	CHEMBL3616	Homo sapiens	Inhibition	%	-1.67
	8120740	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	99.9	CHEMBL3616	Homo sapiens	Inhibition	%	99.9
	8121092	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-1.13	CHEMBL3616	Homo sapiens	Inhibition	%	-1.13
	8121264	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.47	CHEMBL3616	Homo sapiens	Inhibition	%	2.47
	8121488	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	4.45	CHEMBL3616	Homo sapiens	Inhibition	%	4.45
	8121655	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.16	CHEMBL3616	Homo sapiens	Inhibition	%	1.16
	8121818	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.09	CHEMBL3616	Homo sapiens	Inhibition	%	5.09
	8122163	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.01	CHEMBL3616	Homo sapiens	Inhibition	%	0.01
	8122525	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	1.67	CHEMBL3616	Homo sapiens	Inhibition	%	1.67
	8122645	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.18	CHEMBL3616	Homo sapiens	Inhibition	%	5.18
	8123036	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	5.74	CHEMBL3616	Homo sapiens	Inhibition	%	5.74
	8123178	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	5.48	CHEMBL3616	Homo sapiens	Inhibition	%	5.48
	8123402	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	5.95	CHEMBL3616	Homo sapiens	Inhibition	%	5.95
	8123456	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.46	CHEMBL3616	Homo sapiens	Inhibition	%	1.46
	8123680	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	4.9	CHEMBL3616	Homo sapiens	Inhibition	%	4.9
	8123830	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	0.52	CHEMBL3616	Homo sapiens	Inhibition	%	0.52
	8123997	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	3.47	CHEMBL3616	Homo sapiens	Inhibition	%	3.47
	8124221	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.69	CHEMBL3616	Homo sapiens	Inhibition	%	0.69
	8124340	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	2.46	CHEMBL3616	Homo sapiens	Inhibition	%	2.46
	8124703	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.43	CHEMBL3616	Homo sapiens	Inhibition	%	1.43
	8124868	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-2.51	CHEMBL3616	Homo sapiens	Inhibition	%	-2.51
	8125069	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	7.26	CHEMBL3616	Homo sapiens	Inhibition	%	7.26
	8125293	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	5.32	CHEMBL3616	Homo sapiens	Inhibition	%	5.32
	8125423	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.43	CHEMBL3616	Homo sapiens	Inhibition	%	-1.43
	8125815	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.22	CHEMBL3616	Homo sapiens	Inhibition	%	2.22
	8125979	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.24	CHEMBL3616	Homo sapiens	Inhibition	%	0.24
	8126143	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.7	CHEMBL3616	Homo sapiens	Inhibition	%	2.7
	8126367	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	5.27	CHEMBL3616	Homo sapiens	Inhibition	%	5.27
	8126482	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-2.29	CHEMBL3616	Homo sapiens	Inhibition	%	-2.29
	8126842	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	6.53	CHEMBL3616	Homo sapiens	Inhibition	%	6.53
	8126964	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.53	CHEMBL3616	Homo sapiens	Inhibition	%	1.53
	8127188	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	5.81	CHEMBL3616	Homo sapiens	Inhibition	%	5.81
	8127355	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	3.12	CHEMBL3616	Homo sapiens	Inhibition	%	3.12
	8127721	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	0.55	CHEMBL3616	Homo sapiens	Inhibition	%	0.55
	8128009	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	-1.37	CHEMBL3616	Homo sapiens	Inhibition	%	-1.37
	8128161	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.0	CHEMBL3616	Homo sapiens	Inhibition	%	3.0
	8128552	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.33	CHEMBL3616	Homo sapiens	Inhibition	%	1.33
	8128671	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	7.69	CHEMBL3616	Homo sapiens	Inhibition	%	7.69
	8129032	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.81	CHEMBL3616	Homo sapiens	Inhibition	%	1.81
	8129203	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.38	CHEMBL3616	Homo sapiens	Inhibition	%	0.38
	8129427	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.11	CHEMBL3616	Homo sapiens	Inhibition	%	-1.11
	8129616	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	3.18	CHEMBL3616	Homo sapiens	Inhibition	%	3.18
	8129755	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	2.91	CHEMBL3616	Homo sapiens	Inhibition	%	2.91
	8130140	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.8	CHEMBL3616	Homo sapiens	Inhibition	%	1.8
	8130312	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.58	CHEMBL3616	Homo sapiens	Inhibition	%	0.58
	8130696	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	7.25	CHEMBL3616	Homo sapiens	Inhibition	%	7.25
	8130812	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	5.38	CHEMBL3616	Homo sapiens	Inhibition	%	5.38
	8131036	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.36	CHEMBL3616	Homo sapiens	Inhibition	%	4.36
	8131175	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	2.13	CHEMBL3616	Homo sapiens	Inhibition	%	2.13
	8131519	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.18	CHEMBL3616	Homo sapiens	Inhibition	%	3.18
	8131686	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	3.91	CHEMBL3616	Homo sapiens	Inhibition	%	3.91
	8132051	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	6.96	CHEMBL3616	Homo sapiens	Inhibition	%	6.96
	8132337	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	4.46	CHEMBL3616	Homo sapiens	Inhibition	%	4.46
	8132484	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.61	CHEMBL3616	Homo sapiens	Inhibition	%	4.61
	8132708	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.22	CHEMBL3616	Homo sapiens	Inhibition	%	0.22
	8132876	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.39	CHEMBL3616	Homo sapiens	Inhibition	%	2.39
	8132997	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.3	CHEMBL3616	Homo sapiens	Inhibition	%	2.3
	8133221	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	7.54	CHEMBL3616	Homo sapiens	Inhibition	%	7.54
	8133359	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.63	CHEMBL3616	Homo sapiens	Inhibition	%	1.63
	8133755	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.89	CHEMBL3616	Homo sapiens	Inhibition	%	-2.89
	8133935	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.34	CHEMBL3616	Homo sapiens	Inhibition	%	2.34
	8134083	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-4.39	CHEMBL3616	Homo sapiens	Inhibition	%	-4.39
	8134307	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.49	CHEMBL3616	Homo sapiens	Inhibition	%	-1.49
	8134467	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	4.75	CHEMBL3616	Homo sapiens	Inhibition	%	4.75
	8134651	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.7	CHEMBL3616	Homo sapiens	Inhibition	%	-0.7
	8134875	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-4.5	CHEMBL3616	Homo sapiens	Inhibition	%	-4.5
	8135035	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.25	CHEMBL3616	Homo sapiens	Inhibition	%	2.25
	8135374	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.55	CHEMBL3616	Homo sapiens	Inhibition	%	4.55
	8135515	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	6.84	CHEMBL3616	Homo sapiens	Inhibition	%	6.84
	8135860	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	5.19	CHEMBL3616	Homo sapiens	Inhibition	%	5.19
	8136028	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	5.46	CHEMBL3616	Homo sapiens	Inhibition	%	5.46
	8136252	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	4.14	CHEMBL3616	Homo sapiens	Inhibition	%	4.14
	8136396	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	7.87	CHEMBL3616	Homo sapiens	Inhibition	%	7.87
	8136686	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.91	CHEMBL3616	Homo sapiens	Inhibition	%	1.91
	8137045	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	14.11	CHEMBL3616	Homo sapiens	Inhibition	%	14.11
	8137208	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	2.17	CHEMBL3616	Homo sapiens	Inhibition	%	2.17
	8137552	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	3.75	CHEMBL3616	Homo sapiens	Inhibition	%	3.75
	8137700	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.3	CHEMBL3616	Homo sapiens	Inhibition	%	3.3
	8138090	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.15	CHEMBL3616	Homo sapiens	Inhibition	%	1.15
	8138269	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	3.05	CHEMBL3616	Homo sapiens	Inhibition	%	3.05
	8138641	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.29	CHEMBL3616	Homo sapiens	Inhibition	%	-2.29
	8138799	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.88	CHEMBL3616	Homo sapiens	Inhibition	%	3.88
	8139208	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	5.57	CHEMBL3616	Homo sapiens	Inhibition	%	5.57
	8139367	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.16	CHEMBL3616	Homo sapiens	Inhibition	%	5.16
	8139705	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	5.11	CHEMBL3616	Homo sapiens	Inhibition	%	5.11
	8139846	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.12	CHEMBL3616	Homo sapiens	Inhibition	%	2.12
	8140070	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.25	CHEMBL3616	Homo sapiens	Inhibition	%	4.25
	8140193	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.1	CHEMBL3616	Homo sapiens	Inhibition	%	4.1
	8140576	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.68	CHEMBL3616	Homo sapiens	Inhibition	%	3.68
	8140719	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	4.75	CHEMBL3616	Homo sapiens	Inhibition	%	4.75
	8141021	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.35	CHEMBL3616	Homo sapiens	Inhibition	%	3.35
	8141375	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.3	CHEMBL3616	Homo sapiens	Inhibition	%	-0.3
	8141535	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	2.92	CHEMBL3616	Homo sapiens	Inhibition	%	2.92
	8141878	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	1.62	CHEMBL3616	Homo sapiens	Inhibition	%	1.62
	8142039	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	1.65	CHEMBL3616	Homo sapiens	Inhibition	%	1.65
	8142263	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	2.32	CHEMBL3616	Homo sapiens	Inhibition	%	2.32
	8142431	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-5.73	CHEMBL3616	Homo sapiens	Inhibition	%	-5.73
	8142607	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.2	CHEMBL3616	Homo sapiens	Inhibition	%	2.2
	8142831	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.62	CHEMBL3616	Homo sapiens	Inhibition	%	1.62
	8142980	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.07	CHEMBL3616	Homo sapiens	Inhibition	%	-3.07
	8143135	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.79	CHEMBL3616	Homo sapiens	Inhibition	%	4.79
	8143359	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.72	CHEMBL3616	Homo sapiens	Inhibition	%	2.72
	8143546	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.17	CHEMBL3616	Homo sapiens	Inhibition	%	2.17
	8143705	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	5.12	CHEMBL3616	Homo sapiens	Inhibition	%	5.12
	8143929	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	4.11	CHEMBL3616	Homo sapiens	Inhibition	%	4.11
	8144043	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	5.37	CHEMBL3616	Homo sapiens	Inhibition	%	5.37
	8144406	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	5.31	CHEMBL3616	Homo sapiens	Inhibition	%	5.31
	8144536	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	5.29	CHEMBL3616	Homo sapiens	Inhibition	%	5.29
	8144760	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.08	CHEMBL3616	Homo sapiens	Inhibition	%	5.08
	8144913	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.41	CHEMBL3616	Homo sapiens	Inhibition	%	1.41
	8145050	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.07	CHEMBL3616	Homo sapiens	Inhibition	%	4.07
	8145274	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.1	CHEMBL3616	Homo sapiens	Inhibition	%	3.1
	8145363	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	-0.3	CHEMBL3616	Homo sapiens	Inhibition	%	-0.3
	8145587	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.72	CHEMBL3616	Homo sapiens	Inhibition	%	0.72
	8145711	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.42	CHEMBL3616	Homo sapiens	Inhibition	%	1.42
	8145872	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.33	CHEMBL3616	Homo sapiens	Inhibition	%	1.33
	8146096	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	3.8	CHEMBL3616	Homo sapiens	Inhibition	%	3.8
	8146216	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-1.46	CHEMBL3616	Homo sapiens	Inhibition	%	-1.46
	8146600	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.28	CHEMBL3616	Homo sapiens	Inhibition	%	1.28
	8146767	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	5.16	CHEMBL3616	Homo sapiens	Inhibition	%	5.16
	8147160	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.54	CHEMBL3616	Homo sapiens	Inhibition	%	3.54
	8147302	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.08	CHEMBL3616	Homo sapiens	Inhibition	%	2.08
	8147679	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.87	CHEMBL3616	Homo sapiens	Inhibition	%	0.87
	8147866	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.26	CHEMBL3616	Homo sapiens	Inhibition	%	2.26
	8148248	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.48	CHEMBL3616	Homo sapiens	Inhibition	%	2.48
	8148362	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	5.42	CHEMBL3616	Homo sapiens	Inhibition	%	5.42
	8148586	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.8	CHEMBL3616	Homo sapiens	Inhibition	%	3.8
	8148725	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	5.77	CHEMBL3616	Homo sapiens	Inhibition	%	5.77
	8149087	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.97	CHEMBL3616	Homo sapiens	Inhibition	%	5.97
	8149246	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	2.38	CHEMBL3616	Homo sapiens	Inhibition	%	2.38
	8149604	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	73.91	CHEMBL3616	Homo sapiens	Inhibition	%	73.91
	8149926	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	3.06	CHEMBL3616	Homo sapiens	Inhibition	%	3.06
	8150051	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	1.15	CHEMBL3616	Homo sapiens	Inhibition	%	1.15
	8150435	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.23	CHEMBL3616	Homo sapiens	Inhibition	%	1.23
	8150555	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.54	CHEMBL3616	Homo sapiens	Inhibition	%	0.54
	8150779	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-1.16	CHEMBL3616	Homo sapiens	Inhibition	%	-1.16
	8150944	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	3.46	CHEMBL3616	Homo sapiens	Inhibition	%	3.46
	8151107	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-4.21	CHEMBL3616	Homo sapiens	Inhibition	%	-4.21
	8151331	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.72	CHEMBL3616	Homo sapiens	Inhibition	%	-3.72
	8151508	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.47	CHEMBL3616	Homo sapiens	Inhibition	%	0.47
	8151646	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.01	CHEMBL3616	Homo sapiens	Inhibition	%	3.01
	8151870	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.98	CHEMBL3616	Homo sapiens	Inhibition	%	0.98
	8152024	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.72	CHEMBL3616	Homo sapiens	Inhibition	%	0.72
	8152212	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.91	CHEMBL3616	Homo sapiens	Inhibition	%	3.91
	8152436	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.81	CHEMBL3616	Homo sapiens	Inhibition	%	3.81
	8152594	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.31	CHEMBL3616	Homo sapiens	Inhibition	%	5.31
	8152932	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	6.38	CHEMBL3616	Homo sapiens	Inhibition	%	6.38
	8153071	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.86	CHEMBL3616	Homo sapiens	Inhibition	%	4.86
	8153432	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	6.14	CHEMBL3616	Homo sapiens	Inhibition	%	6.14
	8153589	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.49	CHEMBL3616	Homo sapiens	Inhibition	%	1.49
	8153813	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.6	CHEMBL3616	Homo sapiens	Inhibition	%	1.6
	8153946	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	93.64	CHEMBL3616	Homo sapiens	Inhibition	%	93.64
	8154267	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	20.76	CHEMBL3616	Homo sapiens	Inhibition	%	20.76
	8154393	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.71	CHEMBL3616	Homo sapiens	Inhibition	%	-0.71
	8154617	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	2.42	CHEMBL3616	Homo sapiens	Inhibition	%	2.42
	8154776	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.12	CHEMBL3616	Homo sapiens	Inhibition	%	-0.12
	8155120	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.67	CHEMBL3616	Homo sapiens	Inhibition	%	-0.67
	8155296	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.68	CHEMBL3616	Homo sapiens	Inhibition	%	-1.68
	8155681	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.59	CHEMBL3616	Homo sapiens	Inhibition	%	0.59
	8155859	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.53	CHEMBL3616	Homo sapiens	Inhibition	%	0.53
	8156221	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.29	CHEMBL3616	Homo sapiens	Inhibition	%	-0.29
	8156433	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.1	CHEMBL3616	Homo sapiens	Inhibition	%	2.1
	8156583	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.11	CHEMBL3616	Homo sapiens	Inhibition	%	3.11
	8156807	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.71	CHEMBL3616	Homo sapiens	Inhibition	%	4.71
	8156950	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.9	CHEMBL3616	Homo sapiens	Inhibition	%	1.9
	8157294	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	9.11	CHEMBL3616	Homo sapiens	Inhibition	%	9.11
	8157435	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	6.38	CHEMBL3616	Homo sapiens	Inhibition	%	6.38
	8157659	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	3.64	CHEMBL3616	Homo sapiens	Inhibition	%	3.64
	8157789	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.58	CHEMBL3616	Homo sapiens	Inhibition	%	2.58
	8158174	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.27	CHEMBL3616	Homo sapiens	Inhibition	%	1.27
	8158424	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	51.24	CHEMBL3616	Homo sapiens	Inhibition	%	51.24
	8158582	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.22	CHEMBL3616	Homo sapiens	Inhibition	%	2.22
	8158975	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.93	CHEMBL3616	Homo sapiens	Inhibition	%	3.93
	8159110	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.88	CHEMBL3616	Homo sapiens	Inhibition	%	2.88
	8159454	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-2.42	CHEMBL3616	Homo sapiens	Inhibition	%	-2.42
	8159809	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	1.86	CHEMBL3616	Homo sapiens	Inhibition	%	1.86
	8159950	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.85	CHEMBL3616	Homo sapiens	Inhibition	%	1.85
	8160311	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.17	CHEMBL3616	Homo sapiens	Inhibition	%	3.17
	8160461	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-3.17	CHEMBL3616	Homo sapiens	Inhibition	%	-3.17
	8160755	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.62	CHEMBL3616	Homo sapiens	Inhibition	%	1.62
	8161129	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	5.63	CHEMBL3616	Homo sapiens	Inhibition	%	5.63
	8161272	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	4.51	CHEMBL3616	Homo sapiens	Inhibition	%	4.51
	8161496	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	8.26	CHEMBL3616	Homo sapiens	Inhibition	%	8.26
	8161621	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.05	CHEMBL3616	Homo sapiens	Inhibition	%	2.05
	8161983	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.29	CHEMBL3616	Homo sapiens	Inhibition	%	2.29
	8162113	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	7.31	CHEMBL3616	Homo sapiens	Inhibition	%	7.31
	8162497	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.68	CHEMBL3616	Homo sapiens	Inhibition	%	1.68
	8162750	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	88.35	CHEMBL3616	Homo sapiens	Inhibition	%	88.35
	8162898	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	6.21	CHEMBL3616	Homo sapiens	Inhibition	%	6.21
	8163122	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	4.18	CHEMBL3616	Homo sapiens	Inhibition	%	4.18
	8163291	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.52	CHEMBL3616	Homo sapiens	Inhibition	%	3.52
	8163425	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.07	CHEMBL3616	Homo sapiens	Inhibition	%	5.07
	8163649	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	6.39	CHEMBL3616	Homo sapiens	Inhibition	%	6.39
	8163772	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	7.59	CHEMBL3616	Homo sapiens	Inhibition	%	7.59
	8164130	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	1.44	CHEMBL3616	Homo sapiens	Inhibition	%	1.44
	8164270	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.68	CHEMBL3616	Homo sapiens	Inhibition	%	1.68
	8164494	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-2.97	CHEMBL3616	Homo sapiens	Inhibition	%	-2.97
	8164649	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	7.07	CHEMBL3616	Homo sapiens	Inhibition	%	7.07
	8164793	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.04	CHEMBL3616	Homo sapiens	Inhibition	%	-1.04
	8165017	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.05	CHEMBL3616	Homo sapiens	Inhibition	%	4.05
	8165087	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.78	CHEMBL3616	Homo sapiens	Inhibition	%	2.78
	8165311	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.52	CHEMBL3616	Homo sapiens	Inhibition	%	1.52
	8165452	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.28	CHEMBL3616	Homo sapiens	Inhibition	%	2.28
	8165819	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.47	CHEMBL3616	Homo sapiens	Inhibition	%	1.47
	8165945	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	5.24	CHEMBL3616	Homo sapiens	Inhibition	%	5.24
	8166307	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	5.6	CHEMBL3616	Homo sapiens	Inhibition	%	5.6
	8166437	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.41	CHEMBL3616	Homo sapiens	Inhibition	%	2.41
	8166661	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	9.76	CHEMBL3616	Homo sapiens	Inhibition	%	9.76
	8166762	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	-1.03	CHEMBL3616	Homo sapiens	Inhibition	%	-1.03
	8167074	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	71.15	CHEMBL3616	Homo sapiens	Inhibition	%	71.15
	8167439	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	6.04	CHEMBL3616	Homo sapiens	Inhibition	%	6.04
	8167603	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.65	CHEMBL3616	Homo sapiens	Inhibition	%	3.65
	8167960	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	26.63	CHEMBL3616	Homo sapiens	Inhibition	%	26.63
	8168084	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.55	CHEMBL3616	Homo sapiens	Inhibition	%	3.55
	8168308	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	10.84	CHEMBL3616	Homo sapiens	Inhibition	%	10.84
	8168449	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.29	CHEMBL3616	Homo sapiens	Inhibition	%	2.29
	8168809	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-2.13	CHEMBL3616	Homo sapiens	Inhibition	%	-2.13
	8168973	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	31.91	CHEMBL3616	Homo sapiens	Inhibition	%	31.91
	8169339	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.11	CHEMBL3616	Homo sapiens	Inhibition	%	1.11
	8169643	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	5.07	CHEMBL3616	Homo sapiens	Inhibition	%	5.07
	8169777	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	5.57	CHEMBL3616	Homo sapiens	Inhibition	%	5.57
	8170146	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	-0.03	CHEMBL3616	Homo sapiens	Inhibition	%	-0.03
	8170271	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	4.66	CHEMBL3616	Homo sapiens	Inhibition	%	4.66
	8170495	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.34	CHEMBL3616	Homo sapiens	Inhibition	%	3.34
	8170635	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	83.67	CHEMBL3616	Homo sapiens	Inhibition	%	83.67
	8170994	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.03	CHEMBL3616	Homo sapiens	Inhibition	%	1.03
	8171191	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	3.09	CHEMBL3616	Homo sapiens	Inhibition	%	3.09
	8171408	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	94.9	CHEMBL3616	Homo sapiens	Inhibition	%	94.9
	8171773	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	9.1	CHEMBL3616	Homo sapiens	Inhibition	%	9.1
	8171926	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.06	CHEMBL3616	Homo sapiens	Inhibition	%	0.06
	8172150	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.37	CHEMBL3616	Homo sapiens	Inhibition	%	3.37
	8172282	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	3.3	CHEMBL3616	Homo sapiens	Inhibition	%	3.3
	8172634	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-2.29	CHEMBL3616	Homo sapiens	Inhibition	%	-2.29
	8172776	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.92	CHEMBL3616	Homo sapiens	Inhibition	%	4.92
	8173136	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-2.3	CHEMBL3616	Homo sapiens	Inhibition	%	-2.3
	8173301	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.72	CHEMBL3616	Homo sapiens	Inhibition	%	4.72
	8173525	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	2.1	CHEMBL3616	Homo sapiens	Inhibition	%	2.1
	8173666	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.09	CHEMBL3616	Homo sapiens	Inhibition	%	3.09
	8173977	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	2.38	CHEMBL3616	Homo sapiens	Inhibition	%	2.38
	8174109	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.57	CHEMBL3616	Homo sapiens	Inhibition	%	4.57
	8174333	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	5.34	CHEMBL3616	Homo sapiens	Inhibition	%	5.34
	8174481	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.93	CHEMBL3616	Homo sapiens	Inhibition	%	3.93
	8174827	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.54	CHEMBL3616	Homo sapiens	Inhibition	%	3.54
	8174970	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	97.78	CHEMBL3616	Homo sapiens	Inhibition	%	97.78
	8175330	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	3.89	CHEMBL3616	Homo sapiens	Inhibition	%	3.89
	8175586	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	5.57	CHEMBL3616	Homo sapiens	Inhibition	%	5.57
	8175749	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	4.55	CHEMBL3616	Homo sapiens	Inhibition	%	4.55
	8175973	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.34	CHEMBL3616	Homo sapiens	Inhibition	%	2.34
	8176126	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	47.06	CHEMBL3616	Homo sapiens	Inhibition	%	47.06
	8176499	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.02	CHEMBL3616	Homo sapiens	Inhibition	%	2.02
	8176631	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	3.84	CHEMBL3616	Homo sapiens	Inhibition	%	3.84
	8176985	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.53	CHEMBL3616	Homo sapiens	Inhibition	%	-0.53
	8177127	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.0	CHEMBL3616	Homo sapiens	Inhibition	%	1.0
	8177351	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	5.67	CHEMBL3616	Homo sapiens	Inhibition	%	5.67
	8177489	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	3.82	CHEMBL3616	Homo sapiens	Inhibition	%	3.82
	8177877	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	1.76	CHEMBL3616	Homo sapiens	Inhibition	%	1.76
	8178017	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	0.7	CHEMBL3616	Homo sapiens	Inhibition	%	0.7
	8178329	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.05	CHEMBL3616	Homo sapiens	Inhibition	%	1.05
	8178680	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.28	CHEMBL3616	Homo sapiens	Inhibition	%	3.28
	8178829	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-1.4	CHEMBL3616	Homo sapiens	Inhibition	%	-1.4
	8179176	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	-2.11	CHEMBL3616	Homo sapiens	Inhibition	%	-2.11
	8179320	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	6.25	CHEMBL3616	Homo sapiens	Inhibition	%	6.25
	8179544	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.31	CHEMBL3616	Homo sapiens	Inhibition	%	4.31
	8179681	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.45	CHEMBL3616	Homo sapiens	Inhibition	%	2.45
	8179938	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.63	CHEMBL3616	Homo sapiens	Inhibition	%	4.63
	8180316	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.87	CHEMBL3616	Homo sapiens	Inhibition	%	2.87
	8180472	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	88.38	CHEMBL3616	Homo sapiens	Inhibition	%	88.38
	8180844	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.17	CHEMBL3616	Homo sapiens	Inhibition	%	2.17
	8180977	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.56	CHEMBL3616	Homo sapiens	Inhibition	%	2.56
	8181201	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	6.46	CHEMBL3616	Homo sapiens	Inhibition	%	6.46
	8181332	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-1.23	CHEMBL3616	Homo sapiens	Inhibition	%	-1.23
	8181696	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.72	CHEMBL3616	Homo sapiens	Inhibition	%	2.72
	8181835	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	19.48	CHEMBL3616	Homo sapiens	Inhibition	%	19.48
	8182222	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	6.71	CHEMBL3616	Homo sapiens	Inhibition	%	6.71
	8182362	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.94	CHEMBL3616	Homo sapiens	Inhibition	%	0.94
	8182586	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.72	CHEMBL3616	Homo sapiens	Inhibition	%	1.72
	8182678	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.68	CHEMBL3616	Homo sapiens	Inhibition	%	1.68
	8183024	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.58	CHEMBL3616	Homo sapiens	Inhibition	%	2.58
	8183173	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-0.85	CHEMBL3616	Homo sapiens	Inhibition	%	-0.85
	8183397	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.66	CHEMBL3616	Homo sapiens	Inhibition	%	1.66
	8183526	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.27	CHEMBL3616	Homo sapiens	Inhibition	%	1.27
	8183892	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.13	CHEMBL3616	Homo sapiens	Inhibition	%	4.13
	8184028	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	3.94	CHEMBL3616	Homo sapiens	Inhibition	%	3.94
	8184252	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.23	CHEMBL3616	Homo sapiens	Inhibition	%	1.23
	8184294	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.6	CHEMBL3616	Homo sapiens	Inhibition	%	5.6
	8184518	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.13	CHEMBL3616	Homo sapiens	Inhibition	%	6.13
	8184665	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	4.5	CHEMBL3616	Homo sapiens	Inhibition	%	4.5
	8184822	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	2.26	CHEMBL3616	Homo sapiens	Inhibition	%	2.26
	8185046	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	6.09	CHEMBL3616	Homo sapiens	Inhibition	%	6.09
	8185195	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.39	CHEMBL3616	Homo sapiens	Inhibition	%	1.39
	8185550	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	0.97	CHEMBL3616	Homo sapiens	Inhibition	%	0.97
	8185681	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-1.17	CHEMBL3616	Homo sapiens	Inhibition	%	-1.17
	8185905	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.06	CHEMBL3616	Homo sapiens	Inhibition	%	2.06
	8186044	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.77	CHEMBL3616	Homo sapiens	Inhibition	%	2.77
	8186185	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	1.15	CHEMBL3616	Homo sapiens	Inhibition	%	1.15
	8186409	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.16	CHEMBL3616	Homo sapiens	Inhibition	%	7.16
	8186573	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	2.61	CHEMBL3616	Homo sapiens	Inhibition	%	2.61
	8186936	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	5.94	CHEMBL3616	Homo sapiens	Inhibition	%	5.94
	8187034	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.74	CHEMBL3616	Homo sapiens	Inhibition	%	1.74
	8187258	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	-2.58	CHEMBL3616	Homo sapiens	Inhibition	%	-2.58
	8187382	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	6.47	CHEMBL3616	Homo sapiens	Inhibition	%	6.47
	8187754	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.99	CHEMBL3616	Homo sapiens	Inhibition	%	1.99
	8187883	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.69	CHEMBL3616	Homo sapiens	Inhibition	%	6.69
	8188107	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-0.12	CHEMBL3616	Homo sapiens	Inhibition	%	-0.12
	8188250	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.71	CHEMBL3616	Homo sapiens	Inhibition	%	4.71
	8188609	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	2.85	CHEMBL3616	Homo sapiens	Inhibition	%	2.85
	8188883	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.04	CHEMBL3616	Homo sapiens	Inhibition	%	6.04
	8189031	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.82	CHEMBL3616	Homo sapiens	Inhibition	%	0.82
	8189411	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	1.78	CHEMBL3616	Homo sapiens	Inhibition	%	1.78
	8189560	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	3.4	CHEMBL3616	Homo sapiens	Inhibition	%	3.4
	8189916	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	4.94	CHEMBL3616	Homo sapiens	Inhibition	%	4.94
	8190272	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.62	CHEMBL3616	Homo sapiens	Inhibition	%	1.62
	8190412	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.05	CHEMBL3616	Homo sapiens	Inhibition	%	5.05
	8190773	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.08	CHEMBL3616	Homo sapiens	Inhibition	%	3.08
	8190937	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	6.52	CHEMBL3616	Homo sapiens	Inhibition	%	6.52
	8191299	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	-2.33	CHEMBL3616	Homo sapiens	Inhibition	%	-2.33
	8191619	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.89	CHEMBL3616	Homo sapiens	Inhibition	%	2.89
	8191741	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	6.9	CHEMBL3616	Homo sapiens	Inhibition	%	6.9
	8191965	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.55	CHEMBL3616	Homo sapiens	Inhibition	%	2.55
	8192114	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	-0.26	CHEMBL3616	Homo sapiens	Inhibition	%	-0.26
	8192467	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.73	CHEMBL3616	Homo sapiens	Inhibition	%	4.73
	8192611	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.83	CHEMBL3616	Homo sapiens	Inhibition	%	4.83
	8192971	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.53	CHEMBL3616	Homo sapiens	Inhibition	%	1.53
	8193243	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.71	CHEMBL3616	Homo sapiens	Inhibition	%	3.71
	8193388	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	3.21	CHEMBL3616	Homo sapiens	Inhibition	%	3.21
	8193612	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.47	CHEMBL3616	Homo sapiens	Inhibition	%	1.47
	8193769	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.72	CHEMBL3616	Homo sapiens	Inhibition	%	3.72
	8193918	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.82	CHEMBL3616	Homo sapiens	Inhibition	%	1.82
	8194142	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	11.17	CHEMBL3616	Homo sapiens	Inhibition	%	11.17
	8194273	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.76	CHEMBL3616	Homo sapiens	Inhibition	%	3.76
	8194628	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.02	CHEMBL3616	Homo sapiens	Inhibition	%	0.02
	8194771	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	7.89	CHEMBL3616	Homo sapiens	Inhibition	%	7.89
	8194995	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.25	CHEMBL3616	Homo sapiens	Inhibition	%	3.25
	8195128	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.5	CHEMBL3616	Homo sapiens	Inhibition	%	2.5
	8195292	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	4.29	CHEMBL3616	Homo sapiens	Inhibition	%	4.29
	8195516	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	7.64	CHEMBL3616	Homo sapiens	Inhibition	%	7.64
	8195655	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.79	CHEMBL3616	Homo sapiens	Inhibition	%	3.79
	8195977	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.1	CHEMBL3616	Homo sapiens	Inhibition	%	2.1
	8196318	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.75	CHEMBL3616	Homo sapiens	Inhibition	%	2.75
	8196468	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.7	CHEMBL3616	Homo sapiens	Inhibition	%	0.7
	8196820	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	4.49	CHEMBL3616	Homo sapiens	Inhibition	%	4.49
	8196961	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	5.78	CHEMBL3616	Homo sapiens	Inhibition	%	5.78
	8197185	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.33	CHEMBL3616	Homo sapiens	Inhibition	%	4.33
	8197322	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.66	CHEMBL3616	Homo sapiens	Inhibition	%	-0.66
	8197597	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	8.19	CHEMBL3616	Homo sapiens	Inhibition	%	8.19
	8197961	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.19	CHEMBL3616	Homo sapiens	Inhibition	%	2.19
	8198118	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.25	CHEMBL3616	Homo sapiens	Inhibition	%	4.25
	8198480	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.28	CHEMBL3616	Homo sapiens	Inhibition	%	4.28
	8198610	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	0.65	CHEMBL3616	Homo sapiens	Inhibition	%	0.65
	8198834	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.22	CHEMBL3616	Homo sapiens	Inhibition	%	4.22
	8198965	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.59	CHEMBL3616	Homo sapiens	Inhibition	%	3.59
	8199337	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.62	CHEMBL3616	Homo sapiens	Inhibition	%	3.62
	8199471	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	0.23	CHEMBL3616	Homo sapiens	Inhibition	%	0.23
	8199858	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	-1.29	CHEMBL3616	Homo sapiens	Inhibition	%	-1.29
	8199996	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.71	CHEMBL3616	Homo sapiens	Inhibition	%	1.71
	8200220	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.81	CHEMBL3616	Homo sapiens	Inhibition	%	4.81
	8200324	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.59	CHEMBL3616	Homo sapiens	Inhibition	%	-0.59
	8200663	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	0.97	CHEMBL3616	Homo sapiens	Inhibition	%	0.97
	8200813	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.97	CHEMBL3616	Homo sapiens	Inhibition	%	1.97
	8201037	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	2.39	CHEMBL3616	Homo sapiens	Inhibition	%	2.39
	8201167	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	4.09	CHEMBL3616	Homo sapiens	Inhibition	%	4.09
	8201526	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.62	CHEMBL3616	Homo sapiens	Inhibition	%	3.62
	8201659	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.16	CHEMBL3616	Homo sapiens	Inhibition	%	0.16
	8201938	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.51	CHEMBL3616	Homo sapiens	Inhibition	%	4.51
	8202302	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.62	CHEMBL3616	Homo sapiens	Inhibition	%	-1.62
	8202469	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.84	CHEMBL3616	Homo sapiens	Inhibition	%	4.84
	8202818	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	6.6	CHEMBL3616	Homo sapiens	Inhibition	%	6.6
	8203172	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	8.36	CHEMBL3616	Homo sapiens	Inhibition	%	8.36
	8203303	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	4.05	CHEMBL3616	Homo sapiens	Inhibition	%	4.05
	8203673	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.67	CHEMBL3616	Homo sapiens	Inhibition	%	3.67
	8203807	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.62	CHEMBL3616	Homo sapiens	Inhibition	%	4.62
	8204031	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.04	CHEMBL3616	Homo sapiens	Inhibition	%	4.04
	8204197	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.71	CHEMBL3616	Homo sapiens	Inhibition	%	3.71
	8204558	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	3.71	CHEMBL3616	Homo sapiens	Inhibition	%	3.71
	8204663	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.77	CHEMBL3616	Homo sapiens	Inhibition	%	-0.77
	8204887	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-1.89	CHEMBL3616	Homo sapiens	Inhibition	%	-1.89
	8205002	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	7.35	CHEMBL3616	Homo sapiens	Inhibition	%	7.35
	8205375	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	2.99	CHEMBL3616	Homo sapiens	Inhibition	%	2.99
	8205511	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	7.44	CHEMBL3616	Homo sapiens	Inhibition	%	7.44
	8205874	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.52	CHEMBL3616	Homo sapiens	Inhibition	%	3.52
	8206006	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.69	CHEMBL3616	Homo sapiens	Inhibition	%	0.69
	8206230	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-3.78	CHEMBL3616	Homo sapiens	Inhibition	%	-3.78
	8206282	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.84	CHEMBL3616	Homo sapiens	Inhibition	%	4.84
	8206506	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	6.52	CHEMBL3616	Homo sapiens	Inhibition	%	6.52
	8206649	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.96	CHEMBL3616	Homo sapiens	Inhibition	%	-1.96
	8206829	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	6.38	CHEMBL3616	Homo sapiens	Inhibition	%	6.38
	8207053	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	10.03	CHEMBL3616	Homo sapiens	Inhibition	%	10.03
	8207179	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.47	CHEMBL3616	Homo sapiens	Inhibition	%	5.47
	8207533	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	6.81	CHEMBL3616	Homo sapiens	Inhibition	%	6.81
	8207665	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.15	CHEMBL3616	Homo sapiens	Inhibition	%	1.15
	8207889	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.45	CHEMBL3616	Homo sapiens	Inhibition	%	2.45
	8208034	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.05	CHEMBL3616	Homo sapiens	Inhibition	%	2.05
	8208390	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.03	CHEMBL3616	Homo sapiens	Inhibition	%	5.03
	8208556	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	4.97	CHEMBL3616	Homo sapiens	Inhibition	%	4.97
	8208913	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	45.92	CHEMBL3616	Homo sapiens	Inhibition	%	45.92
	8209242	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-1.48	CHEMBL3616	Homo sapiens	Inhibition	%	-1.48
	8209358	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	5.03	CHEMBL3616	Homo sapiens	Inhibition	%	5.03
	8209732	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.31	CHEMBL3616	Homo sapiens	Inhibition	%	3.31
	8209868	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	24.12	CHEMBL3616	Homo sapiens	Inhibition	%	24.12
	8210092	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.41	CHEMBL3616	Homo sapiens	Inhibition	%	4.41
	8210233	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.84	CHEMBL3616	Homo sapiens	Inhibition	%	4.84
	8210593	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.16	CHEMBL3616	Homo sapiens	Inhibition	%	0.16
	8210852	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	7.5	CHEMBL3616	Homo sapiens	Inhibition	%	7.5
	8210996	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.15	CHEMBL3616	Homo sapiens	Inhibition	%	2.15
	8211390	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	5.63	CHEMBL3616	Homo sapiens	Inhibition	%	5.63
	8211513	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	7.42	CHEMBL3616	Homo sapiens	Inhibition	%	7.42
	8211737	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.05	CHEMBL3616	Homo sapiens	Inhibition	%	4.05
	8211866	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	12.91	CHEMBL3616	Homo sapiens	Inhibition	%	12.91
	8212222	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.7	CHEMBL3616	Homo sapiens	Inhibition	%	2.7
	8212363	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.22	CHEMBL3616	Homo sapiens	Inhibition	%	3.22
	8212720	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.46	CHEMBL3616	Homo sapiens	Inhibition	%	3.46
	8212890	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	14.11	CHEMBL3616	Homo sapiens	Inhibition	%	14.11
	8213114	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-1.38	CHEMBL3616	Homo sapiens	Inhibition	%	-1.38
	8213243	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	88.77	CHEMBL3616	Homo sapiens	Inhibition	%	88.77
	8213571	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-3.26	CHEMBL3616	Homo sapiens	Inhibition	%	-3.26
	8213684	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.77	CHEMBL3616	Homo sapiens	Inhibition	%	2.77
	8213908	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.48	CHEMBL3616	Homo sapiens	Inhibition	%	1.48
	8214055	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	-0.1	CHEMBL3616	Homo sapiens	Inhibition	%	-0.1
	8214416	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.05	CHEMBL3616	Homo sapiens	Inhibition	%	4.05
	8214550	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	6.2	CHEMBL3616	Homo sapiens	Inhibition	%	6.2
	8214774	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	4.32	CHEMBL3616	Homo sapiens	Inhibition	%	4.32
	8214926	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-2.82	CHEMBL3616	Homo sapiens	Inhibition	%	-2.82
	8215177	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.26	CHEMBL3616	Homo sapiens	Inhibition	%	4.26
	8215330	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.99	CHEMBL3616	Homo sapiens	Inhibition	%	0.99
	8215554	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.06	CHEMBL3616	Homo sapiens	Inhibition	%	3.06
	8215718	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.54	CHEMBL3616	Homo sapiens	Inhibition	%	3.54
	8216061	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	7.17	CHEMBL3616	Homo sapiens	Inhibition	%	7.17
	8216180	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-0.93	CHEMBL3616	Homo sapiens	Inhibition	%	-0.93
	8216540	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.22	CHEMBL3616	Homo sapiens	Inhibition	%	2.22
	8216678	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	6.59	CHEMBL3616	Homo sapiens	Inhibition	%	6.59
	8216902	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	49.28	CHEMBL3616	Homo sapiens	Inhibition	%	49.28
	8217036	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	6.75	CHEMBL3616	Homo sapiens	Inhibition	%	6.75
	8217434	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.47	CHEMBL3616	Homo sapiens	Inhibition	%	-0.47
	8217565	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	0.91	CHEMBL3616	Homo sapiens	Inhibition	%	0.91
	8217890	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-3.28	CHEMBL3616	Homo sapiens	Inhibition	%	-3.28
	8218229	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.32	CHEMBL3616	Homo sapiens	Inhibition	%	3.32
	8218356	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	2.52	CHEMBL3616	Homo sapiens	Inhibition	%	2.52
	8218580	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	0.62	CHEMBL3616	Homo sapiens	Inhibition	%	0.62
	8218723	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	6.58	CHEMBL3616	Homo sapiens	Inhibition	%	6.58
	8219078	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.1	CHEMBL3616	Homo sapiens	Inhibition	%	1.1
	8219238	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-2.18	CHEMBL3616	Homo sapiens	Inhibition	%	-2.18
	8219488	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	7.49	CHEMBL3616	Homo sapiens	Inhibition	%	7.49
	8219873	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.62	CHEMBL3616	Homo sapiens	Inhibition	%	2.62
	8220042	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.09	CHEMBL3616	Homo sapiens	Inhibition	%	4.09
	8220395	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	0.95	CHEMBL3616	Homo sapiens	Inhibition	%	0.95
	8220509	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.21	CHEMBL3616	Homo sapiens	Inhibition	%	1.21
	8220733	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	5.7	CHEMBL3616	Homo sapiens	Inhibition	%	5.7
	8220871	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	3.7	CHEMBL3616	Homo sapiens	Inhibition	%	3.7
	8221231	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	90.8	CHEMBL3616	Homo sapiens	Inhibition	%	90.8
	8221364	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.71	CHEMBL3616	Homo sapiens	Inhibition	%	2.71
	8221588	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.16	CHEMBL3616	Homo sapiens	Inhibition	%	4.16
	8221753	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.32	CHEMBL3616	Homo sapiens	Inhibition	%	0.32
	8221884	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	-1.63	CHEMBL3616	Homo sapiens	Inhibition	%	-1.63
	8222108	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.81	CHEMBL3616	Homo sapiens	Inhibition	%	2.81
	8222206	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.76	CHEMBL3616	Homo sapiens	Inhibition	%	3.76
	8222564	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.2	CHEMBL3616	Homo sapiens	Inhibition	%	3.2
	8222906	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.4	CHEMBL3616	Homo sapiens	Inhibition	%	3.4
	8223050	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	5.99	CHEMBL3616	Homo sapiens	Inhibition	%	5.99
	8223403	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	4.58	CHEMBL3616	Homo sapiens	Inhibition	%	4.58
	8223564	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.31	CHEMBL3616	Homo sapiens	Inhibition	%	1.31
	8223788	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.03	CHEMBL3616	Homo sapiens	Inhibition	%	-0.03
	8223814	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	7.27	CHEMBL3616	Homo sapiens	Inhibition	%	7.27
	8224038	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	7.65	CHEMBL3616	Homo sapiens	Inhibition	%	7.65
	8224200	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.39	CHEMBL3616	Homo sapiens	Inhibition	%	5.39
	8224370	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.31	CHEMBL3616	Homo sapiens	Inhibition	%	5.31
	8224594	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.87	CHEMBL3616	Homo sapiens	Inhibition	%	2.87
	8224729	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	6.37	CHEMBL3616	Homo sapiens	Inhibition	%	6.37
	8225067	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	39.09	CHEMBL3616	Homo sapiens	Inhibition	%	39.09
	8225201	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.19	CHEMBL3616	Homo sapiens	Inhibition	%	3.19
	8225425	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.17	CHEMBL3616	Homo sapiens	Inhibition	%	2.17
	8225563	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.35	CHEMBL3616	Homo sapiens	Inhibition	%	1.35
	8225922	CHEMBL1961902	GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.18	CHEMBL3616	Homo sapiens	Inhibition	%	5.18
	8226080	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.78	CHEMBL3616	Homo sapiens	Inhibition	%	1.78
	8226429	CHEMBL1961903	GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	-0.12	CHEMBL3616	Homo sapiens	Inhibition	%	-0.12
	10839461	CHEMBL2015492	Inhibition of PKCh at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	77.0	CHEMBL3616	Homo sapiens	INH	%	77.0
Not Active	11011592	CHEMBL2091242	Inhibition of Protein kinase C eta type at 10 uM by luciferase assay	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463		Inhibition	%		CHEMBL3616	Homo sapiens	INH		
	11011595	CHEMBL2091242	Inhibition of Protein kinase C eta type at 10 uM by luciferase assay	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	47.0	CHEMBL3616	Homo sapiens	INH	%	47.0
Active	11011606	CHEMBL2091242	Inhibition of Protein kinase C eta type at 10 uM by luciferase assay	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Inhibition	%		CHEMBL3616	Homo sapiens	INH		
	11011610	CHEMBL2091242	Inhibition of Protein kinase C eta type at 10 uM by luciferase assay	B	Fc1ccc(Cl)cc1-c1nc(Nc2ccncc2)c2nccnc2n1		CHEMBL238125	>	Inhibition	%	25.0	CHEMBL3616	Homo sapiens	INH	%	25.0
	11011621	CHEMBL2091242	Inhibition of Protein kinase C eta type at 10 uM by luciferase assay	B	O=C(c1ccc(Nc2nccc(-c3cc4ccccc4s3)n2)cc1)N1CCC(N2CCCC2)CC1		CHEMBL200027	=	Inhibition	%	83.0	CHEMBL3616	Homo sapiens	INH	%	83.0
	11011644	CHEMBL2091242	Inhibition of Protein kinase C eta type at 10 uM by luciferase assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	20.0	CHEMBL3616	Homo sapiens	INH	%	20.0
	12035133	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL1214929	=	IC50	nM	5.0	CHEMBL3616	Homo sapiens	IC50	nM	5.0
	12035134	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1nc(-c2ccncc2)cc2ccccc12		CHEMBL2147531	=	IC50	nM	743.0	CHEMBL3616	Homo sapiens	IC50	nM	743.0
	12035135	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1nc(-c2ccncc2)cc2ncccc12		CHEMBL2147532	=	IC50	nM	401.0	CHEMBL3616	Homo sapiens	IC50	nM	401.0
	12035136	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1nc(-c2ccncc2)cc2ccncc12		CHEMBL2147533	>	IC50	nM	1000.0	CHEMBL3616	Homo sapiens	IC50	nM	1000.0
	12035137	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1cc(-c2ccncc2)cc2cnccc12		CHEMBL2147534	=	IC50	nM	54.0	CHEMBL3616	Homo sapiens	IC50	nM	54.0
	12035138	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL2147535	=	IC50	nM	27.0	CHEMBL3616	Homo sapiens	IC50	nM	27.0
	12035139	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCOc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147536	=	IC50	nM	82.0	CHEMBL3616	Homo sapiens	IC50	nM	82.0
	12035140	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	C[C@H](N)CNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147537	=	IC50	nM	2.0	CHEMBL3616	Homo sapiens	IC50	nM	2.0
	12035141	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)(N)CNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147538	=	IC50	nM	9.0	CHEMBL3616	Homo sapiens	IC50	nM	9.0
	12035142	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NC(CNc1nc(-c2ccncc2)cc2cnccc12)Cc1ccccc1		CHEMBL2147539	=	IC50	nM	452.0	CHEMBL3616	Homo sapiens	IC50	nM	452.0
	12035143	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CN(CCN)c1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147540	=	IC50	nM	34.0	CHEMBL3616	Homo sapiens	IC50	nM	34.0
	12035144	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CNCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147541	=	IC50	nM	93.0	CHEMBL3616	Homo sapiens	IC50	nM	93.0
	12035145	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	c1cc(-c2cc3cnccc3c(N3CCNCC3)n2)ccn1		CHEMBL1214932	=	IC50	nM	6.0	CHEMBL3616	Homo sapiens	IC50	nM	6.0
	12035146	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	c1cc(-c2cc3cnccc3c(N3CCCNCC3)n2)ccn1		CHEMBL2147542	=	IC50	nM	4.0	CHEMBL3616	Homo sapiens	IC50	nM	4.0
	12035147	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NC1CCCN(c2nc(-c3ccncc3)cc3cnccc23)C1		CHEMBL2147543	=	IC50	nM	13.0	CHEMBL3616	Homo sapiens	IC50	nM	13.0
	12035148	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147544	=	IC50	nM	10.0	CHEMBL3616	Homo sapiens	IC50	nM	10.0
	12035149	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	OCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147545	=	IC50	nM	188.0	CHEMBL3616	Homo sapiens	IC50	nM	188.0
	12035150	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	O=C1CN(c2nc(-c3ccncc3)cc3cnccc23)CCN1		CHEMBL2147546	=	IC50	nM	735.0	CHEMBL3616	Homo sapiens	IC50	nM	735.0
	12035151	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)(N)CNc1nc(-c2cccnc2)cc2cnccc12		CHEMBL2147547	>	IC50	nM	1000.0	CHEMBL3616	Homo sapiens	IC50	nM	1000.0
	12035152	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)(N)CNc1nc(-c2ccnc(N)c2)cc2cnccc12		CHEMBL2147548	=	IC50	nM	60.0	CHEMBL3616	Homo sapiens	IC50	nM	60.0
	12035153	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)Nc1cc(-c2cc3cnccc3c(NCC(C)(C)N)n2)ccn1		CHEMBL2147549	=	IC50	nM	862.0	CHEMBL3616	Homo sapiens	IC50	nM	862.0
	12035154	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)(N)CNc1nc(-c2ccncc2F)cc2cnccc12		CHEMBL2147550	=	IC50	nM	18.0	CHEMBL3616	Homo sapiens	IC50	nM	18.0
	12035155	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)(N)CNc1nc(-c2ccncc2Cl)cc2cnccc12		CHEMBL2147551	=	IC50	nM	15.0	CHEMBL3616	Homo sapiens	IC50	nM	15.0
	12035156	CHEMBL2150524	Inhibition of recombinant human PKCeta assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	Cc1cnccc1-c1cc2cnccc2c(NCC(C)(C)N)n1		CHEMBL2147552	=	IC50	nM	52.0	CHEMBL3616	Homo sapiens	IC50	nM	52.0
	12035188	CHEMBL2150531	Inhibition of recombinant human PKCeta at 1 uM	B	C[C@H](N)CNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147537	>	Inhibition	%	80.0	CHEMBL3616	Homo sapiens	INH	%	80.0
	12039655	CHEMBL2148242	Inhibition of [3H]PDBu binding to PKCeta C1B domain	B	CO[C@@H](CC[C@H](C)[C@H]1O[C@@]23C[C@H](OC(=O)C[C@H]([C@@H](C)O)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)[C@@H]1C)c1cccc(O)c1		CHEMBL2148106	=	Ki	nM	0.11	CHEMBL3616	Homo sapiens	Ki	nM	0.11
	12039677	CHEMBL2148242	Inhibition of [3H]PDBu binding to PKCeta C1B domain	B	CC1(C)CC[C@@H]2CC(=O)O[C@@H](CO)CC(=O)O[C@@H]3C[C@@H](CCCCc4cccc(O)c4)O[C@@]1(C3)O2		CHEMBL1258348	=	Ki	nM	4.4	CHEMBL3616	Homo sapiens	Ki	nM	4.4
	12039694	CHEMBL2148242	Inhibition of [3H]PDBu binding to PKCeta C1B domain	B	C[C@@H]1CC(C)(C)[C@@]23C[C@@H](C[C@@H](CCCCc4cccc(O)c4)O2)OC(=O)C[C@H](CO)OC(=O)C[C@@H]1O3		CHEMBL2148107	=	Ki	nM	5.9	CHEMBL3616	Homo sapiens	Ki	nM	5.9
	12039712	CHEMBL2148242	Inhibition of [3H]PDBu binding to PKCeta C1B domain	B	C[C@H]1[C@@H]2C[C@@]3(O[C@H](CCC3(C)C)CC(=O)O[C@@H](CO)CC(=O)O2)O[C@@H]1CCCCc1cccc(O)c1		CHEMBL2148108	=	Ki	nM	0.45	CHEMBL3616	Homo sapiens	Ki	nM	0.45
	12047317	CHEMBL2157428	Inhibition of PKCeta at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1	Outside typical range	CHEMBL2152768	=	Inhibition	%	-15.6	CHEMBL3616	Homo sapiens	INH	%	-15.6
	12049494	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	IC50	nM	6.1	CHEMBL3616	Homo sapiens	IC50	nM	6.1
	12049503	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CN1CCN(c2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3c2)CC1		CHEMBL568580	=	IC50	nM	25.0	CHEMBL3616	Homo sapiens	IC50	nM	25.0
	12049512	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CN1CCN(c2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2153747	=	IC50	nM	118.0	CHEMBL3616	Homo sapiens	IC50	nM	118.0
	12049521	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CN1CCN(c2cc3ccccc3c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)n2)CC1		CHEMBL2153748	=	IC50	nM	6.2	CHEMBL3616	Homo sapiens	IC50	nM	6.2
	12049530	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	Cc1cccc2nc(N3CCN(C)CC3)nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c12		CHEMBL2153749	=	IC50	nM	9.2	CHEMBL3616	Homo sapiens	IC50	nM	9.2
	12049536	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3cc(F)ccc3n2)CC1		CHEMBL2153750	=	IC50	nM	1.9	CHEMBL3616	Homo sapiens	IC50	nM	1.9
	12049542	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3cc(Cl)ccc3n2)CC1		CHEMBL2153751	=	IC50	nM	5.4	CHEMBL3616	Homo sapiens	IC50	nM	5.4
	12049548	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	Cc1ccc2nc(N3CCN(C)CC3)nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL2153752	=	IC50	nM	25.0	CHEMBL3616	Homo sapiens	IC50	nM	25.0
	12049554	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CC(C)c1ccc2nc(N3CCN(C)CC3)nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL2153753	=	IC50	nM	283.0	CHEMBL3616	Homo sapiens	IC50	nM	283.0
	12049560	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3cc(C(C)(C)C)ccc3n2)CC1		CHEMBL2153754	>	IC50	nM	316.0	CHEMBL3616	Homo sapiens	IC50	nM	316.0
	12049566	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccc(F)cc3n2)CC1		CHEMBL2153755	=	IC50	nM	9.0	CHEMBL3616	Homo sapiens	IC50	nM	9.0
	12049572	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccc(Cl)cc3n2)CC1		CHEMBL2153756	=	IC50	nM	192.0	CHEMBL3616	Homo sapiens	IC50	nM	192.0
	12049578	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	Cc1cccc2c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)nc(N3CCN(C)CC3)nc12		CHEMBL2151406	=	IC50	nM	197.0	CHEMBL3616	Homo sapiens	IC50	nM	197.0
	12049584	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5cccc(Cl)c45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2151407	=	IC50	nM	202.0	CHEMBL3616	Homo sapiens	IC50	nM	202.0
	12049590	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccc(Cl)cc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2151408	=	IC50	nM	9.1	CHEMBL3616	Homo sapiens	IC50	nM	9.1
	12049596	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5cc(Cl)ccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2151409	=	IC50	nM	19.0	CHEMBL3616	Homo sapiens	IC50	nM	19.0
	12049602	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5c(Cl)cccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2151410	=	IC50	nM	17.0	CHEMBL3616	Homo sapiens	IC50	nM	17.0
	12050498	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	Cc1cccc2c(C3=C(c4nc(N5CCN(C)CC5)nc5ccccc45)C(=O)NC3=O)c[nH]c12		CHEMBL2151411	=	IC50	nM	1.7	CHEMBL3616	Homo sapiens	IC50	nM	1.7
	12050504	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2151412	=	IC50	nM	20.0	CHEMBL3616	Homo sapiens	IC50	nM	20.0
	12050510	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	CC(C)n1cc(C2=C(c3nc(N4CCN(C)CC4)nc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL2151413	=	IC50	nM	11.0	CHEMBL3616	Homo sapiens	IC50	nM	11.0
	12050516	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	Cc1[nH]c2ccccc2c1C1=C(c2nc(N3CCN(C)CC3)nc3ccccc23)C(=O)NC1=O		CHEMBL2151414	=	IC50	nM	65.0	CHEMBL3616	Homo sapiens	IC50	nM	65.0
	12050524	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	=	IC50	nM	1.0	CHEMBL3616	Homo sapiens	IC50	nM	1.0
	12050532	CHEMBL2156015	Inhibition of PKCeta by scintillation proximity assay	B	Cn1cc(C2=C(c3nc(N4CCNCC4)nc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL2151415	=	IC50	nM	3.3	CHEMBL3616	Homo sapiens	IC50	nM	3.3
	12074656	CHEMBL2161218	Inhibition of PKCeta at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	12145301	CHEMBL2186674	Inhibition of PKCeta using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1		CHEMBL2177819	>	Inhibition	%	25.0	CHEMBL3616	Homo sapiens	INH	%	25.0
	12145302	CHEMBL2186674	Inhibition of PKCeta using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1		CHEMBL2177818	>	Inhibition	%	25.0	CHEMBL3616	Homo sapiens	INH	%	25.0
	12172251	CHEMBL2212481	Inhibition of PRKCH assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	59.0	CHEMBL3616	Homo sapiens	Activity	%	59.0
	12252334	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12252335	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	79.0	CHEMBL3616	Homo sapiens	Residual Activity	%	79.0
	12252336	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	87.0	CHEMBL3616	Homo sapiens	Residual Activity	%	87.0
	12252337	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	76.0	CHEMBL3616	Homo sapiens	Residual Activity	%	76.0
	12252338	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	70.0	CHEMBL3616	Homo sapiens	Residual Activity	%	70.0
	12252339	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	76.0	CHEMBL3616	Homo sapiens	Residual Activity	%	76.0
	12252340	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	80.0	CHEMBL3616	Homo sapiens	Residual Activity	%	80.0
	12252341	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	73.0	CHEMBL3616	Homo sapiens	Residual Activity	%	73.0
	12252342	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	98.0	CHEMBL3616	Homo sapiens	Residual Activity	%	98.0
	12252343	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	84.0	CHEMBL3616	Homo sapiens	Residual Activity	%	84.0
	12252344	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	60.0	CHEMBL3616	Homo sapiens	Residual Activity	%	60.0
	12252345	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	61.0	CHEMBL3616	Homo sapiens	Residual Activity	%	61.0
	12252346	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	71.0	CHEMBL3616	Homo sapiens	Residual Activity	%	71.0
	12252347	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	17.0	CHEMBL3616	Homo sapiens	Residual Activity	%	17.0
	12252348	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	84.0	CHEMBL3616	Homo sapiens	Residual Activity	%	84.0
	12252349	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12252350	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12252351	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	87.0	CHEMBL3616	Homo sapiens	Residual Activity	%	87.0
	12252352	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	2.0	CHEMBL3616	Homo sapiens	Residual Activity	%	2.0
	12252353	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	67.0	CHEMBL3616	Homo sapiens	Residual Activity	%	67.0
	12252354	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	5.0	CHEMBL3616	Homo sapiens	Residual Activity	%	5.0
	12252355	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	4.0	CHEMBL3616	Homo sapiens	Residual Activity	%	4.0
	12252356	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	82.0	CHEMBL3616	Homo sapiens	Residual Activity	%	82.0
	12252357	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	76.0	CHEMBL3616	Homo sapiens	Residual Activity	%	76.0
	12252358	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	95.0	CHEMBL3616	Homo sapiens	Residual Activity	%	95.0
	12252359	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12252360	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	85.0	CHEMBL3616	Homo sapiens	Residual Activity	%	85.0
	12252361	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	66.0	CHEMBL3616	Homo sapiens	Residual Activity	%	66.0
	12252362	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	79.0	CHEMBL3616	Homo sapiens	Residual Activity	%	79.0
	12252363	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	29.0	CHEMBL3616	Homo sapiens	Residual Activity	%	29.0
	12252364	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	81.0	CHEMBL3616	Homo sapiens	Residual Activity	%	81.0
	12252365	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12252366	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	91.0	CHEMBL3616	Homo sapiens	Residual Activity	%	91.0
	12252367	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	93.0	CHEMBL3616	Homo sapiens	Residual Activity	%	93.0
	12252368	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12252369	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	82.0	CHEMBL3616	Homo sapiens	Residual Activity	%	82.0
	12252370	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	78.0	CHEMBL3616	Homo sapiens	Residual Activity	%	78.0
	12252371	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12252372	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	84.0	CHEMBL3616	Homo sapiens	Residual Activity	%	84.0
	12252373	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	84.0	CHEMBL3616	Homo sapiens	Residual Activity	%	84.0
	12252374	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	1.0	CHEMBL3616	Homo sapiens	Residual Activity	%	1.0
	12252375	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	97.0	CHEMBL3616	Homo sapiens	Residual Activity	%	97.0
	12252376	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	86.0	CHEMBL3616	Homo sapiens	Residual Activity	%	86.0
	12252377	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	80.0	CHEMBL3616	Homo sapiens	Residual Activity	%	80.0
	12252378	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	89.0	CHEMBL3616	Homo sapiens	Residual Activity	%	89.0
	12252379	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	81.0	CHEMBL3616	Homo sapiens	Residual Activity	%	81.0
	12252380	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	81.0	CHEMBL3616	Homo sapiens	Residual Activity	%	81.0
	12252381	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL3616	Homo sapiens	Residual Activity	%	1.0
	12252382	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	100.0	CHEMBL3616	Homo sapiens	Residual Activity	%	100.0
	12252383	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	64.0	CHEMBL3616	Homo sapiens	Residual Activity	%	64.0
	12252384	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	89.0	CHEMBL3616	Homo sapiens	Residual Activity	%	89.0
	12252385	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	5.0	CHEMBL3616	Homo sapiens	Residual Activity	%	5.0
	12252386	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	95.0	CHEMBL3616	Homo sapiens	Residual Activity	%	95.0
	12252387	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	114.0	CHEMBL3616	Homo sapiens	Residual Activity	%	114.0
	12252388	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	73.0	CHEMBL3616	Homo sapiens	Residual Activity	%	73.0
	12252389	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	77.0	CHEMBL3616	Homo sapiens	Residual Activity	%	77.0
	12252390	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	101.0	CHEMBL3616	Homo sapiens	Residual Activity	%	101.0
	12252391	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12252392	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	63.0	CHEMBL3616	Homo sapiens	Residual Activity	%	63.0
	12252393	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	19.0	CHEMBL3616	Homo sapiens	Residual Activity	%	19.0
	12252394	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	90.0	CHEMBL3616	Homo sapiens	Residual Activity	%	90.0
	12252395	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	85.0	CHEMBL3616	Homo sapiens	Residual Activity	%	85.0
	12252396	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	72.0	CHEMBL3616	Homo sapiens	Residual Activity	%	72.0
	12252397	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	26.0	CHEMBL3616	Homo sapiens	Residual Activity	%	26.0
	12252398	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	90.0	CHEMBL3616	Homo sapiens	Residual Activity	%	90.0
	12252399	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	90.0	CHEMBL3616	Homo sapiens	Residual Activity	%	90.0
	12252400	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	86.0	CHEMBL3616	Homo sapiens	Residual Activity	%	86.0
	12252401	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	89.0	CHEMBL3616	Homo sapiens	Residual Activity	%	89.0
	12252402	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	81.0	CHEMBL3616	Homo sapiens	Residual Activity	%	81.0
	12252403	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	7.0	CHEMBL3616	Homo sapiens	Residual Activity	%	7.0
	12252404	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	94.0	CHEMBL3616	Homo sapiens	Residual Activity	%	94.0
	12252405	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	81.0	CHEMBL3616	Homo sapiens	Residual Activity	%	81.0
	12252406	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	93.0	CHEMBL3616	Homo sapiens	Residual Activity	%	93.0
	12252407	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	81.0	CHEMBL3616	Homo sapiens	Residual Activity	%	81.0
	12252408	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	71.0	CHEMBL3616	Homo sapiens	Residual Activity	%	71.0
	12252409	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	80.0	CHEMBL3616	Homo sapiens	Residual Activity	%	80.0
	12252410	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	94.0	CHEMBL3616	Homo sapiens	Residual Activity	%	94.0
	12252411	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	94.0	CHEMBL3616	Homo sapiens	Residual Activity	%	94.0
	12252412	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	68.0	CHEMBL3616	Homo sapiens	Residual Activity	%	68.0
	12252413	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	90.0	CHEMBL3616	Homo sapiens	Residual Activity	%	90.0
	12252414	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	91.0	CHEMBL3616	Homo sapiens	Residual Activity	%	91.0
	12252415	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	80.0	CHEMBL3616	Homo sapiens	Residual Activity	%	80.0
	12252416	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	80.0	CHEMBL3616	Homo sapiens	Residual Activity	%	80.0
	12252417	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	17.0	CHEMBL3616	Homo sapiens	Residual Activity	%	17.0
	12252418	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	60.0	CHEMBL3616	Homo sapiens	Residual Activity	%	60.0
	12252419	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	89.0	CHEMBL3616	Homo sapiens	Residual Activity	%	89.0
	12252420	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	70.0	CHEMBL3616	Homo sapiens	Residual Activity	%	70.0
	12252421	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	95.0	CHEMBL3616	Homo sapiens	Residual Activity	%	95.0
	12252422	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	77.0	CHEMBL3616	Homo sapiens	Residual Activity	%	77.0
	12252423	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	80.0	CHEMBL3616	Homo sapiens	Residual Activity	%	80.0
	12252424	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	75.0	CHEMBL3616	Homo sapiens	Residual Activity	%	75.0
	12252425	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	62.0	CHEMBL3616	Homo sapiens	Residual Activity	%	62.0
	12252426	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12252427	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	81.0	CHEMBL3616	Homo sapiens	Residual Activity	%	81.0
	12252428	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	90.0	CHEMBL3616	Homo sapiens	Residual Activity	%	90.0
	12252429	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	79.0	CHEMBL3616	Homo sapiens	Residual Activity	%	79.0
	12252430	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	94.0	CHEMBL3616	Homo sapiens	Residual Activity	%	94.0
	12252431	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	4.0	CHEMBL3616	Homo sapiens	Residual Activity	%	4.0
	12252432	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12252433	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	76.0	CHEMBL3616	Homo sapiens	Residual Activity	%	76.0
	12252434	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	82.0	CHEMBL3616	Homo sapiens	Residual Activity	%	82.0
	12252435	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	24.0	CHEMBL3616	Homo sapiens	Residual Activity	%	24.0
	12252436	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	64.0	CHEMBL3616	Homo sapiens	Residual Activity	%	64.0
	12252437	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	99.0	CHEMBL3616	Homo sapiens	Residual Activity	%	99.0
	12252438	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	68.0	CHEMBL3616	Homo sapiens	Residual Activity	%	68.0
	12252439	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	55.0	CHEMBL3616	Homo sapiens	Residual Activity	%	55.0
	12252440	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	74.0	CHEMBL3616	Homo sapiens	Residual Activity	%	74.0
	12252441	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	89.0	CHEMBL3616	Homo sapiens	Residual Activity	%	89.0
	12252442	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12252443	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	15.0	CHEMBL3616	Homo sapiens	Residual Activity	%	15.0
	12252444	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	84.0	CHEMBL3616	Homo sapiens	Residual Activity	%	84.0
	12252445	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	92.0	CHEMBL3616	Homo sapiens	Residual Activity	%	92.0
	12252446	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	88.0	CHEMBL3616	Homo sapiens	Residual Activity	%	88.0
	12252447	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	91.0	CHEMBL3616	Homo sapiens	Residual Activity	%	91.0
	12252448	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	106.0	CHEMBL3616	Homo sapiens	Residual Activity	%	106.0
	12252449	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	90.0	CHEMBL3616	Homo sapiens	Residual Activity	%	90.0
	12252450	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	104.0	CHEMBL3616	Homo sapiens	Residual Activity	%	104.0
	12252451	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	73.0	CHEMBL3616	Homo sapiens	Residual Activity	%	73.0
	12252452	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	72.0	CHEMBL3616	Homo sapiens	Residual Activity	%	72.0
	12252453	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	79.0	CHEMBL3616	Homo sapiens	Residual Activity	%	79.0
	12252454	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12252455	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	87.0	CHEMBL3616	Homo sapiens	Residual Activity	%	87.0
	12252456	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	92.0	CHEMBL3616	Homo sapiens	Residual Activity	%	92.0
	12252457	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	90.0	CHEMBL3616	Homo sapiens	Residual Activity	%	90.0
	12252458	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	70.0	CHEMBL3616	Homo sapiens	Residual Activity	%	70.0
	12252459	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12279302	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	93.0	CHEMBL3616	Homo sapiens	Residual Activity	%	93.0
	12279303	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	68.0	CHEMBL3616	Homo sapiens	Residual Activity	%	68.0
	12279304	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	117.0	CHEMBL3616	Homo sapiens	Residual Activity	%	117.0
	12279305	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	115.0	CHEMBL3616	Homo sapiens	Residual Activity	%	115.0
	12279306	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	80.0	CHEMBL3616	Homo sapiens	Residual Activity	%	80.0
	12279307	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	102.0	CHEMBL3616	Homo sapiens	Residual Activity	%	102.0
	12279308	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	96.0	CHEMBL3616	Homo sapiens	Residual Activity	%	96.0
	12279309	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	110.0	CHEMBL3616	Homo sapiens	Residual Activity	%	110.0
	12279310	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	107.0	CHEMBL3616	Homo sapiens	Residual Activity	%	107.0
	12279311	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	93.0	CHEMBL3616	Homo sapiens	Residual Activity	%	93.0
	12279312	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	90.0	CHEMBL3616	Homo sapiens	Residual Activity	%	90.0
	12279313	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	84.0	CHEMBL3616	Homo sapiens	Residual Activity	%	84.0
	12279314	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	85.0	CHEMBL3616	Homo sapiens	Residual Activity	%	85.0
	12279315	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	77.0	CHEMBL3616	Homo sapiens	Residual Activity	%	77.0
	12279316	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	87.0	CHEMBL3616	Homo sapiens	Residual Activity	%	87.0
	12279317	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	115.0	CHEMBL3616	Homo sapiens	Residual Activity	%	115.0
	12279318	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	119.0	CHEMBL3616	Homo sapiens	Residual Activity	%	119.0
	12279319	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	112.0	CHEMBL3616	Homo sapiens	Residual Activity	%	112.0
	12279320	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	98.0	CHEMBL3616	Homo sapiens	Residual Activity	%	98.0
	12279321	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	82.0	CHEMBL3616	Homo sapiens	Residual Activity	%	82.0
	12279322	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	102.0	CHEMBL3616	Homo sapiens	Residual Activity	%	102.0
	12279323	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	91.0	CHEMBL3616	Homo sapiens	Residual Activity	%	91.0
	12279324	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	100.0	CHEMBL3616	Homo sapiens	Residual Activity	%	100.0
	12279325	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	97.0	CHEMBL3616	Homo sapiens	Residual Activity	%	97.0
	12279326	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	116.0	CHEMBL3616	Homo sapiens	Residual Activity	%	116.0
	12279327	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	82.0	CHEMBL3616	Homo sapiens	Residual Activity	%	82.0
	12279328	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	101.0	CHEMBL3616	Homo sapiens	Residual Activity	%	101.0
	12279329	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	94.0	CHEMBL3616	Homo sapiens	Residual Activity	%	94.0
	12279330	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	98.0	CHEMBL3616	Homo sapiens	Residual Activity	%	98.0
	12279331	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	15.0	CHEMBL3616	Homo sapiens	Residual Activity	%	15.0
	12279332	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	92.0	CHEMBL3616	Homo sapiens	Residual Activity	%	92.0
	12279333	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	96.0	CHEMBL3616	Homo sapiens	Residual Activity	%	96.0
	12279334	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	120.0	CHEMBL3616	Homo sapiens	Residual Activity	%	120.0
	12279335	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	94.0	CHEMBL3616	Homo sapiens	Residual Activity	%	94.0
	12279336	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	96.0	CHEMBL3616	Homo sapiens	Residual Activity	%	96.0
	12279337	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	98.0	CHEMBL3616	Homo sapiens	Residual Activity	%	98.0
	12279338	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	102.0	CHEMBL3616	Homo sapiens	Residual Activity	%	102.0
	12279339	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	93.0	CHEMBL3616	Homo sapiens	Residual Activity	%	93.0
	12279340	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	84.0	CHEMBL3616	Homo sapiens	Residual Activity	%	84.0
	12279341	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	102.0	CHEMBL3616	Homo sapiens	Residual Activity	%	102.0
	12279342	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	118.0	CHEMBL3616	Homo sapiens	Residual Activity	%	118.0
	12279343	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	92.0	CHEMBL3616	Homo sapiens	Residual Activity	%	92.0
	12279344	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	72.0	CHEMBL3616	Homo sapiens	Residual Activity	%	72.0
	12279345	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	92.0	CHEMBL3616	Homo sapiens	Residual Activity	%	92.0
	12279346	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	98.0	CHEMBL3616	Homo sapiens	Residual Activity	%	98.0
	12279347	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	64.0	CHEMBL3616	Homo sapiens	Residual Activity	%	64.0
	12279348	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	103.0	CHEMBL3616	Homo sapiens	Residual Activity	%	103.0
	12279349	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	96.0	CHEMBL3616	Homo sapiens	Residual Activity	%	96.0
	12279350	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	117.0	CHEMBL3616	Homo sapiens	Residual Activity	%	117.0
	12279351	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	107.0	CHEMBL3616	Homo sapiens	Residual Activity	%	107.0
	12279352	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	10.0	CHEMBL3616	Homo sapiens	Residual Activity	%	10.0
	12279353	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	95.0	CHEMBL3616	Homo sapiens	Residual Activity	%	95.0
	12279354	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	23.0	CHEMBL3616	Homo sapiens	Residual Activity	%	23.0
	12279355	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	27.0	CHEMBL3616	Homo sapiens	Residual Activity	%	27.0
	12279356	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	93.0	CHEMBL3616	Homo sapiens	Residual Activity	%	93.0
	12279357	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	102.0	CHEMBL3616	Homo sapiens	Residual Activity	%	102.0
	12279358	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	137.0	CHEMBL3616	Homo sapiens	Residual Activity	%	137.0
	12279359	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	106.0	CHEMBL3616	Homo sapiens	Residual Activity	%	106.0
	12279360	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	91.0	CHEMBL3616	Homo sapiens	Residual Activity	%	91.0
	12279361	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	104.0	CHEMBL3616	Homo sapiens	Residual Activity	%	104.0
	12279362	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	95.0	CHEMBL3616	Homo sapiens	Residual Activity	%	95.0
	12279363	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	84.0	CHEMBL3616	Homo sapiens	Residual Activity	%	84.0
	12279364	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	118.0	CHEMBL3616	Homo sapiens	Residual Activity	%	118.0
	12279365	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	116.0	CHEMBL3616	Homo sapiens	Residual Activity	%	116.0
	12279366	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	122.0	CHEMBL3616	Homo sapiens	Residual Activity	%	122.0
	12279367	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	102.0	CHEMBL3616	Homo sapiens	Residual Activity	%	102.0
	12279368	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	118.0	CHEMBL3616	Homo sapiens	Residual Activity	%	118.0
	12279369	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	99.0	CHEMBL3616	Homo sapiens	Residual Activity	%	99.0
	12279370	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	103.0	CHEMBL3616	Homo sapiens	Residual Activity	%	103.0
	12279371	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	98.0	CHEMBL3616	Homo sapiens	Residual Activity	%	98.0
	12279372	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	107.0	CHEMBL3616	Homo sapiens	Residual Activity	%	107.0
	12279373	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	107.0	CHEMBL3616	Homo sapiens	Residual Activity	%	107.0
	12279374	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	9.0	CHEMBL3616	Homo sapiens	Residual Activity	%	9.0
	12279375	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	109.0	CHEMBL3616	Homo sapiens	Residual Activity	%	109.0
	12279376	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	128.0	CHEMBL3616	Homo sapiens	Residual Activity	%	128.0
	12279377	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	111.0	CHEMBL3616	Homo sapiens	Residual Activity	%	111.0
	12279378	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	120.0	CHEMBL3616	Homo sapiens	Residual Activity	%	120.0
	12279379	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	110.0	CHEMBL3616	Homo sapiens	Residual Activity	%	110.0
	12279380	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	111.0	CHEMBL3616	Homo sapiens	Residual Activity	%	111.0
	12279381	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	3.0	CHEMBL3616	Homo sapiens	Residual Activity	%	3.0
	12279382	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	116.0	CHEMBL3616	Homo sapiens	Residual Activity	%	116.0
	12279383	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	90.0	CHEMBL3616	Homo sapiens	Residual Activity	%	90.0
	12279384	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	72.0	CHEMBL3616	Homo sapiens	Residual Activity	%	72.0
	12279385	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	26.0	CHEMBL3616	Homo sapiens	Residual Activity	%	26.0
	12279386	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	102.0	CHEMBL3616	Homo sapiens	Residual Activity	%	102.0
	12279387	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	110.0	CHEMBL3616	Homo sapiens	Residual Activity	%	110.0
	12279388	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	87.0	CHEMBL3616	Homo sapiens	Residual Activity	%	87.0
	12279389	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	79.0	CHEMBL3616	Homo sapiens	Residual Activity	%	79.0
	12279390	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	107.0	CHEMBL3616	Homo sapiens	Residual Activity	%	107.0
	12279391	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	91.0	CHEMBL3616	Homo sapiens	Residual Activity	%	91.0
	12279392	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	77.0	CHEMBL3616	Homo sapiens	Residual Activity	%	77.0
	12279393	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	56.0	CHEMBL3616	Homo sapiens	Residual Activity	%	56.0
	12279394	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	86.0	CHEMBL3616	Homo sapiens	Residual Activity	%	86.0
	12279395	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	79.0	CHEMBL3616	Homo sapiens	Residual Activity	%	79.0
	12279396	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	92.0	CHEMBL3616	Homo sapiens	Residual Activity	%	92.0
	12279397	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	80.0	CHEMBL3616	Homo sapiens	Residual Activity	%	80.0
	12279398	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	106.0	CHEMBL3616	Homo sapiens	Residual Activity	%	106.0
	12279399	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	80.0	CHEMBL3616	Homo sapiens	Residual Activity	%	80.0
	12279400	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12279401	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	78.0	CHEMBL3616	Homo sapiens	Residual Activity	%	78.0
	12279402	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	85.0	CHEMBL3616	Homo sapiens	Residual Activity	%	85.0
	12279403	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	36.0	CHEMBL3616	Homo sapiens	Residual Activity	%	36.0
	12279404	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	101.0	CHEMBL3616	Homo sapiens	Residual Activity	%	101.0
	12279405	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	89.0	CHEMBL3616	Homo sapiens	Residual Activity	%	89.0
	12279406	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	94.0	CHEMBL3616	Homo sapiens	Residual Activity	%	94.0
	12279407	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	88.0	CHEMBL3616	Homo sapiens	Residual Activity	%	88.0
	12279408	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	84.0	CHEMBL3616	Homo sapiens	Residual Activity	%	84.0
	12279409	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	72.0	CHEMBL3616	Homo sapiens	Residual Activity	%	72.0
	12279410	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	94.0	CHEMBL3616	Homo sapiens	Residual Activity	%	94.0
	12279411	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	72.0	CHEMBL3616	Homo sapiens	Residual Activity	%	72.0
	12279412	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	95.0	CHEMBL3616	Homo sapiens	Residual Activity	%	95.0
	12279413	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	101.0	CHEMBL3616	Homo sapiens	Residual Activity	%	101.0
	12279414	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	100.0	CHEMBL3616	Homo sapiens	Residual Activity	%	100.0
	12279415	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	89.0	CHEMBL3616	Homo sapiens	Residual Activity	%	89.0
	12279416	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	86.0	CHEMBL3616	Homo sapiens	Residual Activity	%	86.0
	12279417	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	79.0	CHEMBL3616	Homo sapiens	Residual Activity	%	79.0
	12279418	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	74.0	CHEMBL3616	Homo sapiens	Residual Activity	%	74.0
	12279419	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	78.0	CHEMBL3616	Homo sapiens	Residual Activity	%	78.0
	12279420	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	114.0	CHEMBL3616	Homo sapiens	Residual Activity	%	114.0
	12279421	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	102.0	CHEMBL3616	Homo sapiens	Residual Activity	%	102.0
	12279422	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	96.0	CHEMBL3616	Homo sapiens	Residual Activity	%	96.0
	12279423	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	93.0	CHEMBL3616	Homo sapiens	Residual Activity	%	93.0
	12279424	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	87.0	CHEMBL3616	Homo sapiens	Residual Activity	%	87.0
	12279425	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	59.0	CHEMBL3616	Homo sapiens	Residual Activity	%	59.0
	12279426	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12279427	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	70.0	CHEMBL3616	Homo sapiens	Residual Activity	%	70.0
	12279428	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	100.0	CHEMBL3616	Homo sapiens	Residual Activity	%	100.0
	12279429	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	78.0	CHEMBL3616	Homo sapiens	Residual Activity	%	78.0
	12279430	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	95.0	CHEMBL3616	Homo sapiens	Residual Activity	%	95.0
	12279431	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	30.0	CHEMBL3616	Homo sapiens	Residual Activity	%	30.0
	12279432	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12279433	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	93.0	CHEMBL3616	Homo sapiens	Residual Activity	%	93.0
	12279434	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	86.0	CHEMBL3616	Homo sapiens	Residual Activity	%	86.0
	12279435	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	68.0	CHEMBL3616	Homo sapiens	Residual Activity	%	68.0
	12279436	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12279437	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	97.0	CHEMBL3616	Homo sapiens	Residual Activity	%	97.0
	12279438	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	89.0	CHEMBL3616	Homo sapiens	Residual Activity	%	89.0
	12279439	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12279440	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	76.0	CHEMBL3616	Homo sapiens	Residual Activity	%	76.0
	12279441	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	88.0	CHEMBL3616	Homo sapiens	Residual Activity	%	88.0
	12279442	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	76.0	CHEMBL3616	Homo sapiens	Residual Activity	%	76.0
	12279443	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	66.0	CHEMBL3616	Homo sapiens	Residual Activity	%	66.0
	12279444	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	76.0	CHEMBL3616	Homo sapiens	Residual Activity	%	76.0
	12279445	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	106.0	CHEMBL3616	Homo sapiens	Residual Activity	%	106.0
	12279446	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	94.0	CHEMBL3616	Homo sapiens	Residual Activity	%	94.0
	12279447	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	92.0	CHEMBL3616	Homo sapiens	Residual Activity	%	92.0
	12279448	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	101.0	CHEMBL3616	Homo sapiens	Residual Activity	%	101.0
	12279449	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	93.0	CHEMBL3616	Homo sapiens	Residual Activity	%	93.0
	12279450	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	110.0	CHEMBL3616	Homo sapiens	Residual Activity	%	110.0
	12279451	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	105.0	CHEMBL3616	Homo sapiens	Residual Activity	%	105.0
	12279452	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	84.0	CHEMBL3616	Homo sapiens	Residual Activity	%	84.0
	12279453	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	100.0	CHEMBL3616	Homo sapiens	Residual Activity	%	100.0
	12279454	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	84.0	CHEMBL3616	Homo sapiens	Residual Activity	%	84.0
	12279455	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	111.0	CHEMBL3616	Homo sapiens	Residual Activity	%	111.0
	12279456	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	91.0	CHEMBL3616	Homo sapiens	Residual Activity	%	91.0
	12279457	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	102.0	CHEMBL3616	Homo sapiens	Residual Activity	%	102.0
	12279458	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	100.0	CHEMBL3616	Homo sapiens	Residual Activity	%	100.0
	12279459	CHEMBL2219113	Millipore: Percentage of residual kinase activity of PRKCH at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	85.0	CHEMBL3616	Homo sapiens	Residual Activity	%	85.0
	12279460	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	94.0	CHEMBL3616	Homo sapiens	Residual Activity	%	94.0
	12279461	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	17.0	CHEMBL3616	Homo sapiens	Residual Activity	%	17.0
	12279462	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	87.0	CHEMBL3616	Homo sapiens	Residual Activity	%	87.0
	12279463	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	85.0	CHEMBL3616	Homo sapiens	Residual Activity	%	85.0
	12279464	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	90.0	CHEMBL3616	Homo sapiens	Residual Activity	%	90.0
	12279465	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	76.0	CHEMBL3616	Homo sapiens	Residual Activity	%	76.0
	12279466	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	98.0	CHEMBL3616	Homo sapiens	Residual Activity	%	98.0
	12279467	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	108.0	CHEMBL3616	Homo sapiens	Residual Activity	%	108.0
	12279468	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	111.0	CHEMBL3616	Homo sapiens	Residual Activity	%	111.0
	12279469	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	91.0	CHEMBL3616	Homo sapiens	Residual Activity	%	91.0
	12279470	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	84.0	CHEMBL3616	Homo sapiens	Residual Activity	%	84.0
	12279471	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	82.0	CHEMBL3616	Homo sapiens	Residual Activity	%	82.0
	12279472	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	82.0	CHEMBL3616	Homo sapiens	Residual Activity	%	82.0
	12279473	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	86.0	CHEMBL3616	Homo sapiens	Residual Activity	%	86.0
	12279474	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	58.0	CHEMBL3616	Homo sapiens	Residual Activity	%	58.0
	12279475	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	79.0	CHEMBL3616	Homo sapiens	Residual Activity	%	79.0
	12279476	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	88.0	CHEMBL3616	Homo sapiens	Residual Activity	%	88.0
	12279477	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	86.0	CHEMBL3616	Homo sapiens	Residual Activity	%	86.0
	12279478	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	77.0	CHEMBL3616	Homo sapiens	Residual Activity	%	77.0
	12279479	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	83.0	CHEMBL3616	Homo sapiens	Residual Activity	%	83.0
	12279480	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	81.0	CHEMBL3616	Homo sapiens	Residual Activity	%	81.0
	12279481	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	80.0	CHEMBL3616	Homo sapiens	Residual Activity	%	80.0
	12279482	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	72.0	CHEMBL3616	Homo sapiens	Residual Activity	%	72.0
	12279483	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	75.0	CHEMBL3616	Homo sapiens	Residual Activity	%	75.0
	12279484	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	102.0	CHEMBL3616	Homo sapiens	Residual Activity	%	102.0
	12279485	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	88.0	CHEMBL3616	Homo sapiens	Residual Activity	%	88.0
	12279486	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	77.0	CHEMBL3616	Homo sapiens	Residual Activity	%	77.0
	12279487	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	69.0	CHEMBL3616	Homo sapiens	Residual Activity	%	69.0
	12279488	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	74.0	CHEMBL3616	Homo sapiens	Residual Activity	%	74.0
	12279489	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	2.0	CHEMBL3616	Homo sapiens	Residual Activity	%	2.0
	12279490	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	77.0	CHEMBL3616	Homo sapiens	Residual Activity	%	77.0
	12279491	CHEMBL2219114	Millipore: Percentage of residual kinase activity of PRKCH at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	79.0	CHEMBL3616	Homo sapiens	Residual Activity	%	79.0
	12662199	CHEMBL2330896	Inhibition of PKC eta (unknown origin)	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2Cl)CCN1		CHEMBL2326002	=	Ki	nM	3.5	CHEMBL3616	Homo sapiens	Ki	nM	3.5
	12693188	CHEMBL2343429	Inhibition of PKCeta (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL3616	Homo sapiens	IC50	nM	10000.0
	12727686	CHEMBL2351399	Inhibition of PKCeta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	91.0	CHEMBL3616	Homo sapiens	Activity	%	91.0
	12728972	CHEMBL2350150	Inhibition of PKCeta (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	103.0	CHEMBL3616	Homo sapiens	Activity	%	103.0
	12729853	CHEMBL2352440	Inhibition of PKCeta (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	93.0	CHEMBL3616	Homo sapiens	Activity	%	93.0
	12730115	CHEMBL2351399	Inhibition of PKCeta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	86.0	CHEMBL3616	Homo sapiens	Activity	%	86.0
	13342434	CHEMBL2394159	Competitive binding affinity to PRKCH (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1ccc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1892019	<	Activity	%	10.0	CHEMBL3616	Homo sapiens	Activity	%	10.0
	13374378	CHEMBL2406510	Inhibition of PKCeta (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	10.0	CHEMBL3616	Homo sapiens	INH	%	10.0
	13419742	CHEMBL2422280	Inhibition of PKCeta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	35.0	CHEMBL3616	Homo sapiens	INH	%	35.0
	13419743	CHEMBL2422280	Inhibition of PKCeta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	71.0	CHEMBL3616	Homo sapiens	INH	%	71.0
	13419744	CHEMBL2422280	Inhibition of PKCeta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	61.0	CHEMBL3616	Homo sapiens	INH	%	61.0
	13436876	CHEMBL2421504	Displacement of [3H]PDBu from PKCeta C1B domain (unknown origin)	B	C[C@@H](CCCc1cccc(O)c1)[C@H]1O[C@@]23C[C@H](OC(=O)C[C@H]([C@@H](C)O)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)[C@@H]1C		CHEMBL2418196	=	Ki	nM	0.18	CHEMBL3616	Homo sapiens	Ki	nM	0.18
	13439773	CHEMBL2429014	Competitive binding affinity to PRKCH (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	13442614	CHEMBL2429014	Competitive binding affinity to PRKCH (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	13445606	CHEMBL2429014	Competitive binding affinity to PRKCH (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	13451593	CHEMBL2429014	Competitive binding affinity to PRKCH (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	13871774	CHEMBL3101236	Inhibition of human PKCeta assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	98.0	CHEMBL3616	Homo sapiens	Activity	%	98.0
	13965682	CHEMBL3135232	Inhibition of human truncated PKC eta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	78.5	CHEMBL3616	Homo sapiens	INH	%	78.5
	13966060	CHEMBL3136897	Inhibition of human truncated PKC eta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	52.0	CHEMBL3616	Homo sapiens	INH	%	52.0
	13973335	CHEMBL3135073	Inhibition of human truncated PKC eta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	0.0	CHEMBL3616	Homo sapiens	INH	%	0.0
	13974053	CHEMBL3134713	Inhibition of human truncated PKC eta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	1.0	CHEMBL3616	Homo sapiens	INH	%	1.0
	13974144	CHEMBL3136358	Inhibition of human truncated PKC eta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	54.5	CHEMBL3616	Homo sapiens	INH	%	54.5
	13974235	CHEMBL3135460	Inhibition of human truncated PKC eta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	66.5	CHEMBL3616	Homo sapiens	INH	%	66.5
	13974973	CHEMBL3136995	Inhibition of human truncated PKC eta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	82.0	CHEMBL3616	Homo sapiens	INH	%	82.0
	13975064	CHEMBL3136709	Inhibition of human truncated PKC eta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	34.5	CHEMBL3616	Homo sapiens	INH	%	34.5
	13975155	CHEMBL3134938	Inhibition of human truncated PKC eta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	51.0	CHEMBL3616	Homo sapiens	INH	%	51.0
	13975246	CHEMBL3136527	Inhibition of human truncated PKC eta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	56.5	CHEMBL3616	Homo sapiens	INH	%	56.5
	13975889	CHEMBL3135660	Inhibition of human truncated PKC eta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	82.0	CHEMBL3616	Homo sapiens	INH	%	82.0
	13975982	CHEMBL3136291	Inhibition of human truncated PKC eta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	36.5	CHEMBL3616	Homo sapiens	INH	%	36.5
	13976073	CHEMBL3136057	Inhibition of human truncated PKC eta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	86.5	CHEMBL3616	Homo sapiens	INH	%	86.5
	14585298	CHEMBL3241652	Inhibition of human PKCeta assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	101.0	CHEMBL3616	Homo sapiens	Activity	%	101.0
	14659151	CHEMBL3269726	Inhibition of PKCepsilon (unknown origin) at 50 uM	B	CC(=O)c1cccc(NC(=O)c2sc3nc4cc5c(cc4cc3c2N)OCCO5)c1		CHEMBL3261343	=	Inhibition	%	80.0	CHEMBL3616	Homo sapiens	INH	%	80.0
Not Active	14999386	CHEMBL3368682	Inhibition of human PKCeta at 10 uM relative to control	B	CC(C)(C)C1=NN(c2cccc(Cl)c2)C(c2ccc(F)c(O)c2)C1		CHEMBL3323358		Inhibition	%		CHEMBL3616	Homo sapiens	INH		
	15077439	CHEMBL3387552	Inhibition of human recombinant PKC-eta after 60 mins by 33P-ATP incorporation assay	B	NCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL1214929	=	IC50	nM	5.0	CHEMBL3616	Homo sapiens	IC50	nM	5.0
	15077440	CHEMBL3387552	Inhibition of human recombinant PKC-eta after 60 mins by 33P-ATP incorporation assay	B	CC(C)(N)CNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147538	=	IC50	nM	9.0	CHEMBL3616	Homo sapiens	IC50	nM	9.0
	15077441	CHEMBL3387552	Inhibition of human recombinant PKC-eta after 60 mins by 33P-ATP incorporation assay	B	CC(C)(N)CNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL3338837	=	IC50	nM	75.0	CHEMBL3616	Homo sapiens	IC50	nM	75.0
	15077442	CHEMBL3387552	Inhibition of human recombinant PKC-eta after 60 mins by 33P-ATP incorporation assay	B	CC(C)(N)CNc1nc(-c2ccc3[nH]ncc3c2)nc2cnccc12		CHEMBL3338838	=	IC50	nM	660.0	CHEMBL3616	Homo sapiens	IC50	nM	660.0
	15077443	CHEMBL3387552	Inhibition of human recombinant PKC-eta after 60 mins by 33P-ATP incorporation assay	B	c1cc2c(N3CCNCC3)nc(-c3ccc4[nH]ncc4c3)nc2cn1		CHEMBL3338839	=	IC50	nM	507.0	CHEMBL3616	Homo sapiens	IC50	nM	507.0
	15077444	CHEMBL3387552	Inhibition of human recombinant PKC-eta after 60 mins by 33P-ATP incorporation assay	B	c1ccc2c(N3CCNCC3)nc(-c3ccc4[nH]ncc4c3)nc2c1		CHEMBL3338840	>	IC50	nM	1000.0	CHEMBL3616	Homo sapiens	IC50	nM	1000.0
	15077445	CHEMBL3387552	Inhibition of human recombinant PKC-eta after 60 mins by 33P-ATP incorporation assay	B	c1ccc2c(N3CCNCC3)nc(-c3ccc4[nH]ncc4c3)cc2c1		CHEMBL3338841	>	IC50	nM	1000.0	CHEMBL3616	Homo sapiens	IC50	nM	1000.0
	15077446	CHEMBL3387552	Inhibition of human recombinant PKC-eta after 60 mins by 33P-ATP incorporation assay	B	NCCNc1nc(-c2ccc3[nH]ncc3c2)nc2ccccc12		CHEMBL3338842	>	IC50	nM	1000.0	CHEMBL3616	Homo sapiens	IC50	nM	1000.0
	15077447	CHEMBL3387552	Inhibition of human recombinant PKC-eta after 60 mins by 33P-ATP incorporation assay	B	NCCCNc1nc(-c2ccc3[nH]ncc3c2)nc2ccccc12		CHEMBL3338843	>	IC50	nM	1000.0	CHEMBL3616	Homo sapiens	IC50	nM	1000.0
	15077448	CHEMBL3387552	Inhibition of human recombinant PKC-eta after 60 mins by 33P-ATP incorporation assay	B	CN1CCN(c2nc(-c3ccc4[nH]ncc4c3)nc3ccccc23)CC1		CHEMBL3338844	>	IC50	nM	1000.0	CHEMBL3616	Homo sapiens	IC50	nM	1000.0
Active	15246251	CHEMBL3427908	Inhibition of human N-terminal GST-tagged PKC eta expressed in baculovirus-infected insect cells using PKCe peptide as substrate at 100 nM by radiometric assay in presence of [32P]ATP and lipid activator	B	COC(=O)c1ccc(NC(=O)c2cccc(-c3cc(C(=O)Nc4ccncc4F)ccc3CN)c2)cc1		CHEMBL3426624		Inhibition	%		CHEMBL3616	Homo sapiens	INH		
	15246258	CHEMBL3427915	Inhibition of human N-terminal GST-tagged PKC eta expressed in baculovirus-infected insect cells using PKCe peptide as substrate at 10 nM by radiometric assay in presence of [32P]ATP and lipid activator	B	COC(=O)c1ccc(NC(=O)c2cccc(-c3cc(C(=O)Nc4ccncc4F)ccc3CN)c2)cc1		CHEMBL3426624	>	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	15756852	CHEMBL3630931	Inhibition of PKCeta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	-2.64	CHEMBL3616	Homo sapiens	INH	%	-2.64
	15757871	CHEMBL3630931	Inhibition of PKCeta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	-5.94	CHEMBL3616	Homo sapiens	INH	%	-5.94
	15758850	CHEMBL3630931	Inhibition of PKCeta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	0.75	CHEMBL3616	Homo sapiens	INH	%	0.75
	16426126	CHEMBL3750453	Inhibition of PKCeta (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-8.0	CHEMBL3616	Homo sapiens	INH	%	-8.0
	16431966	CHEMBL3750005	Inhibition of human PKCeta using [ERMRPRKRQGSVRRRV] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3616	Homo sapiens	IC50	uM	10.0
	16451575	CHEMBL3760872	Inhibition of PKCeta (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	15.5	CHEMBL3616	Homo sapiens	INH	%	15.5
	16495188	CHEMBL3777516	Inhibition of N-terminal His6-tagged recombinant human PKCeta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-6.0	CHEMBL3616	Homo sapiens	Activity	%	-6.0
	16496107	CHEMBL3777516	Inhibition of N-terminal His6-tagged recombinant human PKCeta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-2.0	CHEMBL3616	Homo sapiens	Activity	%	-2.0
	16508897	CHEMBL3777516	Inhibition of N-terminal His6-tagged recombinant human PKCeta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-17.0	CHEMBL3616	Homo sapiens	Activity	%	-17.0
	16557689	CHEMBL3796595	Inhibition of human PKC eta at 500 nM	B	Cc1ccc(C(=O)OCc2ccc(C(CN)C(=O)Nc3ccc4cnccc4c3)cc2)c(C)c1		CHEMBL3794389	=	Inhibition	%	93.0	CHEMBL3616	Homo sapiens	INH	%	93.0
	16557701	CHEMBL3796595	Inhibition of human PKC eta at 500 nM	B	NCC(C(=O)Nc1ccc2cnccc2c1)c1ccc(CO)cc1		CHEMBL3792888	=	Inhibition	%	98.0	CHEMBL3616	Homo sapiens	INH	%	98.0
	16614596	CHEMBL3815952	Inhibition of human PKCeta at 1 uM using [ERMRPRKRQGSVRRRV] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-8.0	CHEMBL3616	Homo sapiens	INH	%	-8.0
	16618113	CHEMBL3816499	Inhibition of full length recombinant human His-tagged PKC-eta expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3616	Homo sapiens	INH	%	50.0
	18014658	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cn1cc(C2=C(c3cccc4ccc(CN)cc34)C(=O)NC2=O)c2ccccc21		CHEMBL4083182	>	IC50	nM	316.0	CHEMBL3616	Homo sapiens	IC50	nM	316.0
	18014659	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	NCc1ccc2cccc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4061321	>	IC50	nM	316.0	CHEMBL3616	Homo sapiens	IC50	nM	316.0
	18014660	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cn1cc(C2=C(c3cccc4cc(CN)ccc34)C(=O)NC2=O)c2ccccc21		CHEMBL4072709	=	IC50	nM	308.0	CHEMBL3616	Homo sapiens	IC50	nM	308.0
	18014661	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cc1ccc2ccc(CN)cc2c1C1=C(c2c[nH]c3ccccc23)C(=O)NC1=O		CHEMBL4099609	>	IC50	nM	316.0	CHEMBL3616	Homo sapiens	IC50	nM	316.0
	18014662	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cc1ccc2ccc(CN)cc2c1C1=C(c2cn(C)c3ccccc23)C(=O)NC1=O		CHEMBL4078759	>	IC50	nM	316.0	CHEMBL3616	Homo sapiens	IC50	nM	316.0
	18014663	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cn1cc(C2=C(c3c(Cl)ccc4ccc(CN)cc34)C(=O)NC2=O)c2ccccc21		CHEMBL4089665	>	IC50	nM	316.0	CHEMBL3616	Homo sapiens	IC50	nM	316.0
	18014664	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN(C)Cc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4077967	=	IC50	nM	565.0	CHEMBL3616	Homo sapiens	IC50	nM	565.0
	18014665	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN(C)Cc1ccc2ccc(Cl)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4102228	=	IC50	nM	316.0	CHEMBL3616	Homo sapiens	IC50	nM	316.0
	18014666	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN(C)Cc1ccc2c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c(Cl)ccc2c1		CHEMBL4085837	=	IC50	nM	7.2	CHEMBL3616	Homo sapiens	IC50	nM	7.2
	18014667	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN(C)Cc1ccc2c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c(Cl)ccc2c1		CHEMBL4064291	=	IC50	nM	30.0	CHEMBL3616	Homo sapiens	IC50	nM	30.0
	18014668	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	IC50	nM	6.1	CHEMBL3616	Homo sapiens	IC50	nM	6.1
	18014669	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CNCc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4072879	=	IC50	nM	34.0	CHEMBL3616	Homo sapiens	IC50	nM	34.0
	18014670	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	COCCNCc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4101316	=	IC50	nM	206.0	CHEMBL3616	Homo sapiens	IC50	nM	206.0
	18014671	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CC(C)NCc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4083319	=	IC50	nM	182.0	CHEMBL3616	Homo sapiens	IC50	nM	182.0
	18014672	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cn1cc(C2=C(c3c(Cl)ccc4ccc(CN5CCC5)cc34)C(=O)NC2=O)c2ccccc21		CHEMBL4089217	=	IC50	nM	316.0	CHEMBL3616	Homo sapiens	IC50	nM	316.0
	18014673	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN1CCN(Cc2ccc3ccc(Cl)c(C4=C(c5cn(C)c6ccccc56)C(=O)NC4=O)c3c2)CC1		CHEMBL4068028	=	IC50	nM	316.0	CHEMBL3616	Homo sapiens	IC50	nM	316.0
	18014674	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CC(=O)N(C)Cc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4100747	>	IC50	nM	316.0	CHEMBL3616	Homo sapiens	IC50	nM	316.0
	18014675	CHEMBL4004539	Inhibition of PKCeta (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN(Cc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1)C1CC1		CHEMBL4073977	>	IC50	nM	316.0	CHEMBL3616	Homo sapiens	IC50	nM	316.0
	18114810	CHEMBL4025340	Inhibition of wild-type human partial length PRKCH (S324 to P683 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL3616	Homo sapiens	Activity	%	100.0
	18203864	CHEMBL4044151	Inhibition of wild-type human partial length PRKCH (S324 to P683 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	91.0	CHEMBL3616	Homo sapiens	Activity	%	91.0
	18253301	CHEMBL4054934	Inhibition of wild-type human partial length PKCH (S324 to P683 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	49.0	CHEMBL3616	Homo sapiens	Activity	%	49.0
	18253302	CHEMBL4054934	Inhibition of wild-type human partial length PKCH (S324 to P683 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	70.0	CHEMBL3616	Homo sapiens	Activity	%	70.0
	18265749	CHEMBL4057199	Inhibition of PKC-eta (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	0.3	CHEMBL3616	Homo sapiens	INH	%	0.3
	18265985	CHEMBL4057435	Inhibition of PKC-eta (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	7.0	CHEMBL3616	Homo sapiens	INH	%	7.0
	18282221	CHEMBL4120176	Inhibition of PKCeta (unknown origin) at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	1.7	CHEMBL3616	Homo sapiens	INH	%	1.7
	18282540	CHEMBL4120176	Inhibition of PKCeta (unknown origin) at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	-3.9	CHEMBL3616	Homo sapiens	INH	%	-3.9
	18282744	CHEMBL4120329	Inhibition of PKC-eta (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	0.3	CHEMBL3616	Homo sapiens	INH	%	0.3
	18282971	CHEMBL4120556	Inhibition of PKC-eta (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	2.7	CHEMBL3616	Homo sapiens	INH	%	2.7
	18283140	CHEMBL4120725	Inhibition of PKC-eta (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-4.7	CHEMBL3616	Homo sapiens	INH	%	-4.7
	18440406	CHEMBL4157230	Binding affinity to wild-type human partial length PRKCH (S324 to P683 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	81.0	CHEMBL3616	Homo sapiens	Activity	%	81.0
	18463790	CHEMBL4181206	Inhibition of recombinant human N-terminal His6-tagged PKCeta (2 to end residues) expressed in Sf21 cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	2.0	CHEMBL3616	Homo sapiens	INH	%	2.0
	18484362	CHEMBL4186009	Binding affinity to wild-type human partial length PRKCH (S324 to P683 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL3616	Homo sapiens	Activity	%	100.0
	18484846	CHEMBL4186009	Binding affinity to wild-type human partial length PRKCH (S324 to P683 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL3616	Homo sapiens	Activity	%	100.0
	18507647	CHEMBL4191144	Inhibition of recombinant human PKCeta (2 to end residues) at 1 uM using ERMRPRKRQGSVRRRV as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	6.0	CHEMBL3616	Homo sapiens	INH	%	6.0
	18653425	CHEMBL4230191	Inhibition of PKC-eta (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	-5.0	CHEMBL3616	Homo sapiens	INH	%	-5.0
	18653426	CHEMBL4230191	Inhibition of PKC-eta (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	2.0	CHEMBL3616	Homo sapiens	INH	%	2.0
	18655326	CHEMBL4230909	Binding affinity to wild-type human partial length PRKCH (S324 to P683 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	86.0	CHEMBL3616	Homo sapiens	Activity	%	86.0
Not Active	18726761	CHEMBL4259285	Inhibition of PKCeta (unknown origin) at 10 uM	B	Oc1ccc(C2=NN(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)C2)cc1O		CHEMBL4283413		Inhibition	%		CHEMBL3616	Homo sapiens	INH		
	18751204	CHEMBL4263913	Inhibition of PKC-ETA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	1.0	CHEMBL3616	Homo sapiens	INH	%	1.0
	18752161	CHEMBL4264498	Binding affinity to wild-type human partial length PRKCH (S324 to P683 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	98.0	CHEMBL3616	Homo sapiens	Activity	%	98.0
	18811794	CHEMBL4276098	Inhibition of recombinant N-terminal GST-fused full-length human PKCeta expressed in Baculovirus expression system using STK1-biotin as substrate after 1 hr in presence of ATP by TR-FRET analysis	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](NCCO)[C@H](C3)C2		CHEMBL4289707	>	IC50	nM	300.0	CHEMBL3616	Homo sapiens	IC50	nM	300.0
	18858161	CHEMBL4308007	Binding affinity to wild-type human partial length PRKCH (S324 to P683 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	99.0	CHEMBL3616	Homo sapiens	Activity	%	99.0
Not Active	18883534	CHEMBL4312757	Activity at human PKCeta at 10 uM	B	CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)[C@H](F)[C@@H]2F		CHEMBL4585668		Activity			CHEMBL3616	Homo sapiens	Activity		
	18892692	CHEMBL4314558	Inhibition of recombinant human PKCeta V108L/G109R/L392Q mutant (2 to end residues) assessed as residual activity at 10 uM using ERMRPRKRQGSVRRRV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	98.5	CHEMBL3616	Homo sapiens	Activity	%	98.5
	18919543	CHEMBL4322899	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged PRKCH (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	61.0	CHEMBL3616	Homo sapiens	Kd	nM	61.0
	18919731	CHEMBL4322899	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged PRKCH (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	37.0	CHEMBL3616	Homo sapiens	Kd	nM	37.0
	18938223	CHEMBL4327838	Inhibition of human PKCeta assessed as residual activity at 1 uM using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	101.85	CHEMBL3616	Homo sapiens	Activity	%	101.85
	18938224	CHEMBL4327838	Inhibition of human PKCeta assessed as residual activity at 1 uM using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	104.08	CHEMBL3616	Homo sapiens	Activity	%	104.08
	18938683	CHEMBL4328202	Inhibition of human PKCeta assessed as residual activity at 100 uM using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3616	Homo sapiens	Activity	%	65.0
	18939067	CHEMBL4328566	Inhibition of human PKCeta using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.251	CHEMBL3616	Homo sapiens	IC50	10'-10M	2.51
	18958599	CHEMBL4333592	Binding affinity to wild-type human partial length PRKCH (S324 to P683 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	84.0	CHEMBL3616	Homo sapiens	Activity	%	84.0
	18964604	CHEMBL4335243	Inhibition of recombinant human PKCeta V108L/G109R/L392Q mutant (2 to end residues) assessed as residual activity at 1 uM using ERMRPRKRQGSVRRRV as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	101.0	CHEMBL3616	Homo sapiens	Activity	%	101.0
	18964605	CHEMBL4335243	Inhibition of recombinant human PKCeta V108L/G109R/L392Q mutant (2 to end residues) assessed as residual activity at 1 uM using ERMRPRKRQGSVRRRV as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	99.0	CHEMBL3616	Homo sapiens	Activity	%	99.0
	18972056	CHEMBL4337066	Inhibition of recombinant human PKCeta V108L/G109R/L392Q mutant (2 to end residues) assessed as residual activity at 10 uM using ERMRPRKRQGSVRRRV as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	82.0	CHEMBL3616	Homo sapiens	Activity	%	82.0
	19009307	CHEMBL4345218	Inhibition of wild type human partial length PRKCH (S324 to P683 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CCN(CC)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4452939	>	Inhibition	%	80.0	CHEMBL3616	Homo sapiens	INH	%	80.0
Not Active	19040115	CHEMBL4352018	Inhibition of recombinant human PKCeta V108L/G109R/L392Q mutant (2 to end residues) at 10 uM using ERMRPRKRQGSVRRRV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3616	Homo sapiens	INH		
Active	19041244	CHEMBL4352505	Inhibition of human PKCeta at 10 uM using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3616	Homo sapiens	INH		
	19059786	CHEMBL4358087	Binding affinity to wild-type human partial length PRKCH (S324 to P683 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL3616	Homo sapiens	Activity	%	100.0
	19090350	CHEMBL4365924	Inhibition of wild-type human partial length PRKCH (S324 to P683 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL3616	Homo sapiens	Activity	%	100.0
	19092076	CHEMBL4366550	Inhibition of human PKCeta at 100 nM using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	17.98	CHEMBL3616	Homo sapiens	INH	%	17.98
	19144803	CHEMBL4377819	Inhibition of recombinant human PKCeta V108L/G109R/L392Q mutant (2 to end residues) at 1 uM using ERMRPRKRQGSVRRRV as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	-3.0	CHEMBL3616	Homo sapiens	INH	%	-3.0
	19159614	CHEMBL4382718	Binding affinity to wild-type human partial length PRKCH (S324 to P683 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	100.0	CHEMBL3616	Homo sapiens	Activity	%	100.0
	19181118	CHEMBL4387329	Inhibition of recombinant full length human His-tagged PKCeta expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	35.0	CHEMBL3616	Homo sapiens	INH	%	35.0
	19181343	CHEMBL4387329	Inhibition of recombinant full length human His-tagged PKCeta expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	15.5	CHEMBL3616	Homo sapiens	INH	%	15.5
	19191393	CHEMBL4389437	Inhibition of wild-type human partial length PRKCH (S324 to P683 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	71.0	CHEMBL3616	Homo sapiens	INH	%	71.0
	19192100	CHEMBL4389914	Inhibition of wild-type human partial length PRKCH (S324 to P683 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	80.0	CHEMBL3616	Homo sapiens	INH	%	80.0
	19200356	CHEMBL4391540	Binding affinity to wild-type human partial length PRKCH (S324 to P683 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	3.9	CHEMBL3616	Homo sapiens	Activity	%	3.9
	19276103	CHEMBL4408106	Inhibition of recombinant human full length PKCeta (2 to end residues) at 1 uM using ERMRPRKRQGSVRRRV as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	17.0	CHEMBL3616	Homo sapiens	INH	%	17.0
	20600643	CHEMBL4603595	Inhibition of recombinant full length human His-tagged PRKCH expressed in baculovirus expression system using serine/threonine-7 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3616	Homo sapiens	IC50	uM	100.0
	22392138	CHEMBL4667233	Inhibition of recombinant human His-tagged full length PKCeta expressed in baculovirus expression system using Ser/Thr 07 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	5.0	CHEMBL3616	Homo sapiens	INH	%	5.0
	22423323	CHEMBL4674237	Inhibition of human PKCeta using ERMRPRKRQGSVRRRV as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	98.75	CHEMBL3616	Homo sapiens	Activity	%	98.75
	22423324	CHEMBL4674237	Inhibition of human PKCeta using ERMRPRKRQGSVRRRV as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	95.64	CHEMBL3616	Homo sapiens	Activity	%	95.64
	22770401	CHEMBL4704298	Inhibition of PKCeta (unknown origin) at 1 uM relative to control	B	Cc1cn([C@@H](C)[C@]2(F)CCNC2)c2nc(C(N)=O)cc(Cl)c12		CHEMBL4778578	=	Inhibition	%	57.0	CHEMBL3616	Homo sapiens	INH	%	57.0
	22843605	CHEMBL4720591	Inhibition of human PKCeta using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.17	CHEMBL3616	Homo sapiens	IC50	10^-9M	1.17
	22843950	CHEMBL4720936	Inhibition of human PKCeta assessed as residual activity using ERMRPRKRQGSVRRRV as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	99.68	CHEMBL3616	Homo sapiens	Activity	%	99.68
	22844831	CHEMBL4721506	Inhibition of PKCeta (unknown origin) assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	99.2	CHEMBL3616	Homo sapiens	Activity	%	99.2
	22952963	CHEMBL4766900	Inhibition of recombinant human PKCeta (2 to end residues) assessed as residual activity at 10 uM using ERMRPRKRQGSVRRRV as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	115.0	CHEMBL3616	Homo sapiens	Activity	%	115.0
	23122771	CHEMBL4805122	Inhibition of human PRKCH assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	91.0	CHEMBL3616	Homo sapiens	Activity	%	91.0
	23123466	CHEMBL4805710	Inhibition of human PRKCH assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	81.0	CHEMBL3616	Homo sapiens	Activity	%	81.0
	23123921	CHEMBL4806165	Inhibition of DNA-tagged human PRKCH assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL3616	Homo sapiens	Activity	%	100.0
	23125022	CHEMBL4806727	Inhibition of human PRKCH assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	80.0	CHEMBL3616	Homo sapiens	Activity	%	80.0
	23125023	CHEMBL4806727	Inhibition of human PRKCH assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	96.0	CHEMBL3616	Homo sapiens	Activity	%	96.0
	23128467	CHEMBL4807964	Inhibition of PKCeta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL3616	Homo sapiens	Activity	%	75.0
	23128468	CHEMBL4807964	Inhibition of PKCeta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL3616	Homo sapiens	Activity	%	75.0
	23128469	CHEMBL4807964	Inhibition of PKCeta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL3616	Homo sapiens	Activity	%	75.0
	23246345	CHEMBL4830037	Inhibition of PKCeta (unknown origin)	B	Cl.Cn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)c(F)c1		CHEMBL4556790	>	IC50	nM	2000.0	CHEMBL3616	Homo sapiens	IC50	nM	2000.0
Not Active	23317607	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23318075	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	68.0	CHEMBL3616	Homo sapiens	% Control	%	68.0
Not Active	23318741	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	94.0	CHEMBL3616	Homo sapiens	% Control	%	94.0
Not Active	23319225	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	95.0	CHEMBL3616	Homo sapiens	% Control	%	95.0
Not Active	23319862	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Active	23320337	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	0.0	CHEMBL3616	Homo sapiens	% Control	%	0.0
Not Active	23321015	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	89.0	CHEMBL3616	Homo sapiens	% Control	%	89.0
Not Active	23321483	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23322113	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23322581	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23323270	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	96.0	CHEMBL3616	Homo sapiens	% Control	%	96.0
Not Active	23323738	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23324105	CHEMBL4880724	PKCeta (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-3.0	CHEMBL3616	Homo sapiens	% inhibition	%	-3.0
Not Active	23324592	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	96.1	CHEMBL3616	Homo sapiens	% Control	%	96.1
Not Active	23325227	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	89.0	CHEMBL3616	Homo sapiens	% Control	%	89.0
Not Active	23325695	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23326342	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	93.0	CHEMBL3616	Homo sapiens	% Control	%	93.0
Not Active	23326810	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23327510	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23327978	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	96.0	CHEMBL3616	Homo sapiens	% Control	%	96.0
Not Active	23328565	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	95.0	CHEMBL3616	Homo sapiens	% Control	%	95.0
Not Active	23329033	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	97.0	CHEMBL3616	Homo sapiens	% Control	%	97.0
Not Active	23329486	CHEMBL4881193	PKCeta (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	115.0	CHEMBL3616	Homo sapiens	% residual kinase activity	%	115.0
Not Active	23329979	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	86.0	CHEMBL3616	Homo sapiens	% Control	%	86.0
Not Active	23330447	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	88.0	CHEMBL3616	Homo sapiens	% Control	%	88.0
Not Active	23331203	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23331671	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	95.0	CHEMBL3616	Homo sapiens	% Control	%	95.0
Not Active	23332258	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	99.5	CHEMBL3616	Homo sapiens	% Control	%	99.5
Not Active	23332724	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23333442	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	91.3	CHEMBL3616	Homo sapiens	% Control	%	91.3
Not Active	23334081	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23334549	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23334942	CHEMBL4881564	PKCeta  (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	24.0	CHEMBL3616	Homo sapiens	% inhibition	%	24.0
Not Active	23335528	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	74.0	CHEMBL3616	Homo sapiens	% Control	%	74.0
Not Active	23335996	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	98.0	CHEMBL3616	Homo sapiens	% Control	%	98.0
Not Active	23336623	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23337091	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	98.0	CHEMBL3616	Homo sapiens	% Control	%	98.0
Not Active	23337740	CHEMBL4882111	PRKCH Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	86.0	CHEMBL3616	Homo sapiens	% Ctrl	%	86.0
Not Active	23338172	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23338640	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	91.0	CHEMBL3616	Homo sapiens	% Control	%	91.0
Not Active	23339252	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	94.0	CHEMBL3616	Homo sapiens	% Control	%	94.0
Not Active	23339720	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23340357	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23340825	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	80.0	CHEMBL3616	Homo sapiens	% Control	%	80.0
Not Active	23341482	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23341950	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23342566	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	96.0	CHEMBL3616	Homo sapiens	% Control	%	96.0
Not Active	23343034	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	95.0	CHEMBL3616	Homo sapiens	% Control	%	95.0
Not Active	23343664	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	87.0	CHEMBL3616	Homo sapiens	% Control	%	87.0
Not Active	23344132	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	84.0	CHEMBL3616	Homo sapiens	% Control	%	84.0
Not Active	23344770	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23345343	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23345811	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	91.0	CHEMBL3616	Homo sapiens	% Control	%	91.0
Not Active	23346388	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	97.5	CHEMBL3616	Homo sapiens	% Control	%	97.5
Not Active	23346856	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	74.6	CHEMBL3616	Homo sapiens	% Control	%	74.6
Not Active	23347458	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	90.1	CHEMBL3616	Homo sapiens	% Control	%	90.1
Not Active	23347948	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	95.4	CHEMBL3616	Homo sapiens	% Control	%	95.4
Not Active	23348527	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23348995	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	91.0	CHEMBL3616	Homo sapiens	% Control	%	91.0
Not Active	23349582	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	99.0	CHEMBL3616	Homo sapiens	% Control	%	99.0
Not Active	23350200	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23350668	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	73.0	CHEMBL3616	Homo sapiens	% Control	%	73.0
Not Active	23351273	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23351741	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23352193	CHEMBL4882882	PRKCH (PKC eta) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	6.398	CHEMBL3616	Homo sapiens	% Inhibition	%	6.3978
Not Active	23352765	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	92.0	CHEMBL3616	Homo sapiens	% Control	%	92.0
Not Active	23353233	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23354115	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23354583	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23355315	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	97.0	CHEMBL3616	Homo sapiens	% Control	%	97.0
Not Active	23355783	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	94.0	CHEMBL3616	Homo sapiens	% Control	%	94.0
Not Active	23356419	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	98.0	CHEMBL3616	Homo sapiens	% Control	%	98.0
Not Active	23356887	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23357496	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	75.0	CHEMBL3616	Homo sapiens	% Control	%	75.0
Not Active	23358143	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	77.0	CHEMBL3616	Homo sapiens	% Control	%	77.0
Not Active	23358611	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23359197	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	83.7	CHEMBL3616	Homo sapiens	% Control	%	83.7
Not Active	23359795	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23360263	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	98.0	CHEMBL3616	Homo sapiens	% Control	%	98.0
Not Active	23360848	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	90.0	CHEMBL3616	Homo sapiens	% Control	%	90.0
Not Active	23361316	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	80.0	CHEMBL3616	Homo sapiens	% Control	%	80.0
Not Active	23361889	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	94.0	CHEMBL3616	Homo sapiens	% Control	%	94.0
Not Active	23362425	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	97.0	CHEMBL3616	Homo sapiens	% Control	%	97.0
Not Active	23362893	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	83.0	CHEMBL3616	Homo sapiens	% Control	%	83.0
Not Active	23364535	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	60.0	CHEMBL3616	Homo sapiens	% Control	%	60.0
Not Active	23365003	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23365742	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	74.0	CHEMBL3616	Homo sapiens	% Control	%	74.0
Not Active	23366285	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	94.0	CHEMBL3616	Homo sapiens	% Control	%	94.0
Not Active	23366875	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	98.0	CHEMBL3616	Homo sapiens	% Control	%	98.0
Not Active	23367343	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23367707	CHEMBL4884060	PKC-eta ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	97.0	CHEMBL3616	Homo sapiens	% Residual activity with Skepinone-L	%	97.0
Not Active	23368221	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	76.0	CHEMBL3616	Homo sapiens	% Control	%	76.0
Not Active	23368689	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	93.0	CHEMBL3616	Homo sapiens	% Control	%	93.0
Not Active	23369288	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	84.0	CHEMBL3616	Homo sapiens	% Control	%	84.0
Not Active	23369756	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23370202	CHEMBL4884444	PKCeta (h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	92.0	CHEMBL3616	Homo sapiens	% residual kinase activity	%	92.0
Slightly Active	23370724	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	32.0	CHEMBL3616	Homo sapiens	% Control	%	32.0
Not Active	23371192	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	94.0	CHEMBL3616	Homo sapiens	% Control	%	94.0
Not Active	23372001	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	95.0	CHEMBL3616	Homo sapiens	% Control	%	95.0
Not Active	23372469	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	79.0	CHEMBL3616	Homo sapiens	% Control	%	79.0
	23372863	CHEMBL4884828	PKCeta(PRKHLGRA) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL3616	Homo sapiens	pIC50		6.0
	23373272	CHEMBL4885119	PKCeta(PRKHLGRA) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL3616	Homo sapiens	pIC50		6.0
	23373628	CHEMBL4885405	PKCeta(PRKHLGRA) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3616	Homo sapiens	pIC50		6.0
Not Active	23375073	CHEMBL4886061	PKC_eta Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	8.0	CHEMBL3616	Homo sapiens	% Inhibition	%	8.0
Not Active	23375347	CHEMBL4886329	protein kinase C, eta  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-2.0	CHEMBL3616	Homo sapiens	% inhibition	%	-2.0
Not Active	23375896	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	86.0	CHEMBL3616	Homo sapiens	% Control	%	86.0
Not Active	23376364	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	97.0	CHEMBL3616	Homo sapiens	% Control	%	97.0
Not Active	23376941	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	98.0	CHEMBL3616	Homo sapiens	% Control	%	98.0
Not Active	23377409	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23378269	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	93.0	CHEMBL3616	Homo sapiens	% Control	%	93.0
Not Active	23378737	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	87.0	CHEMBL3616	Homo sapiens	% Control	%	87.0
Not Active	23379904	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23380372	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23381066	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23381714	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	90.0	CHEMBL3616	Homo sapiens	% Control	%	90.0
Not Active	23382182	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23382806	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	86.0	CHEMBL3616	Homo sapiens	% Control	%	86.0
Not Active	23383274	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL3616	Homo sapiens	% Control	%	100.0
Not Active	23383953	CHEMBL4887560	PRKCH Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	100.0	CHEMBL3616	Homo sapiens	% Ctrl	%	100.0
Not Active	23384422	CHEMBL4888017	PKCeta(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	3.77	CHEMBL3616	Homo sapiens	% inhibition	%	3.77
Not Active	23384694	CHEMBL4888220	PRKCH (PKC eta) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	-2.0	CHEMBL3616	Homo sapiens	% Inhibition	%	-2.0
Not Active	23385189	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	86.0	CHEMBL3616	Homo sapiens	% Control	%	86.0
Not Active	23385656	CHEMBL4879913	KinomeScan assay: inhibition of PRKCH	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	78.0	CHEMBL3616	Homo sapiens	% Control	%	78.0
